{"meta":{"query_hash":"cef24c963283","filters":{"venue":"Journal of the National Comprehensive Cancer Network"},"cohort_total":168,"direct_labels_cover":0,"predictions_cover":168,"exported":168,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/cef24c963283","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+the+National+Comprehensive+Cancer+Network"},"results":[{"id":"W1784289554","doi":"10.6004/jnccn.2010.0069","title":"Exercise Programs for Cancer-Related Fatigue: Evidence and Clinical Guidelines","year":2010,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aerobic exercise; Cancer-related fatigue; Survivorship curve; Physical therapy; Physical activity; Clinical trial; Resistance training; Prostate cancer; Physical fitness; Cancer; Exercise therapy; Physical exercise; Physical medicine and rehabilitation; Randomized controlled trial; Oncology; Internal medicine","score_opus":0.3671629895005242,"score_gpt":0.5143988378637816,"score_spread":0.14723584836325743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1784289554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061717794,0.9862149,0.000018509752,0.002316423,0.009493303,0.0017803758,0.00006972384,0.000018817405,0.000026241025],"genre_scores_gemma":[0.000045290308,0.9886074,0.0009549047,0.0009996872,0.008639175,0.00021932906,0.000016241916,0.00006476562,0.00045318244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609745,0.00021207402,0.0020514783,0.00036366296,0.0009622346,0.00031311918],"domain_scores_gemma":[0.9886519,0.0013810792,0.0024901186,0.00023864795,0.006994263,0.00024400756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008801229,0.0004252213,0.0022253687,0.000116013354,0.00018033641,0.00006069368,0.00048272268,0.00055377383,0.000044312845],"category_scores_gemma":[0.00066453114,0.00025481047,0.0016149249,0.0005609181,0.0002045238,0.00011305267,0.00013622432,0.0016185137,0.0000011252879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018646396,0.00005526646,0.00036538206,0.004239657,0.00089724595,0.0000040128602,0.00003996964,0.00009066414,2.9169502e-7,0.00003775379,0.06483889,0.9292444],"study_design_scores_gemma":[0.0006777078,0.0001614164,0.00025427065,0.09318515,0.0043743458,0.00016792964,0.000013084074,0.00010910487,2.658182e-7,0.00029863892,0.90053093,0.00022716126],"about_ca_topic_score_codex":0.000051860403,"about_ca_topic_score_gemma":0.00020107263,"teacher_disagreement_score":0.92901725,"about_ca_system_score_codex":0.00039096424,"about_ca_system_score_gemma":0.0028581086,"threshold_uncertainty_score":0.9999904},"labels":[],"label_agreement":null},{"id":"W1808718376","doi":"10.6004/jnccn.2013.0217","title":"Emerging Treatments in Recurrent and Metastatic Colorectal Cancer","year":2013,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Sanofi; Bayer HealthCare; Regeneron Pharmaceuticals; Amgen; Pfizer; Oncolytics Biotech; Eli Lilly and Company; Bristol-Myers Squibb; Genentech; Bayer","keywords":"Medicine; Bevacizumab; Cetuximab; Regorafenib; Panitumumab; Colorectal cancer; Aflibercept; Oncology; Chemotherapy; Targeted therapy; Epidermal growth factor receptor; Internal medicine; Cancer","score_opus":0.10690245731208563,"score_gpt":0.4167122480531281,"score_spread":0.3098097907410425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1808718376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023434898,0.9942875,4.8003704e-7,0.0005253015,0.0015671966,0.0010328739,0.0000634512,0.0000041332837,0.00017556487],"genre_scores_gemma":[0.0006255849,0.99731636,0.00013354806,0.00024684242,0.0010616106,0.00031170328,0.000006775538,0.00003237521,0.00026518255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783397,0.00019034442,0.000831212,0.00023520278,0.00063790544,0.0002713581],"domain_scores_gemma":[0.9975765,0.00036697896,0.0010623679,0.000072671566,0.0008166432,0.00010483626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011254103,0.00038796684,0.001819562,0.00018931694,0.00013267963,0.000027260881,0.00014957001,0.00008528445,0.00011648854],"category_scores_gemma":[0.000057789697,0.00021073758,0.00052347226,0.0005234332,0.00009481205,0.00007697931,0.000120007084,0.0005555716,0.0000021994813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024874628,0.00016018984,0.0011776189,0.0021957438,0.0046207816,0.000035388417,0.00018135131,0.0003904116,0.0000012537885,0.000028228087,0.017153993,0.9738063],"study_design_scores_gemma":[0.0017141328,0.00036953276,0.008295878,0.022468088,0.0037773575,0.0002894176,0.00004638064,0.000057402307,9.0818565e-7,0.00023065378,0.9625199,0.0002303438],"about_ca_topic_score_codex":0.00007558478,"about_ca_topic_score_gemma":0.00009847797,"teacher_disagreement_score":0.97357595,"about_ca_system_score_codex":0.0017167977,"about_ca_system_score_gemma":0.00088709436,"threshold_uncertainty_score":0.8593629},"labels":[],"label_agreement":null},{"id":"W1880033105","doi":"10.6004/jnccn.2014.0007","title":"The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec; Montreal General Hospital; Juravinski Cancer Centre; Kingston Health Sciences Centre; Cancer Care South East; BC Cancer Agency; Kelowna General Hospital; Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"Ontario Institute for Cancer Research; Association of Canadian Universities for Research in Astronomy; Canadian Association of Radiation Oncology; National Comprehensive Cancer Network; American Society for Radiation Oncology","keywords":"Medicine; Prostate cancer; Brachytherapy; Radiation therapy; Oncology; Proportional hazards model; Risk stratification; Database; Internal medicine; Prostate; Survival analysis; Gynecology; Cancer","score_opus":0.05022082447700471,"score_gpt":0.3718909252158641,"score_spread":0.3216701007388594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1880033105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671404,0.017683614,0.0014444838,0.009801945,0.0014810562,0.0016267492,0.00043786757,0.000024596478,0.00035933824],"genre_scores_gemma":[0.97295415,0.023810191,0.0011106519,0.0002236298,0.0013183958,0.000087687105,0.000044224285,0.000016946155,0.00043410674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763584,0.0004184182,0.000619889,0.00022500817,0.00087544747,0.00022537755],"domain_scores_gemma":[0.99563223,0.00053280627,0.001253024,0.00022185601,0.002264457,0.00009562888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007219675,0.00016489017,0.00032132136,0.00014621466,0.00075538445,0.00010969763,0.00017830246,0.00006212396,0.000021708975],"category_scores_gemma":[0.00027788614,0.000087193825,0.00019247332,0.0009156253,0.00029721737,0.00018381941,0.000043900938,0.000573181,0.0000010788439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015033055,0.0000748779,0.911609,0.00006902615,0.003469337,0.0000013346997,0.00034717616,0.034125954,0.0010582177,0.0013871376,0.00750285,0.038851812],"study_design_scores_gemma":[0.0025697993,0.00021778567,0.94442284,0.00018442872,0.0033408115,0.000039386603,0.00043608795,0.02152839,0.00053469243,0.0036004155,0.022931704,0.00019367812],"about_ca_topic_score_codex":0.0002588343,"about_ca_topic_score_gemma":0.00029853077,"teacher_disagreement_score":0.03865813,"about_ca_system_score_codex":0.0003464057,"about_ca_system_score_gemma":0.00052709493,"threshold_uncertainty_score":0.5809883},"labels":[],"label_agreement":null},{"id":"W1897199628","doi":"10.6004/jnccn.2004.0034","title":"Point: Fluoroquinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Cancer Patients Works for Defined Outcomes in Defined Populations, but Must Be Used Wisely","year":2004,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Chemoprophylaxis; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.10731921514213227,"score_gpt":0.37975980239786516,"score_spread":0.2724405872557329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897199628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04610142,0.938284,0.00002697595,0.0032823486,0.007279681,0.0043095695,0.0006638241,0.000024871562,0.00002735431],"genre_scores_gemma":[0.057397205,0.93205935,0.0012568806,0.0032079439,0.003939496,0.0012275514,0.0004701093,0.0002574486,0.00018399756],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574775,0.0002682042,0.0020004872,0.0004642823,0.00096183177,0.00055743736],"domain_scores_gemma":[0.99495494,0.0005628391,0.002100736,0.00028317803,0.0019405915,0.00015771073],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025573254,0.00063581986,0.0026273807,0.0006263629,0.00020479856,0.000081192135,0.0005049827,0.00042531194,0.00012390828],"category_scores_gemma":[0.00027988196,0.0004507234,0.0013263902,0.0013789278,0.000116466676,0.0002310373,0.00010268653,0.001255409,0.0000023346067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016316628,0.007333286,0.33220184,0.041100975,0.007815141,0.00016747502,0.00047658803,0.27688116,0.0002838517,0.0021246858,0.05250267,0.26279572],"study_design_scores_gemma":[0.033668138,0.0012705864,0.23076704,0.09462913,0.0037279157,0.00011614512,0.000025490706,0.00011181722,0.00004098934,0.0011289543,0.6328958,0.0016179545],"about_ca_topic_score_codex":0.00032060282,"about_ca_topic_score_gemma":0.00079080975,"teacher_disagreement_score":0.5803932,"about_ca_system_score_codex":0.0038672192,"about_ca_system_score_gemma":0.003827742,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W1897407769","doi":"10.6004/jnccn.2014.0074","title":"Intermittent Versus Continuous Androgen Deprivation Therapy","year":2014,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Prostatectomy; Clinical endpoint; Oncology; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Prostate-specific antigen; Cancer","score_opus":0.15959646740038702,"score_gpt":0.43107974396040766,"score_spread":0.27148327656002064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897407769","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001714225,0.9949968,0.000013467556,0.00073540444,0.0028738882,0.0007722889,0.000021471946,0.000008273745,0.00040699638],"genre_scores_gemma":[0.00029155324,0.9932159,0.000081031045,0.0006447727,0.005135485,0.00004887611,0.000027830556,0.00004307363,0.00051143783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974715,0.00027233185,0.00076657714,0.00019750975,0.0010294075,0.00026267185],"domain_scores_gemma":[0.9958047,0.00056182826,0.0012432976,0.00018006522,0.0020840126,0.00012607056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000262655,0.00030358482,0.0014039393,0.00015707123,0.00013780996,0.000039638082,0.0003790429,0.00018451411,0.000089291],"category_scores_gemma":[0.00011265045,0.00015986321,0.0010111035,0.00042426007,0.00010828006,0.00005906526,0.00009898348,0.00078302005,0.000010744719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013417827,0.0000801136,0.00015139136,0.0013243181,0.0031062828,0.000019770989,0.000030430685,0.00024106566,0.000002839593,0.00007744274,0.072981276,0.92064327],"study_design_scores_gemma":[0.0029959248,0.00035452028,0.000309286,0.009770046,0.0006923723,0.00018751115,0.000006179833,0.000018110952,0.000005199809,0.00013662333,0.9853852,0.00013903854],"about_ca_topic_score_codex":0.0000033531885,"about_ca_topic_score_gemma":0.000001371956,"teacher_disagreement_score":0.9205043,"about_ca_system_score_codex":0.00099659,"about_ca_system_score_gemma":0.0012806045,"threshold_uncertainty_score":0.6519032},"labels":[],"label_agreement":null},{"id":"W1920790082","doi":"10.6004/jnccn.2013.0019","title":"Defining Cancer Care Quality or Delivering Quality Cancer Care?","year":2013,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality (philosophy); Context (archaeology); Psychological intervention; Gynecologic oncology; Quality management; Specialty; Oncology; Nursing; Family medicine; Operations management","score_opus":0.3197738329737732,"score_gpt":0.5453922862579675,"score_spread":0.22561845328419433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920790082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93996495,0.037851095,0.00016487665,0.01651833,0.0041528707,0.0007937654,0.00013296206,0.000026601012,0.0003945461],"genre_scores_gemma":[0.9747451,0.002257819,0.0022516507,0.016079033,0.0043850616,0.000094903844,0.000015535907,0.000036649624,0.0001342383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956506,0.0004523493,0.001816594,0.000264556,0.0014692924,0.00034661966],"domain_scores_gemma":[0.9856518,0.0021244097,0.0020156922,0.00020168013,0.009809918,0.00019649864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000557512,0.00024056817,0.0006234965,0.000062068546,0.00030036224,0.00006121261,0.00030956505,0.000120586286,0.001431966],"category_scores_gemma":[0.0018118868,0.00015914967,0.00036780874,0.00045207102,0.000103378494,0.00038602148,0.00016273573,0.0007944964,0.000012562027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036829186,0.00013855995,0.48215824,0.00086943957,0.0018676672,0.00001341554,0.0041591884,0.29000506,0.002728425,0.00070485723,0.127152,0.086520255],"study_design_scores_gemma":[0.00438511,0.0001807523,0.9138036,0.0013604586,0.000577386,0.000051444847,0.006240316,0.00061432057,0.0003616863,0.00058985763,0.07146197,0.0003730914],"about_ca_topic_score_codex":0.0065770154,"about_ca_topic_score_gemma":0.0026631842,"teacher_disagreement_score":0.43164536,"about_ca_system_score_codex":0.001804572,"about_ca_system_score_gemma":0.0020516154,"threshold_uncertainty_score":0.99948084},"labels":[],"label_agreement":null},{"id":"W1932364922","doi":"10.6004/jnccn.2012.0115","title":"Androgen Deprivation Therapy: Minimizing Exposure and Mitigating Side Effects","year":2012,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Radiation therapy; Brachytherapy; Intensive care medicine; Quality of life (healthcare); Disease; Side effect (computer science); Management of prostate cancer; Oncology; Cancer; Internal medicine","score_opus":0.11714701237884668,"score_gpt":0.39061392929566496,"score_spread":0.2734669169168183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1932364922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013413656,0.9964131,0.0000050857757,0.00038888963,0.0008671691,0.0008078175,0.000012393893,0.0000067965016,0.00015738854],"genre_scores_gemma":[0.0018997263,0.99275565,0.00039940336,0.0005344118,0.0041714557,0.000049981478,0.000014958803,0.000042830536,0.00013159795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784577,0.00030158553,0.0005920825,0.00017138761,0.00079948193,0.0002896887],"domain_scores_gemma":[0.99681854,0.0009143735,0.0009793084,0.000114054004,0.0010211284,0.00015260023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029243456,0.0002879678,0.0010603761,0.00013273577,0.00020785026,0.000039077247,0.00017666807,0.00018354195,0.000014444384],"category_scores_gemma":[0.000102355014,0.00015862667,0.0004678926,0.0003873437,0.000097896205,0.00011348496,0.00009579961,0.0007174745,0.0000017732576],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001813674,0.000053650216,0.0015041211,0.0050300877,0.0019924443,0.000019424262,0.00013289004,0.000102296544,0.000041526575,0.000034927976,0.0029274651,0.98797977],"study_design_scores_gemma":[0.0018728515,0.00019845722,0.0030382122,0.02479856,0.0013626363,0.0005646744,0.000017183256,0.000015177438,0.00005018407,0.0002674191,0.96761185,0.00020281816],"about_ca_topic_score_codex":0.0000027017052,"about_ca_topic_score_gemma":8.1401305e-7,"teacher_disagreement_score":0.987777,"about_ca_system_score_codex":0.00049154385,"about_ca_system_score_gemma":0.00076479244,"threshold_uncertainty_score":0.6468608},"labels":[],"label_agreement":null},{"id":"W1952404000","doi":"10.6004/jnccn.2015.0091","title":"Discharge to Primary Care for Survivorship Follow-Up: How Are Patients With Early-Stage Breast Cancer Faring?","year":2015,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Alberta Health Services","keywords":"Medicine; Psychosocial; Survivorship curve; Family medicine; Breast cancer; Mammography; Health care; Public health; Cancer; Physical therapy; Nursing; Psychiatry; Internal medicine","score_opus":0.041595737801169534,"score_gpt":0.2896324071374085,"score_spread":0.24803666933623897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952404000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770068,0.0048659705,0.00026753233,0.008477098,0.0064510177,0.0012223118,0.0014325256,0.000022388525,0.0002543885],"genre_scores_gemma":[0.9894079,0.000047944483,0.0001839785,0.0054665175,0.0034370774,0.00010245099,0.00003914997,0.000059092694,0.0012558802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743974,0.0001162285,0.0003457105,0.00026024535,0.0014578205,0.00038024382],"domain_scores_gemma":[0.9900933,0.00017417462,0.00062624575,0.0001911268,0.008538567,0.00037661192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020066493,0.00027269736,0.00057119277,0.00010956589,0.00021882438,0.00006789534,0.00033250346,0.00009706138,0.000026613254],"category_scores_gemma":[0.000078105244,0.0001748795,0.00030199692,0.0005059218,0.00006245178,0.00019796468,0.000104459665,0.0004586643,0.0000013949739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065701376,0.000068027664,0.93387514,0.0002899543,0.00050112646,0.000003828546,0.0020777807,0.009620926,0.000025262481,0.00007024164,0.045788653,0.0011088906],"study_design_scores_gemma":[0.0052381563,0.0003770377,0.8851111,0.0013516581,0.00025405607,0.000016788035,0.0010565789,0.000027117898,0.000033393368,0.00007983006,0.10618064,0.00027365913],"about_ca_topic_score_codex":0.00039273116,"about_ca_topic_score_gemma":0.0026501063,"teacher_disagreement_score":0.06039199,"about_ca_system_score_codex":0.0013719111,"about_ca_system_score_gemma":0.00095985207,"threshold_uncertainty_score":0.7131379},"labels":[],"label_agreement":null},{"id":"W1958421425","doi":"10.6004/jnccn.2015.0094","title":"Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach","year":2015,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Testicular cancer; Multidisciplinary approach; Cancer; Family medicine; Gynecology; Intensive care medicine; Internal medicine","score_opus":0.08251844369733212,"score_gpt":0.3684153047695581,"score_spread":0.28589686107222595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1958421425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008133202,0.996337,0.000031397198,0.000086609485,0.0007035386,0.0015047684,0.00038698013,0.000007963906,0.00012841725],"genre_scores_gemma":[0.005861358,0.98552,0.0065717082,0.00025151935,0.0009800651,0.0002234466,0.00024405775,0.000118044394,0.00022981506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969653,0.0001713688,0.00080117147,0.00025883323,0.0015637772,0.0002395883],"domain_scores_gemma":[0.9936075,0.00021472394,0.0020522506,0.00024116227,0.0036718533,0.00021251211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012075939,0.0004075463,0.0015643525,0.00012726421,0.00010047828,0.000013196466,0.00028220462,0.000118862634,0.000018375935],"category_scores_gemma":[0.000039414772,0.00021790495,0.0007926674,0.0005801552,0.00014469081,0.000027648233,0.00011565389,0.00036953637,0.000001319543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008135202,0.006481255,0.08866079,0.082568124,0.056974787,0.00061002973,0.0001171973,0.22893263,3.8144046e-7,0.00031389695,0.0811297,0.446076],"study_design_scores_gemma":[0.022213442,0.0011914294,0.08444006,0.119008526,0.045561608,0.00018863974,0.000060393315,0.0009470553,4.3488754e-7,0.00024978968,0.7253196,0.0008189819],"about_ca_topic_score_codex":0.000007217367,"about_ca_topic_score_gemma":0.0000011062115,"teacher_disagreement_score":0.64418995,"about_ca_system_score_codex":0.00087314134,"about_ca_system_score_gemma":0.0020326748,"threshold_uncertainty_score":0.8885906},"labels":[],"label_agreement":null},{"id":"W2116694967","doi":"10.6004/jnccn.2013.0147","title":"Implementing Routine Screening for Distress, the Sixth Vital Sign, for Patients With Head and Neck and Neurologic Cancers","year":2013,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; University of Alberta; Alberta Health Services","funders":"Fondation pour la Recherche Médicale; Alberta Cancer Foundation; National Comprehensive Cancer Network","keywords":"Medicine; Cohort; Head and neck cancer; Quality of life (healthcare); Distress; Cohort study; Worry; Physical therapy; Cancer; Anxiety; Pediatrics; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.028817385652889813,"score_gpt":0.297342806311295,"score_spread":0.2685254206584052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116694967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879566,0.0028945294,0.0008434006,0.006565965,0.00047828723,0.0010871093,0.00013666246,0.0000052189353,0.00003227361],"genre_scores_gemma":[0.99434817,0.00006893262,0.0005526662,0.003723,0.0011533236,0.000082417,0.00001392652,0.00001621729,0.00004134972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898076,0.000038624185,0.00025790892,0.00013281612,0.0003409745,0.00024890972],"domain_scores_gemma":[0.9975494,0.00044280826,0.00037249533,0.00006190393,0.001501184,0.000072191855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013050147,0.00012804863,0.00022864604,0.000024664361,0.00034458333,0.0000503215,0.00010018731,0.000032072185,0.000014361771],"category_scores_gemma":[0.00006698752,0.0000662711,0.00009310376,0.00011645958,0.00009119612,0.00010119115,0.00006373248,0.0001776914,4.810631e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004447301,0.00006284043,0.91176003,0.00025430234,0.0007679235,0.0000012629461,0.00061650353,0.012453827,0.00016363732,0.00033179557,0.04397456,0.025166],"study_design_scores_gemma":[0.0053820536,0.0011021682,0.9497867,0.00032363192,0.00026365698,0.000026664617,0.00032765028,0.0024200322,0.000019415264,0.0009593138,0.039237887,0.00015081615],"about_ca_topic_score_codex":0.00013447,"about_ca_topic_score_gemma":0.00031463386,"teacher_disagreement_score":0.038026664,"about_ca_system_score_codex":0.00009611267,"about_ca_system_score_gemma":0.00010606624,"threshold_uncertainty_score":0.2702457},"labels":[],"label_agreement":null},{"id":"W2120154982","doi":"10.6004/jnccn.2013.0158","title":"Translating Genomics in Cancer Care","year":2013,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Personalized medicine; Precision medicine; Genetic testing; Disease; Health care; Genomics; Breast cancer; Oncology; Bioinformatics; Intensive care medicine; Internal medicine; Cancer; Pathology; Genome; Gene; Genetics","score_opus":0.06627838341564117,"score_gpt":0.3611535352735258,"score_spread":0.2948751518578846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120154982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035848888,0.99667126,0.000015466343,0.00014534897,0.002019494,0.0004347355,0.00016752674,0.0000012579583,0.00018644983],"genre_scores_gemma":[0.00041353633,0.9928775,0.0003028563,0.00062970276,0.005546955,0.00007151723,0.000029900997,0.00005093349,0.00007710715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827933,0.00013302441,0.0007831476,0.00022846824,0.0003191651,0.00025683938],"domain_scores_gemma":[0.9975901,0.00011723326,0.0010460294,0.00015378898,0.0010220502,0.00007075021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102091086,0.0002965422,0.0007825858,0.000079848156,0.00008916343,0.000040935487,0.0005645967,0.0002671055,0.0000327348],"category_scores_gemma":[0.000059153786,0.00021518914,0.00061976776,0.00024339493,0.000058822305,0.0000051231596,0.00014387134,0.00051206426,0.0000019437462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058982565,0.00003863157,0.0002185867,0.0025543193,0.00081154646,0.0000047312324,0.00018111746,0.14523603,0.00018192873,0.00007849758,0.049721513,0.8009141],"study_design_scores_gemma":[0.00033172913,0.000043285567,0.00007164998,0.0034812526,0.00022584436,0.000028920009,0.000030853123,0.000025513242,0.000013967741,0.00009553709,0.995419,0.00023241767],"about_ca_topic_score_codex":0.00004646498,"about_ca_topic_score_gemma":0.00022311702,"teacher_disagreement_score":0.9456975,"about_ca_system_score_codex":0.0006413748,"about_ca_system_score_gemma":0.0021664777,"threshold_uncertainty_score":0.87751585},"labels":[],"label_agreement":null},{"id":"W2163914042","doi":"10.6004/jnccn.2015.0029","title":"Multimodality Approaches for the Curative Treatment of Esophageal Cancer","year":2015,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Esophageal cancer; Chemoradiotherapy; Esophagus; Gastroesophageal Junction; Modality (human–computer interaction); Treatment modality; General surgery; Surgery; Cancer; Radiation therapy; Radiology; Internal medicine; Adenocarcinoma","score_opus":0.39219700837940275,"score_gpt":0.48296294181661337,"score_spread":0.09076593343721062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163914042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017329421,0.99388283,0.000044845758,0.0015137517,0.0010362003,0.0027661282,0.0006524815,0.000004587803,0.000081828926],"genre_scores_gemma":[0.0012302806,0.9926087,0.00033537374,0.00019828176,0.004269377,0.00077472435,0.00003116483,0.00004533472,0.0005067343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968119,0.00034647973,0.00095252664,0.0002569573,0.0012964415,0.00033569706],"domain_scores_gemma":[0.99300826,0.0014885637,0.0017851043,0.00025846227,0.0032648426,0.00019475941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003637934,0.0004271837,0.0019925656,0.000099972975,0.00020718393,0.00002343005,0.00041880892,0.00016528193,0.000055219745],"category_scores_gemma":[0.00011496602,0.00018397134,0.0015812393,0.00045958807,0.000262605,0.00006796948,0.00007543434,0.00044951803,0.0000014377069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015737114,0.0005473422,0.00040798882,0.0039938428,0.011356377,0.000020094274,0.00032691399,0.013925136,2.0783357e-7,0.0004526774,0.040463593,0.9269321],"study_design_scores_gemma":[0.0029969516,0.0009213084,0.0009067776,0.0050549014,0.004206128,0.000110259214,0.000045340457,0.0004433176,0.000008181982,0.00064508995,0.9845056,0.00015615627],"about_ca_topic_score_codex":0.000095268915,"about_ca_topic_score_gemma":0.00003414262,"teacher_disagreement_score":0.94404197,"about_ca_system_score_codex":0.002905715,"about_ca_system_score_gemma":0.0049295356,"threshold_uncertainty_score":0.87447846},"labels":[],"label_agreement":null},{"id":"W2193279488","doi":"10.6004/jnccn.2014.0105","title":"Ipilimumab-Induced Hypophysitis and Uveitis in a Patient With Metastatic Melanoma and a History of Ipilimumab-Induced Skin Rash","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"National Comprehensive Cancer Network; Pfizer","keywords":"Ipilimumab; Medicine; Rash; Hypophysitis; Uveitis; Adverse effect; Melanoma; Internal medicine; Immunology; Nivolumab; Immune system; Dermatology; Oncology; Immunotherapy; Pituitary gland; Cancer research","score_opus":0.02845236996536298,"score_gpt":0.26629667061326306,"score_spread":0.23784430064790008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2193279488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867315,0.00940938,0.000015006478,0.0008526889,0.0005215543,0.0002857208,0.000007244462,0.0000035112184,0.00023171924],"genre_scores_gemma":[0.99694926,0.00044026438,0.0003968909,0.0018361162,0.00029916404,0.000012089928,0.0000013086741,0.000018549845,0.000046333254],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99837136,0.00019107918,0.0005159008,0.000163644,0.0005835412,0.00017446777],"domain_scores_gemma":[0.99812645,0.00033864332,0.0006557012,0.00010822597,0.00068998436,0.00008100169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021924605,0.00017122635,0.00051192933,0.00014411352,0.000050904826,0.000009553368,0.00009700682,0.000050834595,0.000035186556],"category_scores_gemma":[0.00005264663,0.00011454069,0.00011684683,0.0002492094,0.00014095688,0.00009665321,0.000041755306,0.00028408758,1.9074092e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06416489,0.0015719068,0.05435269,0.0017612501,0.008491883,0.00031436648,0.015605278,0.009718775,0.38105363,0.001178957,0.0743862,0.38740018],"study_design_scores_gemma":[0.028686415,0.005153669,0.91779363,0.00425533,0.00068067934,0.0023501255,0.0007351675,0.0027171783,0.004090056,0.0016708627,0.031261817,0.00060507096],"about_ca_topic_score_codex":0.00018407451,"about_ca_topic_score_gemma":0.00016952379,"teacher_disagreement_score":0.86344093,"about_ca_system_score_codex":0.00066353136,"about_ca_system_score_gemma":0.00046450205,"threshold_uncertainty_score":0.46708336},"labels":[],"label_agreement":null},{"id":"W2214708991","doi":"10.6004/jnccn.2015.0149","title":"Making Sense of Variations in Prevalence Estimates of Depression in Cancer: A Co-Calibration of Commonly Used Depression Scales Using Rasch Analysis","year":2015,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rasch model; Depression (economics); Hospital Anxiety and Depression Scale; Cutoff; Medicine; Receiver operating characteristic; Patient Health Questionnaire; Psychometrics; Beck Depression Inventory; Anxiety; Clinical psychology; Psychiatry; Psychology; Internal medicine; Depressive symptoms","score_opus":0.12668161096450306,"score_gpt":0.41028620193817766,"score_spread":0.28360459097367463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2214708991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98648167,0.009697032,0.002926564,0.00021162318,0.000323735,0.00023986842,0.00006893393,0.0000029624837,0.000047607686],"genre_scores_gemma":[0.99815756,0.0002520375,0.0012783849,0.0000974592,0.00018688336,0.0000066397556,0.000006283863,0.0000108881995,0.0000038858284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976712,0.00027159488,0.0008958262,0.00013475672,0.00089319004,0.00013342335],"domain_scores_gemma":[0.9962125,0.0004918803,0.0013937112,0.00014031648,0.0017051089,0.00005648375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004503593,0.00012481416,0.0006205539,0.0003949232,0.00003815753,0.0000074002555,0.00015289546,0.00009186652,0.000021940377],"category_scores_gemma":[0.00019901841,0.00009437075,0.00020795997,0.0014083164,0.00009236247,0.0001677432,0.00006286842,0.00025343758,2.731466e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005423496,0.000061775034,0.55676794,0.00012984968,0.00016482895,0.0000016424376,0.0005447807,0.43694383,0.0044954587,0.000018744626,0.00012741389,0.00020137083],"study_design_scores_gemma":[0.001765957,0.00006330361,0.76153016,0.0037839217,0.0006205959,0.000019610803,0.00024957402,0.225533,0.0057713888,0.00053382985,0.00003140253,0.00009727016],"about_ca_topic_score_codex":0.0007737576,"about_ca_topic_score_gemma":0.0014950188,"teacher_disagreement_score":0.21141084,"about_ca_system_score_codex":0.00036329334,"about_ca_system_score_gemma":0.0005805885,"threshold_uncertainty_score":0.38483274},"labels":[],"label_agreement":null},{"id":"W2223162680","doi":"10.6004/jnccn.2010.0100","title":"The Changing Face of Cervical Cancer Screening in the United States","year":2010,"lang":"en","type":"editorial","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Face (sociological concept); Cervical cancer; Cervical cancer screening; Cancer; Internal medicine","score_opus":0.05118615593635917,"score_gpt":0.3877624335798247,"score_spread":0.33657627764346554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2223162680","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128129255,0.08263348,0.00020665815,0.062937506,0.8375035,0.0020360716,0.0006465464,0.000020079153,0.0012032335],"genre_scores_gemma":[0.045901354,0.016858067,0.00010168755,0.004065414,0.9321951,0.00008716568,0.00009371896,0.0000761143,0.00062133535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942443,0.00043618414,0.00086195016,0.00020764468,0.0037232665,0.0005266899],"domain_scores_gemma":[0.98633456,0.0057305708,0.0009922445,0.00026363492,0.0065636705,0.000115305294],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014693122,0.00027906656,0.00066560257,0.00028574935,0.00040851548,0.00007975459,0.0011696395,0.00040048128,0.00026923273],"category_scores_gemma":[0.000976773,0.00013206812,0.00042471118,0.0015892846,0.0003422759,0.00006226401,0.0002653413,0.0046660583,9.797836e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00149231,0.000043226846,0.0006487809,0.0001552685,0.00043213295,0.000008257379,0.0006562704,0.04069509,0.000017194981,0.00007426025,0.9521461,0.003631102],"study_design_scores_gemma":[0.0015934105,0.00012627264,0.015356608,0.0008201243,0.00019791875,0.000016008933,0.0005468888,0.002654181,0.000023339046,0.00070746295,0.9778158,0.00014197556],"about_ca_topic_score_codex":0.0005859675,"about_ca_topic_score_gemma":0.0008619998,"teacher_disagreement_score":0.09469165,"about_ca_system_score_codex":0.0004026309,"about_ca_system_score_gemma":0.0016185007,"threshold_uncertainty_score":0.99763024},"labels":[],"label_agreement":null},{"id":"W2255713821","doi":"10.6004/jnccn.2016.0006","title":"Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Poisson regression; Internal medicine; Cancer registry; Colorectal cancer; Hazard ratio; Population; Cancer; Proportional hazards model; Propensity score matching; Stage (stratigraphy); Comorbidity; Oncology; Surgery; Confidence interval","score_opus":0.05853885366993404,"score_gpt":0.36204321669971923,"score_spread":0.3035043630297852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255713821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951674,0.0019271264,0.00012911297,0.0008890002,0.00053454895,0.0012468008,0.00009429916,0.0000053568897,0.000006402196],"genre_scores_gemma":[0.99862283,0.00016293248,0.0001644214,0.00046540488,0.00038279887,0.00010618415,0.0000019475972,0.000018716859,0.00007473289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858856,0.00018392285,0.00038538262,0.00015377083,0.00054376107,0.00014457632],"domain_scores_gemma":[0.99545443,0.0020219109,0.00056105084,0.0000900375,0.0017955768,0.00007696868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025986973,0.00014311122,0.000524757,0.000067780886,0.00008562753,0.000010471181,0.00009405738,0.00004873811,0.000043583386],"category_scores_gemma":[0.00014164348,0.00007659509,0.00018804407,0.00022338671,0.00005315619,0.00009400692,0.00002599171,0.00009833048,8.9775156e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01550114,0.0002975961,0.96575874,0.00011489907,0.00081151363,0.000003858465,0.00005568988,0.010754777,0.0033027867,0.0000599396,0.0005196412,0.002819422],"study_design_scores_gemma":[0.012124322,0.00105451,0.98192024,0.001047786,0.00020681342,0.000006063639,0.000013593368,0.00029203558,0.0013600435,0.00028227764,0.0016075983,0.000084706175],"about_ca_topic_score_codex":0.00013575307,"about_ca_topic_score_gemma":0.00006904073,"teacher_disagreement_score":0.016161513,"about_ca_system_score_codex":0.0007062156,"about_ca_system_score_gemma":0.00035330636,"threshold_uncertainty_score":0.3123457},"labels":[],"label_agreement":null},{"id":"W2289764068","doi":"10.6004/jnccn.2005.0049","title":"Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia","year":2005,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Epoetin alfa; Medicine; Anemia; Hemoglobin; Dosing; Chemotherapy; Internal medicine; Erythropoietin; Intensive care medicine","score_opus":0.03423551989230179,"score_gpt":0.314324781219764,"score_spread":0.2800892613274622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289764068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96927595,0.004800137,0.000001228106,0.025137473,0.0001201113,0.0005212469,0.0000145211025,0.0000061983537,0.00012313234],"genre_scores_gemma":[0.993037,0.001350227,0.00052977836,0.0042287153,0.00048010718,0.000019227531,0.000004829383,0.000021815353,0.00032831385],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980876,0.00034128374,0.00047187263,0.00014487581,0.00074429886,0.00021008222],"domain_scores_gemma":[0.9979078,0.00047901648,0.00046668775,0.00015813393,0.0009004808,0.0000878582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003364057,0.00019129636,0.00039167015,0.00009205967,0.00009441501,0.000015349397,0.00019519939,0.00008395469,0.00007651862],"category_scores_gemma":[0.000041585503,0.00009321439,0.0001701969,0.00057364465,0.0000794747,0.000058306738,0.00000826967,0.00020946674,0.0000016794321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085403904,0.00942068,0.20286597,0.000027473383,0.0034532584,0.00012746884,0.023837037,0.5449379,0.013304842,0.00035695956,0.029392177,0.08687233],"study_design_scores_gemma":[0.01223523,0.007963924,0.9623197,0.0006866667,0.00011587099,0.00014138773,0.00026667444,0.00016167917,0.0022483035,0.00012706404,0.013580355,0.00015316463],"about_ca_topic_score_codex":0.000031783973,"about_ca_topic_score_gemma":0.00006484651,"teacher_disagreement_score":0.7594537,"about_ca_system_score_codex":0.0007858849,"about_ca_system_score_gemma":0.00030569188,"threshold_uncertainty_score":0.38011724},"labels":[],"label_agreement":null},{"id":"W2293043909","doi":"10.6004/jnccn.2016.0034","title":"Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Referral; Cancer; Medical record; Cancer registry; Population; Chemotherapy; Internal medicine; Poisson regression; Palliative care; Intensive care medicine; Oncology; Family medicine; Nursing","score_opus":0.0860858806100914,"score_gpt":0.42137763597446964,"score_spread":0.3352917553643783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293043909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95058,0.021983888,0.0011934914,0.020938989,0.0026642305,0.0017433213,0.00073510373,0.0000081980825,0.00015278123],"genre_scores_gemma":[0.984247,0.008207947,0.0024604397,0.0035951673,0.0012744353,0.00003970643,0.0000029862397,0.000026086911,0.00014621626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803954,0.00014419504,0.0008866789,0.00015975238,0.0005918345,0.00017802056],"domain_scores_gemma":[0.9926294,0.0015707355,0.0013485642,0.00012642212,0.0042557796,0.00006908866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018360824,0.00015263441,0.000602528,0.000066125496,0.000034872988,0.000004530258,0.00015472791,0.00008665187,0.00006734211],"category_scores_gemma":[0.00042973328,0.00008522935,0.00034672164,0.00020508037,0.000086568696,0.00017013002,0.000031419066,0.00019769563,2.2029263e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032357205,0.00068465044,0.8674458,0.0003061629,0.003288948,0.000008387468,0.0012311408,0.014610441,0.002943081,0.00041633417,0.012716431,0.06399137],"study_design_scores_gemma":[0.020921988,0.001970223,0.89262015,0.0034372916,0.0006105841,0.000015946986,0.00035951746,0.00009111322,0.006000853,0.0006508484,0.073127866,0.00019359104],"about_ca_topic_score_codex":0.000072992225,"about_ca_topic_score_gemma":0.000090676665,"teacher_disagreement_score":0.06379778,"about_ca_system_score_codex":0.00042159477,"about_ca_system_score_gemma":0.0007756501,"threshold_uncertainty_score":0.34755522},"labels":[],"label_agreement":null},{"id":"W2306826149","doi":"10.6004/jnccn.2016.0019","title":"Evaluating the Impact of Provincial Implementation of Screening for Distress on Quality of Life, Symptom Reports, and Psychosocial Well-Being in Patients With Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Psychosocial; Cohort; Quality of life (healthcare); Psychological intervention; Distress; Anxiety; Intervention (counseling); Family medicine; Physical therapy; Psychiatry; Nursing; Clinical psychology; Internal medicine","score_opus":0.06008552437312038,"score_gpt":0.4321481098150398,"score_spread":0.37206258544191945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306826149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783236,0.00042139256,0.00010351262,0.0006349367,0.00032808137,0.0005054062,0.00014608559,0.000001063391,0.000027182772],"genre_scores_gemma":[0.99912083,0.000042682314,0.000083555235,0.00013107285,0.0005806899,0.000020029202,0.0000047048507,0.00001004611,0.000006363314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981294,0.00014678904,0.0007153754,0.000106432504,0.00078346196,0.00011850078],"domain_scores_gemma":[0.9953617,0.0005144725,0.0018574034,0.00008200549,0.0021462056,0.00003820071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005231459,0.00009938168,0.00035657024,0.00005442473,0.00006186351,0.0000046943537,0.00008105998,0.000035438145,0.000026419946],"category_scores_gemma":[0.00015955321,0.000047181024,0.00016711294,0.0001927014,0.0000891845,0.00006741039,0.00002511124,0.00011422385,6.7350125e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055153603,0.000050337378,0.97394997,0.00009618915,0.00033907592,1.3640845e-7,0.00062150107,0.0077305483,0.0005421717,0.00008416214,0.0006456584,0.010424884],"study_design_scores_gemma":[0.0035994062,0.0007718484,0.99325764,0.0012055024,0.00009268626,0.0000011732421,0.00020288462,0.000069228816,0.00021075843,0.0004946401,0.00003778778,0.000056435994],"about_ca_topic_score_codex":0.0012455878,"about_ca_topic_score_gemma":0.0010011472,"teacher_disagreement_score":0.019307673,"about_ca_system_score_codex":0.00025902918,"about_ca_system_score_gemma":0.0005676478,"threshold_uncertainty_score":0.19239862},"labels":[],"label_agreement":null},{"id":"W2307758074","doi":"10.6004/jnccn.2014.0187","title":"New Developments in the Treatment of Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Achieve Life Sciences (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Clinical trial; Intensive care medicine; Hormonal therapy; Immunotherapy; Oncology; Cancer; Internal medicine","score_opus":0.13388232305812728,"score_gpt":0.4345753972711803,"score_spread":0.300693074213053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307758074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002767657,0.99601287,0.0000023457023,0.0011456804,0.00085069885,0.0013822761,0.00006702415,0.0000025019904,0.00025986438],"genre_scores_gemma":[0.0005047185,0.99539185,0.00023938544,0.00027488434,0.0019951977,0.0001393913,0.000024982324,0.000029811543,0.0013997654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968481,0.0003286454,0.0010815976,0.00019988994,0.0012423092,0.00029943982],"domain_scores_gemma":[0.9966785,0.00050428236,0.0013338487,0.00017625514,0.0012012771,0.00010584964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026302325,0.0003389695,0.0014172607,0.00019114636,0.000115993185,0.00003027708,0.00037283325,0.00013197321,0.00006270195],"category_scores_gemma":[0.000034408542,0.00015064332,0.00062395365,0.0007689729,0.00008996111,0.000054368753,0.000032326338,0.0004334988,0.0000025645124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001462205,0.00044138974,0.0014009787,0.0048966086,0.0037129396,0.00007264133,0.0012687623,0.0030624452,0.00001671222,0.00019250372,0.060894947,0.92257786],"study_design_scores_gemma":[0.002019208,0.00041847792,0.0033605883,0.013725866,0.00084376737,0.000079157006,0.00003150013,0.00000615581,0.000008682084,0.00015681704,0.9792212,0.00012858439],"about_ca_topic_score_codex":0.00012261671,"about_ca_topic_score_gemma":0.00012199474,"teacher_disagreement_score":0.9224493,"about_ca_system_score_codex":0.0018394208,"about_ca_system_score_gemma":0.005823686,"threshold_uncertainty_score":0.99981236},"labels":[],"label_agreement":null},{"id":"W2329368040","doi":"10.6004/jnccn.2007.0016","title":"Role of Bone Marrow Transplantation in the Disease Pathway of Myeloma","year":2007,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Celgene","keywords":"Medicine; Multiple myeloma; Thalidomide; Bortezomib; Autologous stem-cell transplantation; Lenalidomide; Oncology; Transplantation; Internal medicine; Surgery","score_opus":0.08784823920259621,"score_gpt":0.3916811902525102,"score_spread":0.303832951049914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329368040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013690452,0.99694693,0.0000071857626,0.00020817814,0.00020498448,0.00075374555,0.00019637181,0.0000014707431,0.0003120639],"genre_scores_gemma":[0.026816145,0.9719038,0.00013342906,0.0001780845,0.0008248338,0.000026182164,0.000047249174,0.000020371313,0.000049880204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680644,0.00038792274,0.0010220844,0.00012564154,0.0014495646,0.00020835878],"domain_scores_gemma":[0.9963401,0.0009533484,0.0012753991,0.00015729692,0.0011648879,0.00010896534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004901577,0.00020931345,0.0010553139,0.0002520843,0.00005099436,0.0000071735863,0.000293472,0.00010349686,0.00004316577],"category_scores_gemma":[0.0001327674,0.000105997264,0.00073458307,0.0006326312,0.00011102159,0.000050310064,0.000027999478,0.00056269066,0.0000012234901],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043364344,0.0007996793,0.004270362,0.020301592,0.002431762,0.0004280181,0.00044590977,0.0026279306,0.00009699477,0.0008350291,0.0042497874,0.9591765],"study_design_scores_gemma":[0.003980154,0.0003701321,0.102396496,0.05209614,0.0022461468,0.0007121466,0.00009021438,0.00013854516,0.000033970096,0.0013762843,0.8363116,0.00024818906],"about_ca_topic_score_codex":0.000016353551,"about_ca_topic_score_gemma":0.00001770333,"teacher_disagreement_score":0.9589283,"about_ca_system_score_codex":0.0002736777,"about_ca_system_score_gemma":0.0012173567,"threshold_uncertainty_score":0.4322443},"labels":[],"label_agreement":null},{"id":"W2336174752","doi":"10.6004/jnccn.2016.0043","title":"Letting Nature Loose","year":2016,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interim; Program director; Clinical Oncology; Family medicine; Advisory committee; Library science; Management; Internal medicine; Cancer; Oncology; Medical education; Political science; Law","score_opus":0.05524643350920548,"score_gpt":0.3840717427323899,"score_spread":0.3288253092231844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336174752","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018536196,0.023270696,0.00003069146,0.96566623,0.0034417931,0.00035291066,0.000044882272,0.000008951262,0.0053302133],"genre_scores_gemma":[0.0033679,0.0011694985,0.00057103526,0.891745,0.09189811,0.000013981607,0.000010048375,0.00004650318,0.011177941],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99659735,0.0002939457,0.0006330386,0.00020070482,0.0018381495,0.00043680647],"domain_scores_gemma":[0.9932011,0.0014568149,0.0010699014,0.00019425346,0.003983631,0.00009430331],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00037642434,0.0002519009,0.0008782312,0.00015274406,0.00019044557,0.000022438475,0.0004875918,0.0009515281,0.00048894197],"category_scores_gemma":[0.00047048804,0.00013142923,0.00051833055,0.0002703318,0.0002233787,0.000062953164,0.00013900244,0.005555201,0.000021989445],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020927924,0.000011753211,0.004619802,0.000110321605,0.00092296465,0.00019574063,0.000015319527,0.00010677481,0.00009079198,0.000046666333,0.9926981,0.00097248994],"study_design_scores_gemma":[0.0012368656,0.00011487303,0.01058661,0.0022189151,0.000432752,0.0008191152,0.0000039724932,0.00004989983,0.000016011814,0.0032589193,0.981128,0.00013411335],"about_ca_topic_score_codex":0.0000022999511,"about_ca_topic_score_gemma":0.0000010147667,"teacher_disagreement_score":0.08845632,"about_ca_system_score_codex":0.0008471,"about_ca_system_score_gemma":0.0018504917,"threshold_uncertainty_score":0.99673903},"labels":[],"label_agreement":null},{"id":"W2336746419","doi":"10.6004/jnccn.2014.0084","title":"Insights Into Preferences for Psycho-Oncology Services Among Women With Gynecologic Cancer Following Distress Screening","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Referral; Distress; Psychosocial; Gynecologic oncology; Psycho-oncology; Coping (psychology); Social support; Family medicine; Stressor; Gynecologic cancer; Psychiatry; Nursing; Clinical psychology; Cancer; Psychotherapist; Ovarian cancer; Oncology; Psychology; Internal medicine","score_opus":0.030797715207918484,"score_gpt":0.3262946043522757,"score_spread":0.29549688914435723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336746419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98853385,0.0054789335,0.00082081056,0.0017065887,0.0026277206,0.00037197876,0.000012653979,0.000013944936,0.0004335305],"genre_scores_gemma":[0.99215186,0.00023233128,0.0006307637,0.0038350767,0.0028438973,0.00017808525,0.0000061550086,0.000021907763,0.000099934805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827486,0.00015094828,0.00041316636,0.00021275623,0.000663082,0.00028519085],"domain_scores_gemma":[0.9968572,0.00063045084,0.0007055118,0.0001152114,0.001540399,0.00015120981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020182626,0.00019665367,0.00052256836,0.000080773214,0.00028444643,0.0000388258,0.00032867747,0.00011579492,0.0000490726],"category_scores_gemma":[0.00004664497,0.000115390976,0.00020451793,0.00034571157,0.000105746185,0.00016516617,0.000059484308,0.00036426683,3.6785073e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011011226,0.00030174284,0.64681756,0.0010856888,0.005006815,0.000021631773,0.016534165,0.23187527,0.0017588196,0.0006036005,0.018504653,0.06647882],"study_design_scores_gemma":[0.006160399,0.0019732427,0.75317746,0.0027722595,0.0006204207,0.000028288605,0.004002994,0.0033709304,0.00019111774,0.009270357,0.21798415,0.00044838726],"about_ca_topic_score_codex":0.0001983449,"about_ca_topic_score_gemma":0.0034653319,"teacher_disagreement_score":0.22850434,"about_ca_system_score_codex":0.0005992981,"about_ca_system_score_gemma":0.00033615198,"threshold_uncertainty_score":0.47055075},"labels":[],"label_agreement":null},{"id":"W2336799541","doi":"10.6004/jnccn.2014.0023","title":"The International Endorsement of US Distress Screening and Psychosocial Guidelines in Oncology: A Model for Dissemination","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Tata Memorial Centre; Peter MacCallum Cancer Centre; Israel Cancer Association; Cancerfonden; Irish Cancer Society; Prostate Cancer Foundation of Australia; Macmillan Cancer Support; Livestrong Foundation; Breast Cancer Alliance; Prostate Cancer Foundation","keywords":"Medicine; Distress; Psychosocial; Context (archaeology); Sign (mathematics); Clinical Oncology; Psycho-oncology; Cancer; Family medicine; Intensive care medicine; Psychiatry; Internal medicine; Clinical psychology","score_opus":0.062482567009147845,"score_gpt":0.4051274239786391,"score_spread":0.34264485696949126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336799541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72949755,0.019921107,0.05269622,0.18047278,0.012973477,0.0019879711,0.0004464285,0.00001718365,0.0019872752],"genre_scores_gemma":[0.9940019,0.0006549513,0.0013935522,0.0016654681,0.0020186205,0.000031854233,0.000006718582,0.000009172197,0.00021773846],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988056,0.000052686457,0.00045865626,0.000083423205,0.0004970927,0.0001025456],"domain_scores_gemma":[0.9966859,0.0006116995,0.00050207187,0.000051860236,0.002113573,0.000034861798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046379713,0.00007633194,0.00020025444,0.00004683198,0.000098119206,0.000014912503,0.00016964674,0.000045238383,0.000004234038],"category_scores_gemma":[0.00034230162,0.000046715886,0.00012805987,0.00011218872,0.00007129871,0.00004729283,0.000046427733,0.00015768084,3.0668037e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066170343,0.0001822692,0.0472703,0.00015430701,0.0008690226,0.0000017947985,0.0022586754,0.4158164,0.0035944926,0.0074167885,0.24445787,0.27136105],"study_design_scores_gemma":[0.0044434858,0.0002803068,0.06587908,0.001421966,0.0001812979,0.000038950475,0.000576956,0.49133152,0.00021484843,0.009701859,0.42576948,0.00016027146],"about_ca_topic_score_codex":0.00003571957,"about_ca_topic_score_gemma":0.00064215466,"teacher_disagreement_score":0.27120078,"about_ca_system_score_codex":0.00020692407,"about_ca_system_score_gemma":0.00014108661,"threshold_uncertainty_score":0.19050185},"labels":[],"label_agreement":null},{"id":"W2339449145","doi":"10.6004/jnccn.2004.0040","title":"Relationship Between Hemoglobin Levels and Quality of Life During Radiation Therapy Plus Concomitant or Sequential Chemotherapy in Patients With Cancer and Anemia Treated With Epoetin Alfa","year":2004,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Epoetin alfa; Hemoglobin; Anemia; Quality of life (healthcare); Concomitant; Internal medicine; Cancer; Radiation therapy; Chemotherapy; Gastroenterology","score_opus":0.07720077244212115,"score_gpt":0.3353597564653536,"score_spread":0.25815898402323245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339449145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943885,0.0027425964,0.000010642656,0.0023409827,0.000051380142,0.00040985178,0.000038205606,0.0000042535494,0.000013544453],"genre_scores_gemma":[0.99826264,0.0004875953,0.0004255822,0.0004582385,0.0002977987,0.00000885099,0.000007527692,0.000016078333,0.000035692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866706,0.00009848362,0.0004638507,0.00014013209,0.00049516826,0.00013527833],"domain_scores_gemma":[0.9983241,0.00025567497,0.00064892677,0.00006660919,0.0006161208,0.00008858346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342624,0.00015466157,0.00042968208,0.00006827856,0.00009897787,0.0000121740495,0.000053471074,0.00006994231,0.000019749308],"category_scores_gemma":[0.000044174983,0.00008465201,0.00004616444,0.00026996038,0.00014537775,0.00008553329,0.000013063675,0.00023221498,6.514485e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061960276,0.000067100766,0.9843896,0.000060026523,0.00021359362,0.0000025799259,0.00030880325,0.008125206,0.0001601195,0.000032995275,0.000059027992,0.00038491658],"study_design_scores_gemma":[0.026449593,0.00046255006,0.9714634,0.00059292687,0.00006800419,0.000013252881,0.00005543943,0.000008430282,0.00065013213,0.000084414125,0.000054037177,0.000097856835],"about_ca_topic_score_codex":0.00019688322,"about_ca_topic_score_gemma":0.000079305115,"teacher_disagreement_score":0.020253565,"about_ca_system_score_codex":0.00062321016,"about_ca_system_score_gemma":0.00058994914,"threshold_uncertainty_score":0.34520087},"labels":[],"label_agreement":null},{"id":"W2341473062","doi":"10.6004/jnccn.2014.0172","title":"Analysis of Recurrence Patterns in Acral Versus Nonacral Melanoma: Should Histologic Subtype Influence Treatment Guidelines?","year":2014,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; York University; National Cancer Institute; Melanoma Research Alliance","keywords":"Medicine; Melanoma; Acral lentiginous melanoma; Hazard ratio; Stage (stratigraphy); Overall survival; Internal medicine; Dermatology; Oncology; Surgery; Confidence interval","score_opus":0.11275097229597587,"score_gpt":0.3753103503837248,"score_spread":0.26255937808774893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341473062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939623,0.0013347822,0.00020227316,0.002457274,0.0014535146,0.0001926346,0.0000140419625,0.000006153079,0.00037701038],"genre_scores_gemma":[0.9973204,0.00040652658,0.00030226933,0.0012783152,0.00050517195,0.000007843647,0.0000044335034,0.0000070427564,0.00016799629],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99833024,0.00012152694,0.00064962223,0.00014831031,0.0005870861,0.0001632177],"domain_scores_gemma":[0.9974065,0.0002787774,0.0006765091,0.00014092545,0.0014316257,0.00006567974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021092694,0.00014041405,0.000504027,0.00027607658,0.000052714313,0.000008534534,0.00018310364,0.00006151811,0.00009818688],"category_scores_gemma":[0.00024685307,0.000092346934,0.0003196127,0.0007867828,0.000055286724,0.000048093814,0.000051087784,0.00020069262,0.000001512416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00275827,0.00018977272,0.32472977,0.00003909925,0.002123687,0.0000306668,0.00015178342,0.6543331,0.00047371772,0.00032959096,0.004827372,0.010013185],"study_design_scores_gemma":[0.0033718073,0.0010097484,0.92947906,0.00026913272,0.0016074638,0.00007958348,0.00007423573,0.01925603,0.0001151055,0.00018619558,0.044390507,0.00016112949],"about_ca_topic_score_codex":0.00013461582,"about_ca_topic_score_gemma":0.0004690259,"teacher_disagreement_score":0.63507706,"about_ca_system_score_codex":0.0007021309,"about_ca_system_score_gemma":0.00015719942,"threshold_uncertainty_score":0.37657988},"labels":[],"label_agreement":null},{"id":"W2346494368","doi":"10.6004/jnccn.2004.0043","title":"Patients and Clinical Practice Guidelines Development","year":2004,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Paternalism; Medicine; Set (abstract data type); Health care; Guideline; Function (biology); MEDLINE; Medical education","score_opus":0.3354320687749796,"score_gpt":0.54763007206618,"score_spread":0.21219800329120037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346494368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8225214,0.004827958,0.0011826291,0.16497213,0.0052740388,0.00071458664,0.000009567744,0.000015824346,0.00048185166],"genre_scores_gemma":[0.629261,0.002337815,0.18360922,0.17613944,0.008476643,0.000009013223,0.000012012508,0.00003793354,0.00011687246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670386,0.0001312747,0.0018582883,0.00013632355,0.0010326206,0.00013762408],"domain_scores_gemma":[0.9844525,0.001438428,0.0014678034,0.000074619085,0.012439937,0.00012670307],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001125614,0.000112745634,0.00028581853,0.00004323553,0.00013567308,0.000022031154,0.000121367455,0.00006741932,0.000025982545],"category_scores_gemma":[0.014572486,0.00007383932,0.0001436623,0.00020669897,0.00007486362,0.00025284052,0.00010514603,0.00044412693,0.0000049158557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044877403,0.0013076931,0.17985429,0.000082460276,0.0024902846,0.000031579217,0.00033807792,0.05795733,0.00012455633,0.0009642923,0.592083,0.16027875],"study_design_scores_gemma":[0.005064787,0.00025617823,0.4576097,0.00029843167,0.0003132776,0.00016592603,0.00011044409,0.000095272604,0.000025342579,0.0013684322,0.53459775,0.00009441353],"about_ca_topic_score_codex":0.000012963983,"about_ca_topic_score_gemma":0.000011756273,"teacher_disagreement_score":0.27775544,"about_ca_system_score_codex":0.0003367195,"about_ca_system_score_gemma":0.001254562,"threshold_uncertainty_score":0.99372816},"labels":[],"label_agreement":null},{"id":"W2402411756","doi":"10.6004/jnccn.2011.0114","title":"The Changing Paradigm of Treating Pancreatic Neuroendocrine Tumors","year":2011,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Neuroendocrine tumors; Internal medicine; Oncology","score_opus":0.09535950678860665,"score_gpt":0.39411798062022296,"score_spread":0.2987584738316163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402411756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023605315,0.9967318,0.000004102826,0.0006472469,0.0010179257,0.0008530266,0.000024654362,0.000009812102,0.00047534794],"genre_scores_gemma":[0.0010449857,0.995,0.00012965006,0.00030677693,0.002541953,0.000059499365,0.0000037324996,0.00007435613,0.0008390182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99582994,0.0005693232,0.0014586205,0.00024067835,0.0012947837,0.0006066461],"domain_scores_gemma":[0.9928704,0.0023430125,0.0029238767,0.00032830966,0.0013636482,0.00017079084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027430826,0.00041666566,0.0019021718,0.00029578933,0.00034470318,0.00003233492,0.0008254699,0.000017825663,0.00004696902],"category_scores_gemma":[0.0008121854,0.0002073562,0.0011533517,0.0011533168,0.00029167245,0.00010180559,0.00027699082,0.0012968071,0.0000039504166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019440015,0.0004334226,0.0010872215,0.030964838,0.007805825,0.0026465377,0.00026374595,0.0060047936,0.00002272082,0.0074492823,0.06161901,0.8797586],"study_design_scores_gemma":[0.00058081676,0.00027411958,0.00020552457,0.022303345,0.0010711249,0.008540755,0.000032795622,0.00004431168,0.000013477199,0.0010228197,0.9657534,0.00015752585],"about_ca_topic_score_codex":0.000010353445,"about_ca_topic_score_gemma":0.00000467092,"teacher_disagreement_score":0.9041344,"about_ca_system_score_codex":0.00036999033,"about_ca_system_score_gemma":0.0011835448,"threshold_uncertainty_score":0.8455741},"labels":[],"label_agreement":null},{"id":"W2471651470","doi":"10.6004/jnccn.2008.0020","title":"Should Cost of Care be Considered in a Clinical Practice Guideline?","year":2008,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Clinical Practice; Medical physics; Family medicine; Pathology","score_opus":0.7874786500660446,"score_gpt":0.6385482320829241,"score_spread":0.14893041798312046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471651470","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4472265,0.061035678,0.00048287393,0.44798923,0.023782384,0.004358435,0.00034305945,0.000051388255,0.014730456],"genre_scores_gemma":[0.81111056,0.0047172573,0.007835344,0.17024717,0.005839881,0.00004417292,0.000007954228,0.000041418672,0.00015626417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.988089,0.00606758,0.0035985927,0.00022530467,0.0015945092,0.0004249775],"domain_scores_gemma":[0.9635066,0.016335882,0.0046668425,0.00024860102,0.015046337,0.00019573451],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0041016424,0.00019047224,0.00077387533,0.00013585063,0.00052450027,0.000006415059,0.0005054172,0.0003231107,0.00019522531],"category_scores_gemma":[0.016891314,0.00014141446,0.00028889638,0.000645278,0.0002858299,0.0004049402,0.00022166343,0.002823361,0.000009112137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020724032,0.00020074907,0.19896643,0.00024849296,0.0003036358,0.000059539252,0.0045719673,0.023360752,0.000033818695,0.0017483108,0.76687944,0.0015544491],"study_design_scores_gemma":[0.0023741235,0.00015793901,0.16332206,0.00095524784,0.00008343738,0.00011521395,0.0053063533,0.0002626625,0.000007882814,0.0009066121,0.82635367,0.00015480348],"about_ca_topic_score_codex":0.0004824915,"about_ca_topic_score_gemma":0.000752179,"teacher_disagreement_score":0.36388403,"about_ca_system_score_codex":0.00087543984,"about_ca_system_score_gemma":0.006237915,"threshold_uncertainty_score":0.99947715},"labels":[],"label_agreement":null},{"id":"W2497337193","doi":"10.6004/jnccn.2016.0091","title":"Care and Outcomes of Patients With Cancer Admitted to the Hospital on Weekends and Holidays: A Retrospective Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hospital Admissions and Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Weekend effect; Retrospective cohort study; Emergency medicine; Odds ratio; Hospital admission; Cancer; Pediatrics; Internal medicine","score_opus":0.01222804662223706,"score_gpt":0.2928450423484863,"score_spread":0.2806169957262492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497337193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910667,0.0010442171,0.0000030766705,0.0065316088,0.0004891094,0.0007128405,0.000068993904,0.0000033334238,0.00008014761],"genre_scores_gemma":[0.99793786,0.00014253527,0.0000564682,0.0013503102,0.0003283203,0.000023043953,5.947658e-7,0.000013757973,0.00014713431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856085,0.00005831509,0.0002796065,0.00015389448,0.0008118715,0.00013546503],"domain_scores_gemma":[0.9969787,0.00021859871,0.00033788054,0.000117794014,0.002221553,0.00012545362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092183924,0.00014655227,0.0004118791,0.000062736115,0.0001310748,0.000011926669,0.000121147474,0.000032548047,0.000033530472],"category_scores_gemma":[0.00017787193,0.000054147542,0.00008133291,0.00022111145,0.000085843065,0.000057928868,0.00008291418,0.00017914288,3.5433186e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046373045,0.00010833647,0.9936751,0.000008455759,0.00050369103,0.0000021528426,0.0007415,0.00018903018,0.000006418757,0.000031914697,0.0030313851,0.0012382604],"study_design_scores_gemma":[0.0024146785,0.0020068423,0.992582,0.00040163254,0.00019363285,0.0000031531372,0.0004172885,0.0000028842107,0.000016693715,0.000050796665,0.0018266535,0.00008371915],"about_ca_topic_score_codex":0.000026843727,"about_ca_topic_score_gemma":0.000034984747,"teacher_disagreement_score":0.0068711624,"about_ca_system_score_codex":0.0002602255,"about_ca_system_score_gemma":0.00015149893,"threshold_uncertainty_score":0.22080727},"labels":[],"label_agreement":null},{"id":"W2507079668","doi":"10.6004/jnccn.2016.0103","title":"NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Health care; Global health; Context (archaeology); Cancer; Breast cancer; Family medicine; Intensive care medicine; Internal medicine; Nursing; Public health; Economic growth; Pathology","score_opus":0.1776502830492418,"score_gpt":0.4605876596149657,"score_spread":0.28293737656572393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507079668","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18134832,0.048809562,0.66623807,0.093426,0.00472021,0.0040785144,0.00048316456,0.00006525556,0.00083091913],"genre_scores_gemma":[0.8825257,0.00012793276,0.10561381,0.006019698,0.00555527,0.00009365587,0.0000035694802,0.000018708122,0.000041695628],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9981096,0.000116251074,0.0006273327,0.00024923927,0.0005969613,0.00030062313],"domain_scores_gemma":[0.99355894,0.0021697078,0.0009687304,0.00014940223,0.0030083524,0.00014483539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048319748,0.00016840232,0.00043600914,0.000033814005,0.00033714785,0.000041756433,0.00024195359,0.0002186286,0.000012720391],"category_scores_gemma":[0.0019371852,0.000102441605,0.00026863336,0.00023619398,0.00013528582,0.00013978028,0.000066423396,0.0002999445,3.3771227e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018236538,0.00014914795,0.065984055,0.0012423358,0.0013715037,0.000010524795,0.0019418845,0.0076011685,0.0047003017,0.5210822,0.06389404,0.3137863],"study_design_scores_gemma":[0.006920598,0.002454113,0.10780711,0.007351321,0.00080702885,0.0003676217,0.004109393,0.0006230381,0.0010367618,0.5895043,0.27838728,0.0006314412],"about_ca_topic_score_codex":0.00001407775,"about_ca_topic_score_gemma":0.000021554102,"teacher_disagreement_score":0.70117736,"about_ca_system_score_codex":0.0011992961,"about_ca_system_score_gemma":0.0009758672,"threshold_uncertainty_score":0.41774473},"labels":[],"label_agreement":null},{"id":"W2507815012","doi":"10.6004/jnccn.2016.0120","title":"The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Guideline; Radiation therapy; Oncology; Population; Internal medicine; Environmental health; Pathology","score_opus":0.03232647556880424,"score_gpt":0.3788988547676054,"score_spread":0.34657237919880113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507815012","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.077854075,0.026487373,0.8157315,0.075047396,0.0029402243,0.0017161713,0.00020521483,0.0000119988645,0.000006007525],"genre_scores_gemma":[0.9453862,0.000830087,0.03733693,0.01168394,0.0044326037,0.00006848244,0.000006943022,0.00004142143,0.00021341791],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99880916,0.000079809426,0.00055785675,0.00010365166,0.00028890008,0.0001606096],"domain_scores_gemma":[0.9899087,0.007495265,0.0007081515,0.00008244141,0.0017579077,0.00004753063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052884105,0.000116244635,0.00037256585,0.000037648977,0.00023034035,0.00000978404,0.00012526847,0.00006866277,0.0000070246338],"category_scores_gemma":[0.0005603914,0.000051718962,0.0001947568,0.000077563476,0.00024597527,0.000081162325,0.000007194962,0.00009646261,2.8866337e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037851606,0.00018966035,0.15657945,0.00015288213,0.0024616532,0.0000036355293,0.00008171631,0.56953204,0.016699282,0.02396001,0.11738891,0.07509916],"study_design_scores_gemma":[0.04572235,0.0033615401,0.40707228,0.002324606,0.00057894416,0.00024188722,0.00006577012,0.16065241,0.0016574656,0.073704295,0.30417934,0.00043910323],"about_ca_topic_score_codex":0.0000060909547,"about_ca_topic_score_gemma":0.000015939793,"teacher_disagreement_score":0.8675321,"about_ca_system_score_codex":0.00024249853,"about_ca_system_score_gemma":0.00021167472,"threshold_uncertainty_score":0.21090381},"labels":[],"label_agreement":null},{"id":"W2529727747","doi":"10.6004/jnccn.2016.0135","title":"Effects of a Provincial-Wide Implementation of Screening for Distress on Healthcare Professionals' Confidence and Understanding of Person-Centered Care in Oncology","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Distress; Cohort; Intervention (counseling); Health care; Confidence interval; Health professionals; Family medicine; Cohort study; Nursing; Internal medicine; Clinical psychology","score_opus":0.0833770864487617,"score_gpt":0.39675851763553655,"score_spread":0.31338143118677486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529727747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98166215,0.0071583567,0.0015583957,0.007384281,0.0008671898,0.0010992388,0.00024530786,0.0000020635148,0.000022983631],"genre_scores_gemma":[0.9989614,0.00018168992,0.0001340954,0.00046740824,0.00021638787,0.000020089,0.000003559833,0.0000079002575,0.0000074712957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998809,0.00014421414,0.00041338295,0.00009556946,0.00042207033,0.000115755785],"domain_scores_gemma":[0.996449,0.0013159916,0.0008594088,0.00004627609,0.0012860573,0.000043297638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001649217,0.00008282566,0.0003654859,0.0000953552,0.000044903667,0.0000019028324,0.000079966165,0.000052763215,0.0000060724014],"category_scores_gemma":[0.00012907742,0.00005090215,0.000112647904,0.00013881187,0.00008793033,0.000048757785,0.000026389536,0.00011489977,1.018179e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036175806,0.00052207225,0.7630918,0.015025518,0.0014155329,0.000020748328,0.03271735,0.0024312695,0.043732546,0.016219981,0.010030569,0.07861681],"study_design_scores_gemma":[0.021155238,0.0049225627,0.85846186,0.033835422,0.00036876742,0.000033223234,0.04599719,0.00012866315,0.03007249,0.0032028432,0.0015576575,0.00026409217],"about_ca_topic_score_codex":0.0002078026,"about_ca_topic_score_gemma":0.0016281541,"teacher_disagreement_score":0.095370054,"about_ca_system_score_codex":0.00059296197,"about_ca_system_score_gemma":0.0005698324,"threshold_uncertainty_score":0.20757294},"labels":[],"label_agreement":null},{"id":"W2547811651","doi":"10.6004/jnccn.2016.0151","title":"Psychotropic and Opioid Medication Use in Older Patients With Breast Cancer Across the Care Trajectory: A Population-Based Cohort Study","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Population; Cohort; Antipsychotic; Cancer; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming); Environmental health","score_opus":0.015176101626621068,"score_gpt":0.29965681875267947,"score_spread":0.2844807171260584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547811651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99267805,0.0029527438,0.000014774567,0.0028705872,0.00055536925,0.0008624699,0.000057380035,0.000005181764,0.000003420875],"genre_scores_gemma":[0.99728,0.0003705813,0.000022575521,0.0012305037,0.0009523477,0.000074308045,0.0000052946025,0.000019585525,0.00004480751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815565,0.00020637283,0.00038458742,0.00017914442,0.00087877875,0.00019543516],"domain_scores_gemma":[0.99738544,0.00038476757,0.000472759,0.000165043,0.0015226051,0.000069364585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015462839,0.00015916578,0.00031453653,0.000068990965,0.00018770839,0.000030989017,0.00015806314,0.000053173717,0.00004517622],"category_scores_gemma":[0.000057287296,0.00007178463,0.00008570705,0.00028600715,0.00012213433,0.00014955873,0.000020004958,0.00023217953,3.162713e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023376774,0.000121315934,0.98910815,0.000020538253,0.00015921422,0.0000017139527,0.0005363816,0.0029002822,0.000014915125,0.0000021636058,0.0015193166,0.0032783393],"study_design_scores_gemma":[0.005606699,0.00016196168,0.9909661,0.0009077905,0.00012670776,0.000023445027,0.0002358704,0.000052944753,0.0000041579224,0.000010950131,0.0018068574,0.000096562544],"about_ca_topic_score_codex":0.00047252513,"about_ca_topic_score_gemma":0.0010833755,"teacher_disagreement_score":0.0046019233,"about_ca_system_score_codex":0.00061423617,"about_ca_system_score_gemma":0.0004475475,"threshold_uncertainty_score":0.2927292},"labels":[],"label_agreement":null},{"id":"W2561994402","doi":"10.6004/jnccn.2016.0167","title":"Effective Translation of Research to Practice: Hospital-Based Rehabilitation Program Improves Health-Related Physical Fitness and Quality of Life of Cancer Survivors","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; TRIUMF","funders":"Canadian Institutes of Health Research; Alberta Innovates","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Rehabilitation; Aerobic exercise; Cancer; Physical fitness; Flexibility (engineering); Health care; Internal medicine; Nursing","score_opus":0.05737214392641822,"score_gpt":0.44571760098379665,"score_spread":0.38834545705737844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561994402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96756464,0.006239068,0.0001181039,0.02388704,0.00072901475,0.0013458685,0.00007717606,0.000005961074,0.000033105294],"genre_scores_gemma":[0.99847883,0.00019782092,0.0005528471,0.00025859935,0.00039627496,0.00008397287,0.0000019386155,0.000014737435,0.000014984608],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99645627,0.0010038685,0.00084995345,0.00017507796,0.0013312533,0.000183585],"domain_scores_gemma":[0.9854617,0.0052549075,0.0012826088,0.000131986,0.0077371853,0.00013158968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016131996,0.000121306366,0.00063009193,0.00015942457,0.00006935485,0.0000055003247,0.0001261996,0.00007651026,0.000011436569],"category_scores_gemma":[0.0017453943,0.000074966294,0.00022003197,0.00086376636,0.00035758415,0.00013588223,0.00003084156,0.0002906552,1.3116117e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044157296,0.0037217971,0.3784433,0.007644879,0.0035004735,0.000001956236,0.02543978,0.042584654,0.07035836,0.003139021,0.008861424,0.41214705],"study_design_scores_gemma":[0.0038321044,0.004245025,0.9799109,0.0032693697,0.00014200121,0.0000016854319,0.0010138375,0.00042288797,0.0024619508,0.0014946267,0.0030663663,0.0001392171],"about_ca_topic_score_codex":0.0021909433,"about_ca_topic_score_gemma":0.00086009817,"teacher_disagreement_score":0.6014676,"about_ca_system_score_codex":0.00035307612,"about_ca_system_score_gemma":0.0010431507,"threshold_uncertainty_score":0.33120656},"labels":[],"label_agreement":null},{"id":"W2564952891","doi":"10.6004/jnccn.2016.0166","title":"Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice","year":2016,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Oxaliplatin; Medicine; Colorectal cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cancer registry; Poisson regression; Stage (stratigraphy); Population; Cancer; Oncology; Surgery; Confidence interval","score_opus":0.07993162547078687,"score_gpt":0.402997621087353,"score_spread":0.3230659956165661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564952891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.922429,0.053480525,0.00015260528,0.01886862,0.0036952363,0.00062337366,0.0002708936,0.0000078465455,0.00047187918],"genre_scores_gemma":[0.9844453,0.0064641004,0.001642071,0.0032461989,0.0039264625,0.000035383026,0.0000029926198,0.000015747222,0.00022178591],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99813163,0.00013615019,0.00079016463,0.00016123733,0.0006288986,0.00015193595],"domain_scores_gemma":[0.9914613,0.002888882,0.0012367079,0.000096887095,0.004234613,0.00008163646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001810728,0.00014578372,0.000600817,0.000041777403,0.00012315725,0.000006712053,0.00014710384,0.00007766572,0.000060727427],"category_scores_gemma":[0.0005863485,0.000072261435,0.00036203038,0.00017148942,0.00013468764,0.000117758194,0.000073422045,0.0001824906,8.962009e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05950328,0.0014259841,0.22815567,0.0001704164,0.01527176,0.000051227118,0.0011332007,0.008894368,0.012018424,0.001981641,0.5577099,0.11368413],"study_design_scores_gemma":[0.012838998,0.0018208612,0.5798401,0.0021600327,0.0017229444,0.000044236025,0.0001915243,0.00035120914,0.0013489529,0.003568247,0.3958988,0.00021406263],"about_ca_topic_score_codex":0.000107241736,"about_ca_topic_score_gemma":0.00011439594,"teacher_disagreement_score":0.35168448,"about_ca_system_score_codex":0.00045707737,"about_ca_system_score_gemma":0.00067599263,"threshold_uncertainty_score":0.2946736},"labels":[],"label_agreement":null},{"id":"W2609928112","doi":"10.6004/jnccn.2017.0044","title":"NCCN Guidelines Insights: Breast Cancer, Version 1.2017","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Kyowa Hakko Kirin; Astellas Pharma; Clovis Oncology; National Comprehensive Cancer Network; Novocure; Jazz Pharmaceuticals; AstraZeneca; Novartis Pharmaceuticals Corporation; Celldex Therapeutics; Genomic Health","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Medical physics; Systemic therapy; Intensive care medicine; Oncology; Internal medicine","score_opus":0.0616633971341642,"score_gpt":0.3633957124153162,"score_spread":0.301732315281152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609928112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7722862,0.12889591,0.00015094291,0.076645724,0.017807968,0.00054163043,0.00065917376,0.000018975761,0.0029935045],"genre_scores_gemma":[0.97882986,0.00794246,0.00031880487,0.0033837876,0.009141976,0.00001539694,0.0000065362265,0.000021309477,0.00033984423],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987631,0.000056100627,0.00033181763,0.0001830194,0.00048115556,0.00018485058],"domain_scores_gemma":[0.995629,0.00003353967,0.0009167918,0.00026647348,0.0030887013,0.000065502216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087850676,0.00017775195,0.00023476618,0.000029110004,0.00075819617,0.00005609524,0.00068058405,0.00008452388,0.000032090127],"category_scores_gemma":[0.00011842571,0.00011668914,0.00023289587,0.000059602473,0.00017767564,0.000021771093,0.0003249418,0.00015485361,0.0000031333975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091314485,0.000060521954,0.043257866,0.000019081646,0.0011253936,0.000005828936,0.000054465698,0.03444171,0.009029625,0.00012414245,0.90710497,0.0038632536],"study_design_scores_gemma":[0.001986542,0.00006285863,0.59374964,0.00041263146,0.00016067094,0.00016834903,0.000050106424,0.00011800143,0.0021265927,0.0009345824,0.39999425,0.00023577808],"about_ca_topic_score_codex":0.000087926586,"about_ca_topic_score_gemma":0.00010275076,"teacher_disagreement_score":0.55049175,"about_ca_system_score_codex":0.00017082802,"about_ca_system_score_gemma":0.0003478098,"threshold_uncertainty_score":0.58315086},"labels":[],"label_agreement":null},{"id":"W2610066140","doi":"10.6004/jnccn.2017.0032","title":"Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Cystectomy; Comorbidity; Cohort; Akaike information criterion; Internal medicine; Logistic regression; Retrospective cohort study; Hazard ratio; Population; Charlson comorbidity index; Perioperative; Proportional hazards model; Bladder cancer; Database; Surgery; Cancer; Confidence interval; Statistics","score_opus":0.11222096430922492,"score_gpt":0.42711369084857614,"score_spread":0.31489272653935124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610066140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889952,0.0019918696,0.00076980627,0.0033426501,0.002145848,0.0010262248,0.0002307378,0.000005953539,0.0014917119],"genre_scores_gemma":[0.9958743,0.00019196665,0.000549709,0.0009942285,0.0021318172,0.0000741727,0.000004170569,0.000016244638,0.00016342428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982834,0.000065308435,0.0004771752,0.00014656414,0.000841924,0.00018566636],"domain_scores_gemma":[0.9969332,0.00011252631,0.00059580954,0.00022671824,0.0020227514,0.00010899321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023192726,0.00016430758,0.0005114374,0.000041100597,0.0003065047,0.000037311645,0.0002856348,0.000084117026,0.00010156337],"category_scores_gemma":[0.000073438096,0.000103088474,0.00037869904,0.00006669774,0.0002338147,0.00015710882,0.00008197233,0.00032742956,3.1881225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025421523,0.000316896,0.97983855,0.00018563613,0.0021955296,0.000018945168,0.00026440428,0.0029622717,0.0008057912,0.0005544519,0.0077586183,0.0025567822],"study_design_scores_gemma":[0.0031308553,0.0002973011,0.9815066,0.00038865593,0.00032856993,0.000048313505,0.000026240272,0.0011994423,0.0004588439,0.00049180235,0.012028094,0.00009526752],"about_ca_topic_score_codex":0.00004273741,"about_ca_topic_score_gemma":0.00004324471,"teacher_disagreement_score":0.0068790684,"about_ca_system_score_codex":0.00045648502,"about_ca_system_score_gemma":0.00074493256,"threshold_uncertainty_score":0.4203826},"labels":[],"label_agreement":null},{"id":"W2612400171","doi":"10.6004/jnccn.2017.0059","title":"NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; Kyowa Hakko Kirin; Advanced Accelerator Applications; Jazz Pharmaceuticals; Cook Medical; Boston Scientific Corporation; National Cancer Institute; Sirtex Medical; Genomic Health; Clovis Oncology; Varian Medical Systems; Novartis Pharmaceuticals Corporation; AstraZeneca; Celgene; Gilead Sciences; Astellas Pharma; Novocure; Celldex Therapeutics; Amgen","keywords":"Medicine; Hepatocellular carcinoma; Gallbladder; Gallbladder cancer; General surgery; Internal medicine; Intensive care medicine; Oncology","score_opus":0.21004862632452748,"score_gpt":0.3705305788115665,"score_spread":0.160481952487039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612400171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92892474,0.040194653,0.000027718537,0.02192206,0.0047700056,0.00047906212,0.000029732884,0.000016752223,0.003635303],"genre_scores_gemma":[0.9875929,0.0028856471,0.00075281574,0.0035620118,0.004525266,0.000009954184,0.0000051587417,0.000019073712,0.00064718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982728,0.00007662415,0.00047079404,0.00015526844,0.00083090254,0.00019363483],"domain_scores_gemma":[0.99532884,0.00012308313,0.0009077993,0.00028734692,0.0032177428,0.00013517408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000180207,0.0001740904,0.00037811606,0.000067859204,0.000670813,0.000060754697,0.00042671317,0.00009527266,0.00011400996],"category_scores_gemma":[0.00027046134,0.00010698956,0.00039357893,0.00010909767,0.00013852275,0.00021808497,0.00013478665,0.00032043323,0.000012364216],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064650906,0.00005026821,0.47800934,0.00004104274,0.0006307297,0.000085163556,0.000088605426,0.0020446375,0.0009398655,0.00013639973,0.5149824,0.00234505],"study_design_scores_gemma":[0.003648067,0.0002960675,0.3447529,0.0014563209,0.0005955717,0.00028643396,0.000060395116,0.0059641963,0.0017034833,0.0020022742,0.6389902,0.00024406766],"about_ca_topic_score_codex":0.000097667995,"about_ca_topic_score_gemma":0.000028925711,"teacher_disagreement_score":0.13325644,"about_ca_system_score_codex":0.00058114185,"about_ca_system_score_gemma":0.000795605,"threshold_uncertainty_score":0.5159419},"labels":[],"label_agreement":null},{"id":"W2614394261","doi":"10.6004/jnccn.2017.0070","title":"Use of Biomarkers and Multigene Assays in Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Breast cancer; Oncology; Estrogen receptor; Internal medicine; Endocrine system; Adjuvant therapy; Adjuvant; Chemotherapy; Estrogen; Cancer; Bioinformatics; Hormone","score_opus":0.05250035401155284,"score_gpt":0.32708279851086314,"score_spread":0.2745824444993103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614394261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838014,0.010758781,0.000014303437,0.0042526885,0.000822811,0.00011566443,0.00016906716,9.883137e-7,0.000064286985],"genre_scores_gemma":[0.99478126,0.0036397255,0.0003248909,0.0005006394,0.00070336356,0.000008215182,0.0000016168472,0.000009534243,0.000030744355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992213,0.00005713463,0.00024299085,0.00011995965,0.00023411999,0.00012449228],"domain_scores_gemma":[0.9983844,0.000057880618,0.00059865287,0.00013108556,0.00079192664,0.00003602354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086964465,0.00010865111,0.00019533146,0.000032320662,0.00015653737,0.000023081539,0.00021732223,0.000056459277,0.000008639462],"category_scores_gemma":[0.00006572751,0.00007661492,0.00009594321,0.000055103657,0.00019259704,0.000015880109,0.00016872636,0.000090376874,9.35297e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010848297,0.000070226204,0.9058201,0.000026586506,0.0011188784,0.000003129498,0.000067123234,0.024694627,0.036306903,0.000046666235,0.024850365,0.005910602],"study_design_scores_gemma":[0.00090495404,0.000020620986,0.99052334,0.00018478646,0.000044768203,0.000035806763,0.000016266542,0.00010719984,0.002025043,0.00012872746,0.0059296223,0.00007887518],"about_ca_topic_score_codex":0.00029283538,"about_ca_topic_score_gemma":0.0002996497,"teacher_disagreement_score":0.08470327,"about_ca_system_score_codex":0.00008373814,"about_ca_system_score_gemma":0.00015693327,"threshold_uncertainty_score":0.31242657},"labels":[],"label_agreement":null},{"id":"W2615945276","doi":"10.6004/jnccn.2017.0075","title":"Immunotherapies for Lung Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pembrolizumab; Atezolizumab; Medicine; Nivolumab; Immunotherapy; Oncology; Lung cancer; PD-L1; Internal medicine; Standard of care; First line; Cancer","score_opus":0.05760166304265469,"score_gpt":0.3876294147813151,"score_spread":0.3300277517386604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615945276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5109482,0.33738416,0.0010533825,0.121786416,0.023757542,0.0023764889,0.00023832281,0.00003542925,0.0024200974],"genre_scores_gemma":[0.9674984,0.0072743157,0.0012084652,0.012375221,0.009038585,0.0000831769,0.0000021504225,0.000044206216,0.0024754796],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987934,0.000032609285,0.00037583933,0.000107534106,0.0004968089,0.00019377108],"domain_scores_gemma":[0.99678016,0.00016098567,0.00096422527,0.00019557333,0.0018495057,0.000049553088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021391452,0.00013280477,0.00031280183,0.000044672754,0.0006159762,0.00007115821,0.00040915978,0.00006645426,0.00016862308],"category_scores_gemma":[0.000084599706,0.00008346921,0.00045026324,0.00007997764,0.00016954195,0.00014166006,0.00004696861,0.00022219936,3.2154205e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018234085,0.00014512827,0.056449834,0.0002832175,0.0062480457,0.000006633563,0.00051454525,0.014456927,0.029807713,0.0009032011,0.83305234,0.039898355],"study_design_scores_gemma":[0.0074111414,0.00020977894,0.42971143,0.0015568472,0.00038377414,0.000104734216,0.00005100599,0.0016894612,0.0018795625,0.0015091224,0.5552757,0.00021746119],"about_ca_topic_score_codex":0.00005222513,"about_ca_topic_score_gemma":0.00002322125,"teacher_disagreement_score":0.45655024,"about_ca_system_score_codex":0.00039067958,"about_ca_system_score_gemma":0.0005644602,"threshold_uncertainty_score":0.47376534},"labels":[],"label_agreement":null},{"id":"W2742308385","doi":"10.6004/jnccn.2017.0136","title":"Costs and Benefits of Extended Endocrine Strategies for Premenopausal Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endocrine system; Breast cancer; Oncology; Gynecology; Cancer; Internal medicine; Hormone","score_opus":0.024812774516495623,"score_gpt":0.31948362384133916,"score_spread":0.29467084932484355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742308385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97732425,0.01985975,0.000045704663,0.0014096218,0.00081880955,0.0002177912,0.00013377494,0.0000013947978,0.0001888844],"genre_scores_gemma":[0.9960862,0.0020010474,0.00018574456,0.00024283418,0.0013903023,0.000012026908,0.0000031543832,0.000010783342,0.00006790704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993214,0.00003404637,0.00020842018,0.000102937614,0.00020268495,0.0001305301],"domain_scores_gemma":[0.99812704,0.000038737442,0.0005676715,0.00010436296,0.001116503,0.000045679295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084186555,0.00010055118,0.00016578194,0.000017722105,0.00020945599,0.000034743774,0.00024939585,0.00006264486,0.0000050583476],"category_scores_gemma":[0.000034371427,0.00006802781,0.0000916694,0.00002738836,0.000120715194,0.000014329352,0.0000966727,0.000112798836,6.3953685e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005137443,0.00019604886,0.021074645,0.00022525259,0.0028835307,0.0000040483765,0.00009556422,0.18728274,0.6849204,0.007147155,0.073491655,0.017541563],"study_design_scores_gemma":[0.0077563,0.0014233129,0.8548363,0.0012326689,0.0005339848,0.000612202,0.00010791209,0.0010361242,0.09794599,0.0052751875,0.028672531,0.0005675041],"about_ca_topic_score_codex":0.000016946873,"about_ca_topic_score_gemma":0.000019081155,"teacher_disagreement_score":0.83376163,"about_ca_system_score_codex":0.00003408973,"about_ca_system_score_gemma":0.00023517286,"threshold_uncertainty_score":0.27740934},"labels":[],"label_agreement":null},{"id":"W2744712610","doi":"10.6004/jnccn.2017.0139","title":"Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Pilocytic astrocytoma; KRAS; Cancer research; MAPK/ERK pathway; Oncology; Internal medicine; Astrocytoma; Vemurafenib; Glioma; Melanoma; Kinase; Cancer; Metastatic melanoma; Genetics; Biology","score_opus":0.019482378393887785,"score_gpt":0.2836547623742144,"score_spread":0.2641723839803266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744712610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611497,0.0011455436,0.0000021799078,0.001543223,0.00067285873,0.00030172282,0.000015849768,0.000004115867,0.00019951051],"genre_scores_gemma":[0.9986862,0.000033097524,0.00019469298,0.00044177956,0.0005702823,0.000012452412,0.000006322636,0.000016000782,0.000039199153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985387,0.000046898138,0.00034977173,0.00012514494,0.00074276875,0.00019675805],"domain_scores_gemma":[0.9976241,0.000100024175,0.00073592394,0.00016488889,0.0012779702,0.00009708958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000832562,0.0001505543,0.0003255798,0.00008698375,0.00022532823,0.00004134195,0.00020458373,0.00005012525,0.000032316908],"category_scores_gemma":[0.00011021042,0.00008497282,0.00012873558,0.00016352182,0.00008405168,0.00012797782,0.00006259295,0.00027614398,0.0000021160347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001345162,0.00038266892,0.977146,0.000018509556,0.00033959543,0.00006537572,0.000050322607,0.008153429,0.00029233715,0.000058971058,0.010978265,0.0011693175],"study_design_scores_gemma":[0.0057662153,0.00038606554,0.98845613,0.00094680954,0.000085057305,0.000025552969,0.000015082921,0.00010809352,0.0012664015,0.00015653687,0.002701858,0.000086172106],"about_ca_topic_score_codex":0.000016009642,"about_ca_topic_score_gemma":0.000021979831,"teacher_disagreement_score":0.011310107,"about_ca_system_score_codex":0.0005166399,"about_ca_system_score_gemma":0.000250632,"threshold_uncertainty_score":0.3465091},"labels":[],"label_agreement":null},{"id":"W2752378953","doi":"10.6004/jnccn.2017.0149","title":"A Double-Blind, Randomized, Placebo-Controlled Trial of<i>Panax Ginseng</i>for Cancer-Related Fatigue in Patients With Advanced Cancer","year":2017,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Genentech; GlaxoSmithKline; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Placebo; Quality of life (healthcare); Mood; Internal medicine; Ginseng; Anxiety; Randomized controlled trial; Cancer-related fatigue; Clinical endpoint; Profile of mood states; Physical therapy; Depression (economics); Placebo-controlled study; Cancer; Double blind; Psychiatry; Alternative medicine","score_opus":0.03422671687455836,"score_gpt":0.3393581911611152,"score_spread":0.30513147428655685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752378953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912563,0.0021906549,0.00013120043,0.0015603467,0.0010085383,0.003660321,0.00006030209,0.0000029432874,0.00012938977],"genre_scores_gemma":[0.9967429,0.00079206744,0.00030234264,0.00031687322,0.0007807278,0.00093751866,0.000013081089,0.000015568517,0.00009893819],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99852407,0.00015599745,0.0005905998,0.0002007781,0.00032839476,0.00020015067],"domain_scores_gemma":[0.99634284,0.00027612256,0.0016243076,0.0001936888,0.0015063351,0.00005669617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003569785,0.00018256098,0.0006727989,0.00004095496,0.00023430052,0.00002739737,0.00044706004,0.00013153612,0.000010968515],"category_scores_gemma":[0.00022186483,0.00010288793,0.0003418617,0.00010040678,0.00019176755,0.000013091574,0.000067909175,0.0002087217,1.2274667e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8749159,0.00014695575,0.0011885229,0.0000148958725,0.00061405497,1.5566131e-7,0.00001877872,0.12023157,0.0010057294,0.00023260429,0.000928495,0.00070232863],"study_design_scores_gemma":[0.98703927,0.00045945978,0.005527612,0.00019633652,0.00018550741,7.866544e-7,0.000004965844,0.0005795489,0.0006978955,0.00037619116,0.0047718855,0.0001605536],"about_ca_topic_score_codex":0.000056765806,"about_ca_topic_score_gemma":0.000112760084,"teacher_disagreement_score":0.11965202,"about_ca_system_score_codex":0.000086743705,"about_ca_system_score_gemma":0.00037632644,"threshold_uncertainty_score":0.41956478},"labels":[],"label_agreement":null},{"id":"W2803149877","doi":"10.6004/jnccn.2018.0046","title":"Targeted Therapy for Patients With Metastatic Non–Small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"Ariad Pharmaceuticals","keywords":"Medicine; Alectinib; Osimertinib; ROS1; Targeted therapy; Lung cancer; Oncology; Anaplastic lymphoma kinase; Erlotinib; Ceritinib; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Cancer; Epidermal growth factor receptor; Adenocarcinoma; Receptor","score_opus":0.02476331531661414,"score_gpt":0.3389768553128095,"score_spread":0.3142135399961954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803149877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97725946,0.012417741,0.0013082671,0.003474671,0.0026327912,0.0021424235,0.00017795901,0.000012683421,0.0005740236],"genre_scores_gemma":[0.98588526,0.00039586314,0.0048638317,0.0054690177,0.002530725,0.00013469314,0.000017389742,0.000036662692,0.00066655065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879754,0.000038813152,0.00031333955,0.0001381478,0.00050159515,0.00021055472],"domain_scores_gemma":[0.9944966,0.00016559972,0.0005269432,0.00009240612,0.0046259128,0.00009256302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006772033,0.00015900501,0.0002973032,0.000064079584,0.00023187952,0.000020837258,0.00013880103,0.000033038898,0.00011661269],"category_scores_gemma":[0.000020221474,0.00008650443,0.00017287735,0.000291925,0.00007909519,0.00008378065,0.00001792252,0.00014947992,0.0000010137206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009398272,0.0012992563,0.4596473,0.00028470054,0.008186454,0.000007090228,0.002007841,0.050492764,0.0010829332,0.00017236319,0.4596155,0.0078055165],"study_design_scores_gemma":[0.025895322,0.002665597,0.8487164,0.0010276882,0.0022749137,0.00002018915,0.00011838796,0.0026258398,0.0014255864,0.0007602162,0.114122055,0.0003478474],"about_ca_topic_score_codex":0.000028478307,"about_ca_topic_score_gemma":0.00003139872,"teacher_disagreement_score":0.38906905,"about_ca_system_score_codex":0.00043366363,"about_ca_system_score_gemma":0.00091385667,"threshold_uncertainty_score":0.3527548},"labels":[],"label_agreement":null},{"id":"W2808656455","doi":"10.6004/jnccn.2018.7014","title":"Outcomes From a Patient-Centered, Interprofessional, Palliative Consult Team in Oncology","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Medicine; Psychosocial; Palliative care; Referral; Anxiety; Distress; Quality of life (healthcare); Family medicine; Depression (economics); Physical therapy; Psychiatry; Nursing; Clinical psychology","score_opus":0.1782823076023507,"score_gpt":0.46578988694121953,"score_spread":0.28750757933886883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808656455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824491,0.0068424903,0.00006196488,0.0053874,0.0030756702,0.0002572875,0.000082532075,0.000005244629,0.0018382929],"genre_scores_gemma":[0.9878095,0.0006904889,0.002193549,0.0078016566,0.0013823542,0.000008659052,0.0000069067723,0.000012583388,0.00009430789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981347,0.00022388241,0.0006986521,0.00013815843,0.0006238226,0.00018078482],"domain_scores_gemma":[0.9950829,0.0012025627,0.000883443,0.00009653695,0.0026539816,0.0000805582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012490677,0.00015046645,0.00058022974,0.000110115434,0.00006423891,0.000005620144,0.00021233846,0.00010246255,0.00024229901],"category_scores_gemma":[0.00052351604,0.00009229512,0.00021590668,0.00030203204,0.00024697694,0.000075454795,0.00011272852,0.0004406619,0.0000065952245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030240435,0.00027184648,0.89400077,0.000021835382,0.0007706049,0.000015763693,0.0037078634,0.00071927346,0.0010256589,0.00016567252,0.09315086,0.003125799],"study_design_scores_gemma":[0.0063725417,0.00094909477,0.78290313,0.006149107,0.00016524267,0.000020936497,0.00234534,0.0005595479,0.0014487997,0.004154405,0.19473857,0.0001932869],"about_ca_topic_score_codex":0.00008508842,"about_ca_topic_score_gemma":0.00011557537,"teacher_disagreement_score":0.11109764,"about_ca_system_score_codex":0.0005604851,"about_ca_system_score_gemma":0.0007005079,"threshold_uncertainty_score":0.37636858},"labels":[],"label_agreement":null},{"id":"W2886592807","doi":"10.6004/jnccn.2018.7020","title":"DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Cilag; National Cancer Institute; Janssen Biotech; Astellas Pharma; Celgene; University of Michigan; Valeant Pharmaceuticals International; Varian Medical Systems; Gilead Sciences","keywords":"DNA repair; PARP inhibitor; Prostate cancer; Medicine; Cancer research; Mutation; Cancer; Poly ADP ribose polymerase; Gene; Homologous recombination; DNA damage; Gene mutation; Oncology; Internal medicine; DNA; Biology; Genetics","score_opus":0.035890937354533,"score_gpt":0.3342492008840909,"score_spread":0.29835826352955785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886592807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991898,0.0034301868,0.0000051010798,0.003561326,0.0003734228,0.0006173319,0.00007769282,0.0000068422137,0.00003010885],"genre_scores_gemma":[0.99668145,0.00030569953,0.00086519826,0.0009168125,0.0008467913,0.000050533024,0.000008793498,0.000017844806,0.00030689788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820554,0.00020750573,0.00041573643,0.00017000397,0.0007734857,0.0002277181],"domain_scores_gemma":[0.9966088,0.00020614614,0.00031908843,0.00009835432,0.0026535904,0.00011405194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027336043,0.00014596303,0.00027399432,0.00013465555,0.00021500896,0.000034317014,0.000077106306,0.00003231533,0.000046558453],"category_scores_gemma":[0.00008761584,0.00008447182,0.0000768453,0.00050520396,0.00021800719,0.00016397043,0.000038288257,0.0002495809,0.0000010043763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16877614,0.0009501302,0.712639,0.0002586003,0.002811925,0.00013541227,0.0032737148,0.024637043,0.027994536,0.00018658074,0.05639335,0.0019435963],"study_design_scores_gemma":[0.007379724,0.0016762927,0.9822709,0.00075974944,0.0001682879,0.000035433117,0.000076750606,0.0004285361,0.0013692293,0.00024228398,0.0054622837,0.00013051613],"about_ca_topic_score_codex":0.000027885646,"about_ca_topic_score_gemma":0.000116240226,"teacher_disagreement_score":0.26963195,"about_ca_system_score_codex":0.0005493316,"about_ca_system_score_gemma":0.0010816038,"threshold_uncertainty_score":0.34446612},"labels":[],"label_agreement":null},{"id":"W2887093231","doi":"10.6004/jnccn.2018.7027","title":"Swedish Version of the Distress Thermometer: Validity Evidence in Patients With Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Trinity Western University; Providence Health Care","funders":"Centrum fÖr Personcentrerad Vård; Göteborgs Universitet; Canada Research Chairs; Västra Götalandsregionen","keywords":"Medicine; Discriminant validity; Cronbach's alpha; Quality of life (healthcare); Distress; Construct validity; Convergent validity; Clinical psychology; Population; Colorectal cancer; Confirmatory factor analysis; Internal medicine; Psychometrics; Cancer; Internal consistency; Statistics","score_opus":0.04888381308805103,"score_gpt":0.31291428675480243,"score_spread":0.2640304736667514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887093231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939596,0.001583899,0.0000068179183,0.0014304213,0.0025529743,0.00025888238,0.00006982206,0.0000025244126,0.00013507405],"genre_scores_gemma":[0.99752265,0.00015829674,0.000017665847,0.00095549977,0.0012766122,0.000008385465,0.0000016818025,0.0000112703165,0.000047937872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815756,0.00016442584,0.00032139075,0.000121045414,0.0010783244,0.00015724143],"domain_scores_gemma":[0.9962907,0.0002707274,0.0005639898,0.00011956534,0.002700941,0.000054067234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016475651,0.000119396886,0.000276291,0.000047093185,0.00010798373,0.0000104036935,0.00030532017,0.00004718046,0.00012685277],"category_scores_gemma":[0.00010941412,0.00006110728,0.00016240282,0.0005746618,0.000239784,0.00010983426,0.0000974891,0.00031829756,5.990287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003317215,0.0000752893,0.9780611,0.00005003891,0.00014127104,0.0000011198568,0.00035777097,0.002511923,0.00033295233,0.000012798735,0.01419974,0.00093879143],"study_design_scores_gemma":[0.0013567557,0.00036752154,0.99149656,0.0021534413,0.00011327586,0.0000060137213,0.000053276974,0.00008105175,0.0008339069,0.000104332896,0.0033596964,0.00007417817],"about_ca_topic_score_codex":0.00021914982,"about_ca_topic_score_gemma":0.00091933616,"teacher_disagreement_score":0.01343546,"about_ca_system_score_codex":0.0005075525,"about_ca_system_score_gemma":0.00039932263,"threshold_uncertainty_score":0.24918827},"labels":[],"label_agreement":null},{"id":"W2892196452","doi":"10.6004/jnccn.2018.7038","title":"Ability to Predict New-Onset Psychological Distress Using Routinely Collected Health Data: A Population-Based Cohort Study of Women Diagnosed With Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Canadian Foundation for Healthcare Improvement; McGill University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Population; Anxiety; Cohort; Incidence (geometry); Distress; Cancer; Internal medicine; Psychiatry; Clinical psychology","score_opus":0.06772431429818167,"score_gpt":0.38580396908505094,"score_spread":0.3180796547868693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892196452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942236,0.0003474389,0.00023413647,0.0022760213,0.0010426212,0.0010985568,0.00075623847,0.000011951003,0.000009438017],"genre_scores_gemma":[0.99472004,0.000019282505,0.00026928706,0.002809002,0.0020696726,0.000037476522,0.000034456913,0.000020779771,0.000019996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698734,0.00032943083,0.0007495226,0.00034027282,0.0012568685,0.00033657608],"domain_scores_gemma":[0.9951622,0.0003004425,0.0009170384,0.00039268815,0.0028927387,0.00033490083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050049816,0.00019985173,0.0006973041,0.00009803979,0.00022079378,0.000024440067,0.00040988374,0.000060633134,0.00017874892],"category_scores_gemma":[0.00015378767,0.00012699135,0.00008825743,0.0011349937,0.00010691321,0.000091756294,0.00009980789,0.00032056705,2.632892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050094626,0.00040269346,0.93144476,0.000039472805,0.00032436926,0.000002801813,0.00072161417,0.045772456,0.000022237045,0.0000014812649,0.015823893,0.00043474245],"study_design_scores_gemma":[0.003106322,0.0012215797,0.9922193,0.0005795686,0.0001538968,0.00006068685,0.00037653488,0.0016511708,0.0000020232953,0.000025149335,0.00048327053,0.00012045737],"about_ca_topic_score_codex":0.007959683,"about_ca_topic_score_gemma":0.009867706,"teacher_disagreement_score":0.060774565,"about_ca_system_score_codex":0.0019967167,"about_ca_system_score_gemma":0.0014810307,"threshold_uncertainty_score":0.9986464},"labels":[],"label_agreement":null},{"id":"W2908650768","doi":"10.6004/jnccn.2018.7079","title":"Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Multiple myeloma; Internal medicine; Oncology","score_opus":0.03695116062310916,"score_gpt":0.2964003712810561,"score_spread":0.25944921065794696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908650768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974635,0.0010967364,0.0000066145662,0.0004559785,0.00032303506,0.00056297705,0.00003318777,0.000003060591,0.000054909204],"genre_scores_gemma":[0.9978582,0.00014181956,0.0011663772,0.00047009936,0.00014278463,0.00001006799,0.00000941091,0.000017098111,0.00018412663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998119,0.00008655544,0.00040583342,0.00012786462,0.001035833,0.00022492424],"domain_scores_gemma":[0.9963516,0.00082026585,0.0004478172,0.00012254102,0.002155487,0.00010231076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079915655,0.00013711929,0.00037551887,0.00012476322,0.00004101972,0.000014866289,0.00015284056,0.00005356091,0.00009764435],"category_scores_gemma":[0.00023214151,0.00007903557,0.00013976538,0.000441075,0.00006655813,0.00017014515,0.000050222126,0.00029910257,0.0000044775798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038440835,0.0002496794,0.9516325,0.000036302532,0.0003308194,0.000015159775,0.00005948619,0.037344478,0.00022207823,0.000019102583,0.0030068785,0.00323942],"study_design_scores_gemma":[0.009324689,0.00063096173,0.9834658,0.0006942622,0.000039145743,0.000010378471,0.000020668955,0.0011876759,0.0004665252,0.000077127865,0.0040076445,0.000075118034],"about_ca_topic_score_codex":0.00014774992,"about_ca_topic_score_gemma":0.00010829662,"teacher_disagreement_score":0.0361568,"about_ca_system_score_codex":0.00027414178,"about_ca_system_score_gemma":0.00035289908,"threshold_uncertainty_score":0.3222977},"labels":[],"label_agreement":null},{"id":"W2911213912","doi":"10.6004/jnccn.2018.7066","title":"Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services; Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Epirubicin; Docetaxel; Breast cancer; Internal medicine; Oncology; Carboplatin; Cyclophosphamide; Chemotherapy; Cancer; Gynecology; Cisplatin","score_opus":0.01437594280338184,"score_gpt":0.30522759471591804,"score_spread":0.2908516519125362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911213912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759293,0.0067931167,0.00014253701,0.012252923,0.001496032,0.0009179146,0.0018502501,0.0000054213165,0.0006125083],"genre_scores_gemma":[0.99285644,0.0019509787,0.0008203783,0.0029755812,0.0009798115,0.000044791508,0.000013748556,0.000030724117,0.00032756347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875695,0.000082528815,0.00036775845,0.0002322661,0.00034956197,0.00021096753],"domain_scores_gemma":[0.9967239,0.0002755293,0.00071226904,0.000113631904,0.0021203433,0.000054333213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009824291,0.00022831344,0.00047680057,0.00005067968,0.0001208287,0.000013103605,0.00020151144,0.00007222297,0.000027662218],"category_scores_gemma":[0.000022364426,0.0001561158,0.00025931682,0.00016342415,0.00016603967,0.000014982383,0.00009993404,0.0001339085,4.3295984e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007411169,0.00032122538,0.8661284,0.00013426354,0.008818616,0.0000019916743,0.00095455605,0.044421863,0.02812279,0.00074552494,0.03815296,0.0047866716],"study_design_scores_gemma":[0.0029638621,0.0001401534,0.98395324,0.00031132757,0.00016886821,0.0000219041,0.00010900276,0.000111407724,0.009671602,0.00060507044,0.0017556824,0.00018786252],"about_ca_topic_score_codex":0.00021237141,"about_ca_topic_score_gemma":0.0001562456,"teacher_disagreement_score":0.11782488,"about_ca_system_score_codex":0.00021059623,"about_ca_system_score_gemma":0.00025806043,"threshold_uncertainty_score":0.6366218},"labels":[],"label_agreement":null},{"id":"W2923871137","doi":"10.6004/jnccn.2018.7184","title":"CLO19-033: Afatinib Followed by Osimertinib in EGFR Mutation-Positive (EGFRm+) Advanced NSCLC: Subgroup Analyses of the GioTag Study by ECOG PS, Age, and Ethnicity","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Afatinib; Medicine; Osimertinib; T790M; Discontinuation; Internal medicine; Oncology; Clinical trial; Erlotinib; Cancer; Epidermal growth factor receptor; Gefitinib","score_opus":0.03281158859745364,"score_gpt":0.3887960014115104,"score_spread":0.35598441281405674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923871137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854713,0.009972793,0.000030885873,0.002084817,0.00073936325,0.001146144,0.00010370434,0.0000052801056,0.0004457189],"genre_scores_gemma":[0.9971284,0.00028479937,0.00017080507,0.0016301752,0.00019658927,0.000029849956,0.000018335853,0.00002107062,0.0005199351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776775,0.00028772574,0.0006973693,0.00022673763,0.0008131153,0.00020731434],"domain_scores_gemma":[0.99708885,0.00060196425,0.00093022076,0.00016617274,0.0011313512,0.00008145536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020038382,0.00020923479,0.00054070534,0.00008646638,0.00014780997,0.000021638567,0.00021556001,0.00006989429,0.000053097017],"category_scores_gemma":[0.00012091862,0.00012481066,0.00022845664,0.00064665766,0.0001122682,0.0001549065,0.0000726876,0.0003969788,0.0000010963923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051249233,0.0028569915,0.6336245,0.00018911867,0.007518213,0.000060582395,0.007023864,0.13569182,0.058326934,0.00020074741,0.14185241,0.007529923],"study_design_scores_gemma":[0.011034834,0.0008209223,0.97801083,0.0008059623,0.001021309,0.000039045244,0.00127921,0.00050281,0.0029453088,0.00045386047,0.002863372,0.00022256195],"about_ca_topic_score_codex":0.00025903116,"about_ca_topic_score_gemma":0.00017618947,"teacher_disagreement_score":0.34438634,"about_ca_system_score_codex":0.00044338556,"about_ca_system_score_gemma":0.0003490703,"threshold_uncertainty_score":0.5089631},"labels":[],"label_agreement":null},{"id":"W2924703224","doi":"10.6004/jnccn.2018.7181","title":"CLO19-042: Quality Assurance for Cancer Radiotherapy: An Update on the Ottawa Hospital Peer Review Experience","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Radiation therapy; Quality assurance; Peer review; Cancer; Medical physics; Surgery; Internal medicine; Pathology","score_opus":0.0546913518596147,"score_gpt":0.44729871715032343,"score_spread":0.3926073652907087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924703224","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2711405,0.3183182,0.0022708522,0.38460892,0.018801766,0.0036615867,0.00014890778,0.000034474902,0.0010147999],"genre_scores_gemma":[0.45696658,0.12349685,0.008380217,0.38325965,0.021590402,0.00046783758,0.00001625851,0.0001172088,0.005705001],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749374,0.00031202703,0.0005985147,0.00022985408,0.0011056573,0.00026021563],"domain_scores_gemma":[0.9943512,0.0012387545,0.00096934376,0.00027564645,0.003078464,0.000086580505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000928996,0.00020433932,0.0005836538,0.000030443938,0.00024926293,0.0000171938,0.00050454657,0.000096650445,0.00054022647],"category_scores_gemma":[0.00039959516,0.000106312,0.0003438833,0.00027181773,0.00020404265,0.00018236702,0.00002125708,0.0005462629,0.0000028206236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002252738,0.00028646796,0.025062017,0.0003650981,0.00101312,0.000004462793,0.0007239347,0.055950888,0.00090571743,0.0060780398,0.8968707,0.010486868],"study_design_scores_gemma":[0.0017736923,0.00055314304,0.04441274,0.0017055181,0.00007609336,0.000046008285,0.00006683847,0.00053771446,0.00013426717,0.0011941374,0.9493214,0.00017845722],"about_ca_topic_score_codex":0.000006602256,"about_ca_topic_score_gemma":0.000010390923,"teacher_disagreement_score":0.19482134,"about_ca_system_score_codex":0.0005418377,"about_ca_system_score_gemma":0.00051427487,"threshold_uncertainty_score":0.5915101},"labels":[],"label_agreement":null},{"id":"W2924811243","doi":"10.6004/jnccn.2018.7118","title":"QIM19-115: Barriers and Trends in Cancer Patients` Pain Management in Qatar: A Randomized Cohort Prospective Study","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer pain; Pharmacy; Cancer; McGill Pain Questionnaire; Population; Physical therapy; Patient satisfaction; Pain medicine; Family medicine; Pain assessment; Pain control; Descriptive statistics; Pain management; Psychiatry; Nursing; Internal medicine; Surgery; Visual analogue scale","score_opus":0.01374777838173413,"score_gpt":0.3025226510876097,"score_spread":0.28877487270587554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924811243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273294,0.0019967863,0.000007532268,0.0013574322,0.000707754,0.0020849255,0.000004992591,0.0000050515614,0.0011025938],"genre_scores_gemma":[0.99576414,0.0005861516,0.000089815774,0.0022158113,0.00030339553,0.00013338302,0.0000029585283,0.000014767262,0.0008895671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771446,0.000497317,0.0005783836,0.00021273228,0.00078097056,0.00021615118],"domain_scores_gemma":[0.99860114,0.00032887422,0.00039945557,0.00010156275,0.0004914981,0.000077452576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013857089,0.00016987017,0.00064776023,0.0003658523,0.000053514206,0.000021424134,0.00016175155,0.000041198775,0.00016491262],"category_scores_gemma":[0.00012336811,0.00011387661,0.00014680854,0.0007118401,0.000064512744,0.000103577186,0.00010348336,0.000354663,9.2334744e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012968099,0.00017647166,0.962482,0.0000363431,0.0007693711,0.000011542278,0.00050435285,0.013361669,0.0000026603448,0.00013873864,0.008193916,0.001354834],"study_design_scores_gemma":[0.077340044,0.00016484449,0.91637087,0.00036105444,0.00020768172,6.892187e-7,0.00041342195,0.0025001925,8.980346e-7,0.00059510104,0.0019364647,0.00010871871],"about_ca_topic_score_codex":0.00008103261,"about_ca_topic_score_gemma":0.0001553164,"teacher_disagreement_score":0.06437194,"about_ca_system_score_codex":0.00065787084,"about_ca_system_score_gemma":0.00007695058,"threshold_uncertainty_score":0.46437535},"labels":[],"label_agreement":null},{"id":"W2925037395","doi":"10.6004/jnccn.2018.7120","title":"QIM19-119: Validity of the French-Language Mammography Satisfaction Instrument Evaluating Women’s Satisfaction With an Organized Breast Cancer Screening Program: A Confirmatory Study","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Centres Intégré Universitaires de Santé et de Services Sociaux; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Medicine; Mammography; Confirmatory factor analysis; Breast cancer; Logistic regression; Structural equation modeling; Clinical psychology; Family medicine; Gerontology; Statistics; Cancer; Internal medicine","score_opus":0.08095070419248306,"score_gpt":0.37498865571731804,"score_spread":0.294037951524835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925037395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962793,0.00065025804,0.000036081594,0.00058372936,0.001003008,0.0013509262,0.000038967144,0.000019552743,0.000038156515],"genre_scores_gemma":[0.9971705,0.000041000865,0.0009261853,0.0009049036,0.0008271725,0.000080116275,0.000002044234,0.000025814485,0.000022276563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617326,0.00044896742,0.0006705464,0.0002467618,0.0021481419,0.00031229673],"domain_scores_gemma":[0.99538493,0.0001381,0.0014318367,0.00025325883,0.0026528505,0.00013902913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006903461,0.00024157426,0.0005202435,0.00011521479,0.00027262472,0.00004911102,0.00025499024,0.000077299635,0.0003498895],"category_scores_gemma":[0.000051876705,0.00014155042,0.00020135764,0.0008549385,0.00011549252,0.00033419995,0.00008750247,0.0006270467,8.040809e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014207576,0.00009834678,0.9501738,0.000053459196,0.00061592954,0.000002847995,0.0013548317,0.028313963,0.002265427,0.000008335034,0.000574469,0.015117839],"study_design_scores_gemma":[0.0034963295,0.0012826293,0.9880586,0.0010271962,0.00032266238,0.00022375658,0.0038646453,0.00119458,0.00016825578,0.000066033586,0.00014161986,0.00015367709],"about_ca_topic_score_codex":0.002163384,"about_ca_topic_score_gemma":0.0012627187,"teacher_disagreement_score":0.03788482,"about_ca_system_score_codex":0.0009781575,"about_ca_system_score_gemma":0.0008292785,"threshold_uncertainty_score":0.57722586},"labels":[],"label_agreement":null},{"id":"W2925222500","doi":"10.6004/jnccn.2018.7231","title":"EPR19-069: Opioid Use Among Cancer Patients Undergoing Surgery and Their Associated Risk of Re-admissions and Emergency Department Visits in the 1-Year Postsurgical Period","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Hydromorphone; Emergency department; Emergency medicine; Oxycodone; Medical prescription; Opioid; Pharmacy; Health care; Prospective cohort study; Medical emergency; Family medicine; Internal medicine; Psychiatry","score_opus":0.07602377924189122,"score_gpt":0.36072584305655375,"score_spread":0.28470206381466256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925222500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855674,0.009896308,0.0000021643157,0.0006669635,0.0004943121,0.0002529771,0.00008078006,0.000002042736,0.00004772982],"genre_scores_gemma":[0.9826802,0.01672947,0.000040137515,0.00029356024,0.00019976478,0.000005449802,0.0000074241602,0.0000102772365,0.00003372553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983817,0.00030638697,0.0005224229,0.00012190612,0.0005139971,0.00015360654],"domain_scores_gemma":[0.99614537,0.0017651641,0.00078563485,0.000081784194,0.0011372154,0.00008483091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032252748,0.00013296749,0.00043828005,0.00007990027,0.00008549734,0.000010756786,0.000097971526,0.00006958791,0.0000769155],"category_scores_gemma":[0.00089550874,0.00007261704,0.00016654156,0.00029128607,0.00005024511,0.00011054659,0.00006163963,0.00029205927,2.0258625e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028263542,0.0000690915,0.9916074,0.000043389453,0.00031965878,0.000001733171,0.0010311311,0.0019595707,0.00007041469,0.000024108891,0.004433861,0.00015699217],"study_design_scores_gemma":[0.0011310698,0.0001229526,0.99337023,0.0019258674,0.0001033777,0.0000034139202,0.00046762638,0.0002475034,0.00007116126,0.0002542054,0.0022278083,0.00007477759],"about_ca_topic_score_codex":0.000097210504,"about_ca_topic_score_gemma":0.00019541239,"teacher_disagreement_score":0.006833163,"about_ca_system_score_codex":0.00018968574,"about_ca_system_score_gemma":0.0003102214,"threshold_uncertainty_score":0.29612368},"labels":[],"label_agreement":null},{"id":"W2944970488","doi":"10.6004/jnccn.2018.7109","title":"Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Medicine; Internal medicine; Testicular cancer; Sex hormone-binding globulin; Odds ratio; Population; Gynecology; Chemotherapy; Endocrinology; Hormone; Androgen","score_opus":0.04068535105628981,"score_gpt":0.350278980485831,"score_spread":0.3095936294295412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944970488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98440164,0.0036548618,0.0000036035697,0.010077433,0.00088038505,0.0008944719,0.000011968779,0.0000029846149,0.0000726258],"genre_scores_gemma":[0.9953944,0.00012065546,0.00018284604,0.003273812,0.000466107,0.000034129276,4.1917033e-7,0.000014641928,0.0005129826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998238,0.00014680358,0.0005653706,0.00017243724,0.00069609843,0.00018127287],"domain_scores_gemma":[0.9977451,0.00029278113,0.0004306306,0.00012487418,0.0013252489,0.000081374346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028055086,0.00014067581,0.00054678787,0.00013561339,0.00005713905,0.0000034316095,0.000120521225,0.0000326438,0.00008410037],"category_scores_gemma":[0.00016391985,0.000083568964,0.00015861723,0.0004488407,0.000043198706,0.000059043436,0.000060185772,0.00031014642,0.0000040004957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000913808,0.00034131884,0.9581065,0.000043027834,0.00037601884,0.0000034477528,0.0021929964,0.036809925,0.00006597396,0.00001435104,0.00090478256,0.00022785757],"study_design_scores_gemma":[0.0024260369,0.00035073212,0.99331295,0.00041674575,0.000052872638,0.000004439777,0.00083856226,0.0000753162,0.000008581552,0.0001114063,0.0023235367,0.000078802106],"about_ca_topic_score_codex":0.00042010852,"about_ca_topic_score_gemma":0.0007325843,"teacher_disagreement_score":0.036734607,"about_ca_system_score_codex":0.00040297187,"about_ca_system_score_gemma":0.0002741414,"threshold_uncertainty_score":0.34078434},"labels":[],"label_agreement":null},{"id":"W2953214266","doi":"10.6004/jnccn.2018.7276","title":"Maintenance of Fitness and Quality-of-Life Benefits From Supervised Exercise Offered as Supportive Care for Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Waist; Physical therapy; Aerobic exercise; Quality of life (healthcare); Randomized controlled trial; Breast cancer; Physical fitness; Internal medicine; Cancer; Body mass index","score_opus":0.04801169281054981,"score_gpt":0.3285238128102642,"score_spread":0.2805121199997144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953214266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615353,0.031999797,0.000024361101,0.0018280179,0.0017689865,0.0005834784,0.0021697998,0.0000039929396,0.00008631287],"genre_scores_gemma":[0.995622,0.0017885688,0.00011538367,0.0013778694,0.00088004576,0.000026763344,0.000021618103,0.000024025861,0.00014372736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980493,0.000082761355,0.0007127871,0.00019354,0.0007618618,0.00019972677],"domain_scores_gemma":[0.99267703,0.00049077783,0.0009772254,0.00015608637,0.005568479,0.00013041955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015861649,0.00017917628,0.00083226705,0.000068491194,0.000062776715,0.000009726553,0.00021738221,0.000100628444,0.00027564538],"category_scores_gemma":[0.000082941755,0.00012676007,0.0003389065,0.00024840946,0.00011152272,0.00009647767,0.000071101684,0.00022967586,5.344545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039462198,0.00025836748,0.8295045,0.004100231,0.00287763,0.0000040246646,0.011322971,0.052989587,0.0108100185,0.0027755932,0.019616034,0.026278837],"study_design_scores_gemma":[0.006237246,0.00022313677,0.97942597,0.0044698277,0.00038265903,0.000016050342,0.0032855032,0.00029805288,0.0013539474,0.0009680919,0.0031154803,0.00022402284],"about_ca_topic_score_codex":0.0011642806,"about_ca_topic_score_gemma":0.00060567306,"teacher_disagreement_score":0.14992148,"about_ca_system_score_codex":0.00022519007,"about_ca_system_score_gemma":0.0009051659,"threshold_uncertainty_score":0.5169126},"labels":[],"label_agreement":null},{"id":"W2966508195","doi":"10.6004/jnccn.2019.7286","title":"Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Epirubicin; Internal medicine; Breast cancer; Docetaxel; Cyclophosphamide; Oncology; Chemotherapy; Anthracycline; Cumulative dose; Fluorouracil; Taxane; Cancer; Gastroenterology","score_opus":0.02260403580150976,"score_gpt":0.3359374223175592,"score_spread":0.3133333865160494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966508195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993797,0.0025476976,0.00007097309,0.0019066342,0.00065786275,0.0004606167,0.00042465987,0.0000028337336,0.00013172919],"genre_scores_gemma":[0.99605876,0.00074939267,0.00019685192,0.0011879569,0.0015924529,0.000027672473,0.000008201805,0.000035083587,0.00014360639],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99879885,0.000061655854,0.0002884091,0.00019943884,0.00043813404,0.0002135296],"domain_scores_gemma":[0.9971923,0.00012403904,0.0006766251,0.00014479527,0.001812014,0.000050207076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009515123,0.00022859182,0.00040111813,0.00003821531,0.000078666046,0.000010256007,0.0002377945,0.000072290524,0.000076723525],"category_scores_gemma":[0.00001018135,0.00013134153,0.0003686856,0.00017033842,0.00009595174,0.000010005435,0.000033830485,0.00012652489,5.581379e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043442637,0.00048677655,0.29187533,0.00007307261,0.008756821,0.0000010505286,0.00037581509,0.5852,0.027091991,0.000166846,0.032692496,0.009837191],"study_design_scores_gemma":[0.0073800706,0.0010004606,0.98307234,0.0003090462,0.00009191352,0.000030561776,0.000040714483,0.00021003718,0.0039525083,0.00033101815,0.0033648103,0.00021650565],"about_ca_topic_score_codex":0.000058796482,"about_ca_topic_score_gemma":0.000028525448,"teacher_disagreement_score":0.69119704,"about_ca_system_score_codex":0.00027547427,"about_ca_system_score_gemma":0.00045435713,"threshold_uncertainty_score":0.5355952},"labels":[],"label_agreement":null},{"id":"W2971731803","doi":"10.6004/jnccn.2019.7301","title":"Edmonton Symptom Assessment Scale and Clinical Characteristics Associated With Cannabinoid Use in Oncology Supportive Care Outpatients","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quartile; Internal medicine; Cannabinoid; Population; Nausea; Statistical significance; Urine; Cancer; Confidence interval","score_opus":0.03876270851438969,"score_gpt":0.38467563807874994,"score_spread":0.34591292956436026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971731803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936811,0.0005635182,0.0000031080713,0.0040024165,0.00086792937,0.0005320632,0.00005314414,0.0000036652023,0.00029307656],"genre_scores_gemma":[0.9959391,0.000250049,0.000089478715,0.0019814617,0.00056504767,0.000013752077,0.000019391751,0.000019518842,0.0011222005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975781,0.0003076594,0.00067144394,0.00020021005,0.0009615126,0.00028109233],"domain_scores_gemma":[0.9950277,0.00018999772,0.0007359991,0.00011006424,0.0037636543,0.00017256048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003839055,0.0001503114,0.00058513304,0.000104702325,0.00007507,0.000033972115,0.0001410579,0.00014097994,0.0000569608],"category_scores_gemma":[0.00020657733,0.00009618836,0.00014999967,0.00029932382,0.00015325639,0.00011740522,0.00010207108,0.0008746873,9.645614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009888903,0.0001915226,0.9764835,0.000035344907,0.00023845636,0.000025240948,0.00023593982,0.0008988103,0.000080138845,0.000019896104,0.019418586,0.0013836455],"study_design_scores_gemma":[0.0035681622,0.0013880221,0.9761997,0.00057244493,0.00010696934,0.000046458237,0.00030175765,0.0005765942,0.000010214621,0.000024246434,0.01710205,0.00010338682],"about_ca_topic_score_codex":0.000089305235,"about_ca_topic_score_gemma":0.00046612322,"teacher_disagreement_score":0.0028021417,"about_ca_system_score_codex":0.0015697363,"about_ca_system_score_gemma":0.0019741396,"threshold_uncertainty_score":0.4104806},"labels":[],"label_agreement":null},{"id":"W2972016640","doi":"10.6004/jnccn.2019.7298","title":"Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple Myeloma","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Decile; Multiple myeloma; Hazard ratio; Cancer; Proportional hazards model; Internal medicine; Population; Community hospital; Cohort; Emergency medicine; Family medicine; Nursing; Confidence interval; Environmental health","score_opus":0.02461337907977604,"score_gpt":0.2907486100880378,"score_spread":0.26613523100826175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972016640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987872,0.00034351804,0.0000030731603,0.00012963523,0.000094884985,0.0004621963,0.00007958132,0.0000022788777,0.0000976221],"genre_scores_gemma":[0.9995048,0.000022256756,0.00020906262,0.0001259792,0.00006324388,0.0000052879145,0.0000057227803,0.000008484935,0.000055172175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821305,0.0000676583,0.00040182198,0.0001379722,0.0010189638,0.00016052292],"domain_scores_gemma":[0.9965582,0.0003469388,0.00060129917,0.000117062635,0.0022929884,0.00008352569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000839961,0.0001215766,0.0003530171,0.00007613501,0.000058219674,0.000007819426,0.00011405305,0.000037515656,0.000026279096],"category_scores_gemma":[0.00022310554,0.00007139861,0.00008738716,0.00019850713,0.000090613976,0.0001073168,0.00008568022,0.00020816839,0.0000012497163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023546498,0.00013345032,0.93029815,0.00010809253,0.00030205588,0.0000016722212,0.0001235868,0.06364459,0.00039952464,0.000011958613,0.00012394693,0.002498341],"study_design_scores_gemma":[0.0039593354,0.0009429908,0.9921947,0.0006867577,0.00004299658,0.0000050689073,0.000046505393,0.0012706575,0.0004601248,0.00004830973,0.00028374325,0.000058814217],"about_ca_topic_score_codex":0.00004204949,"about_ca_topic_score_gemma":0.000011698815,"teacher_disagreement_score":0.062373932,"about_ca_system_score_codex":0.00014199901,"about_ca_system_score_gemma":0.00016618302,"threshold_uncertainty_score":0.29115507},"labels":[],"label_agreement":null},{"id":"W2984531433","doi":"10.6004/jnccn.2019.0029","title":"NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Amgen (Canada)","funders":"National Comprehensive Cancer Network","keywords":"Medicine; Follicular lymphoma; Oncology; Lymphoma; Internal medicine; Refractory (planetary science); Diffuse large B-cell lymphoma; Cancer research; Biology","score_opus":0.054509489926656274,"score_gpt":0.3547670538761647,"score_spread":0.3002575639495084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984531433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140428,0.044527642,0.000037784175,0.015059745,0.0066666813,0.00088236196,0.000022906444,0.000024523499,0.0187356],"genre_scores_gemma":[0.9075756,0.0060560396,0.0014980172,0.021293864,0.01144437,0.000009310492,0.00001564601,0.00008548149,0.052021667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972865,0.00012942619,0.00055816665,0.00016896552,0.0016091412,0.00024778157],"domain_scores_gemma":[0.99395174,0.00034475257,0.00047480155,0.00020235273,0.0048952927,0.00013106063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026984242,0.00016573649,0.00039214888,0.00014047988,0.00011354062,0.000028668233,0.00036348304,0.00010248089,0.0025501184],"category_scores_gemma":[0.00010630822,0.000105015,0.00036342192,0.00049878174,0.00006918304,0.00012777677,0.00013281632,0.00046030988,0.000097790464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020247614,0.000117444826,0.009851891,0.00007196103,0.00037726585,0.000014007722,0.00010757816,0.048468336,0.0774824,0.00019946492,0.8589824,0.0023024776],"study_design_scores_gemma":[0.004785005,0.0003119034,0.018146342,0.00056554197,0.000088483175,0.0001831843,0.00008624147,0.0021059166,0.0035727106,0.0010403955,0.96896297,0.0001513274],"about_ca_topic_score_codex":0.00001915061,"about_ca_topic_score_gemma":0.0000023496277,"teacher_disagreement_score":0.109980546,"about_ca_system_score_codex":0.00069657044,"about_ca_system_score_gemma":0.0008492592,"threshold_uncertainty_score":0.9983617},"labels":[],"label_agreement":null},{"id":"W2985558334","doi":"10.6004/jnccn.2019.0039","title":"NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"Genentech; Puma Biotechnology; Clovis Oncology; Eisai; National Comprehensive Cancer Network; Gilead Sciences; Novartis Pharmaceuticals Corporation; Biogen; Celgene; Bristol-Myers Squibb; AstraZeneca; Genomic Health; Amgen","keywords":"Medicine; Bevacizumab; Ovarian cancer; Chemotherapy; Oncology; Cytoreductive surgery; Internal medicine; Disease; Cancer; Hyperthermic intraperitoneal chemotherapy; Intensive care medicine","score_opus":0.05275035830377755,"score_gpt":0.3485380236263211,"score_spread":0.2957876653225435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985558334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6719925,0.16261746,0.00007225763,0.13287863,0.024518523,0.0016999092,0.0001483098,0.000047140602,0.006025264],"genre_scores_gemma":[0.9547421,0.00995716,0.0014050405,0.0226467,0.008588994,0.000027553173,0.000010991733,0.00004646027,0.0025750182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794525,0.00007375648,0.00057756715,0.0001968521,0.0009916872,0.00021487405],"domain_scores_gemma":[0.99549085,0.00019674734,0.00064694235,0.0001802413,0.0033600016,0.00012522978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013090462,0.00019258811,0.0004536655,0.00009673142,0.00012870903,0.000027837246,0.00023568801,0.00009149441,0.0007602106],"category_scores_gemma":[0.000060741786,0.000117256226,0.00034465297,0.000414644,0.000045713172,0.00013892805,0.000082146944,0.00033328903,0.000042391548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008588617,0.00014398196,0.06013178,0.000057767993,0.0011449028,0.000015353924,0.00009909535,0.086703345,0.0009192406,0.0010723218,0.84547263,0.003380731],"study_design_scores_gemma":[0.0049440865,0.00029056173,0.22477798,0.0016594863,0.00038308016,0.00010191807,0.00005098335,0.0009574787,0.00049859,0.0013520356,0.76480883,0.00017496536],"about_ca_topic_score_codex":0.00009748219,"about_ca_topic_score_gemma":0.000015012395,"teacher_disagreement_score":0.28274956,"about_ca_system_score_codex":0.0008540065,"about_ca_system_score_gemma":0.00089242175,"threshold_uncertainty_score":0.8323774},"labels":[],"label_agreement":null},{"id":"W2986820418","doi":"10.6004/jnccn.2019.7319","title":"Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Logistic regression; Odds ratio; Internal medicine; Palliative care; Genitourinary system; Cancer; Guideline; Bladder cancer; Oncology; Emergency medicine; Nursing","score_opus":0.03137088782638336,"score_gpt":0.3416066677829699,"score_spread":0.3102357799565865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986820418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821806,0.012711903,0.000015582365,0.0031130044,0.0008958186,0.00065995444,0.00025780697,0.0000050901945,0.00016025602],"genre_scores_gemma":[0.99690884,0.0001080362,0.00036089963,0.0020045722,0.00046663726,0.000065320695,0.000013068035,0.000025337844,0.000047294645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859834,0.000089695044,0.0003022403,0.0001748051,0.0006135929,0.00022131308],"domain_scores_gemma":[0.9971666,0.0002317844,0.00024915507,0.00005742877,0.0022178327,0.00007720837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047772577,0.00017818899,0.0003993183,0.00010776194,0.00015925468,0.00002241189,0.00009018294,0.000050302056,0.00011873125],"category_scores_gemma":[0.000033894637,0.0001097445,0.00013490704,0.00024686143,0.00009799786,0.00010605513,0.000028508804,0.00024414802,2.5866078e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044216863,0.00007025283,0.9653999,0.00028333222,0.0010231436,0.0000018702295,0.013522789,0.0049590254,0.00001747576,0.00013692497,0.0017228355,0.008440718],"study_design_scores_gemma":[0.008370851,0.0010397151,0.9813801,0.00056605256,0.00042316428,0.0000018591784,0.0032797928,0.00006746726,0.000036639918,0.00022725013,0.0044515743,0.0001555524],"about_ca_topic_score_codex":0.000026634303,"about_ca_topic_score_gemma":0.000095188174,"teacher_disagreement_score":0.015980136,"about_ca_system_score_codex":0.0006698078,"about_ca_system_score_gemma":0.00049523107,"threshold_uncertainty_score":0.44752508},"labels":[],"label_agreement":null},{"id":"W2994498882","doi":"10.6004/jnccn.2019.7333","title":"Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Canadian Agency for Drugs and Technologies in Health; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Surrogate endpoint; Hazard ratio; Internal medicine; Clinical endpoint; Randomized controlled trial; Clinical trial; Progression-free survival; Overall survival; Oncology; Confidence interval","score_opus":0.39117253971620003,"score_gpt":0.47214923265836745,"score_spread":0.08097669294216742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994498882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95971733,0.009848284,0.0001977965,0.022030417,0.0069768303,0.00060149643,0.00018843457,0.000004939414,0.00043446358],"genre_scores_gemma":[0.9768577,0.00049211463,0.0010764648,0.01983221,0.0015501507,0.000009679817,0.0000014556427,0.0000247792,0.00015542866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934019,0.000748248,0.004802129,0.00028196108,0.00046796614,0.000297782],"domain_scores_gemma":[0.9825563,0.005675284,0.0103361,0.00036206102,0.0009715746,0.00009866845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009047193,0.00017714214,0.0011621203,0.00027402455,0.000118906646,0.000038080765,0.0008757414,0.00020536016,0.00022119752],"category_scores_gemma":[0.0075952196,0.00014181178,0.0005276717,0.00093254785,0.0001260372,0.00023909843,0.000161525,0.0008208935,0.00006155783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069248126,0.00006729889,0.79047894,0.00008376213,0.00016076013,3.9589105e-7,0.0001270669,0.16266577,0.0000013651126,0.030552877,0.015729694,0.00006279839],"study_design_scores_gemma":[0.0010435012,0.000044045286,0.8956054,0.0009275326,0.000015372381,0.0000056199733,0.00012958095,0.005354424,0.00000803765,0.08436736,0.012352568,0.00014658223],"about_ca_topic_score_codex":0.00010696058,"about_ca_topic_score_gemma":0.00010298563,"teacher_disagreement_score":0.15731135,"about_ca_system_score_codex":0.0008094798,"about_ca_system_score_gemma":0.00041263612,"threshold_uncertainty_score":0.90927356},"labels":[],"label_agreement":null},{"id":"W2999289987","doi":"10.6004/jnccn.2019.7350","title":"Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Surgical Specialties (Canada)","funders":"Università degli Studi di Brescia","keywords":"Medicine; Renal cell carcinoma; Proportional hazards model; Nephrectomy; Stage (stratigraphy); Internal medicine; Kidney cancer; Cancer; Oncology; T-stage; Surgery; Kidney","score_opus":0.057162086944132565,"score_gpt":0.27677181937038,"score_spread":0.21960973242624743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999289987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868611,0.0062739463,0.000108174216,0.0052429205,0.0005207206,0.00048527942,0.00039011042,0.000005665774,0.00011209372],"genre_scores_gemma":[0.99543166,0.00015417047,0.0005763262,0.0019023741,0.0017665937,0.00004071365,0.00004204128,0.000030411791,0.00005568104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971604,0.00017594743,0.0004431827,0.00023594887,0.0017296261,0.00025490363],"domain_scores_gemma":[0.99568874,0.00021930508,0.00093583635,0.00013473346,0.0028001734,0.00022124182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010360985,0.00026392651,0.0006278437,0.0000751846,0.00008705288,0.000021388649,0.00020586005,0.000059223472,0.00029099948],"category_scores_gemma":[0.000023917435,0.00016449566,0.00026714086,0.00044617587,0.00018134406,0.00010915757,0.00006990846,0.00039113715,0.0000017053607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056187133,0.0003255268,0.94299525,0.0003047777,0.001133247,0.000074908945,0.00035454755,0.022547415,0.0017825387,0.00005335393,0.024575472,0.00023426472],"study_design_scores_gemma":[0.0042724367,0.0007066301,0.9823908,0.00018849268,0.00050879584,0.000014774683,0.000050856754,0.00012767212,0.0019605327,0.000093839364,0.009525555,0.00015958461],"about_ca_topic_score_codex":0.000014886007,"about_ca_topic_score_gemma":0.000030889125,"teacher_disagreement_score":0.039395597,"about_ca_system_score_codex":0.00042661544,"about_ca_system_score_gemma":0.00050968525,"threshold_uncertainty_score":0.67079383},"labels":[],"label_agreement":null},{"id":"W2999610977","doi":"10.6004/jnccn.2019.7342","title":"High-Cost Patients and Preventable Spending: A Population-Based Study","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Canadian Partnership Against Cancer; Health Sciences Centre; CARE Canada; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Cancer; Emergency department; Population; Emergency medicine; Pancreatic cancer; Prostate cancer; Colorectal cancer; Health care; Internal medicine; Environmental health","score_opus":0.06240826885090329,"score_gpt":0.27654871673092896,"score_spread":0.21414044788002567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999610977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211353,0.002094426,0.00017359738,0.0032859524,0.0013941603,0.00042265572,0.00012289522,0.0000058335427,0.00038693435],"genre_scores_gemma":[0.99365646,0.000052836767,0.00023309248,0.004831861,0.0011452838,0.00000848851,0.0000036662027,0.000015404166,0.000052926025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887866,0.000028669085,0.000646711,0.00016993386,0.00011228766,0.00016376845],"domain_scores_gemma":[0.9984281,0.00009575124,0.0010361129,0.000062458974,0.0002719235,0.00010564482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015942668,0.00012323436,0.00038175363,0.00005884364,0.00014993455,0.000059375918,0.00023551525,0.000043121556,0.00015816548],"category_scores_gemma":[0.00015854354,0.00010870332,0.000113395225,0.00020912898,0.000022567134,0.0002516485,0.00006021699,0.00020705424,0.000010130373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012269268,0.0000717906,0.90880764,0.000010403634,0.00010004367,4.8805435e-7,0.00011493134,0.07548506,0.0000013352749,0.0034335456,0.011593173,0.00025887872],"study_design_scores_gemma":[0.001686731,0.00016323871,0.9690827,0.000032208074,0.00001906922,6.889431e-7,0.000021016122,0.001194823,0.000004417031,0.008101163,0.019561619,0.00013230076],"about_ca_topic_score_codex":0.00009067237,"about_ca_topic_score_gemma":0.000021717742,"teacher_disagreement_score":0.07429024,"about_ca_system_score_codex":0.00027168344,"about_ca_system_score_gemma":0.00006567132,"threshold_uncertainty_score":0.4432793},"labels":[],"label_agreement":null},{"id":"W3000286044","doi":"10.6004/jnccn.2019.7345","title":"Response Rates and Durations of Response for Biomarker-Based Cancer Drugs in Nonrandomized Versus Randomized Trials","year":2020,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Randomized controlled trial; Relative risk; Meta-analysis; Pharmacogenomics; Confidence interval; Biomarker; Internal medicine; Oncology; Pharmacology","score_opus":0.7160078237002326,"score_gpt":0.6306847045581461,"score_spread":0.08532311914208657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000286044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012971925,0.9796828,0.0051948274,0.0044187387,0.0039123986,0.005399151,0.0012441025,0.000009133162,0.000009152033],"genre_scores_gemma":[0.00008111091,0.88547343,0.11148656,0.00038292122,0.0014981751,0.00095186045,0.000003981115,0.00008004174,0.00004193989],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9443724,0.047378197,0.006486718,0.00037919192,0.0010787749,0.000304698],"domain_scores_gemma":[0.46958283,0.52229625,0.006110841,0.00015298139,0.0017551931,0.00010191517],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.041515503,0.0004987288,0.0099802315,0.00033515727,0.00012855513,0.000052910487,0.0005874547,0.00038793017,0.00010091147],"category_scores_gemma":[0.53112775,0.00029503976,0.0029292572,0.0009042855,0.00046730487,0.00006258168,0.00011546426,0.0007308991,4.6798056e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94611603,0.00008794915,5.9176847e-7,0.0022441242,0.0027601132,0.0000030880447,0.00006946252,0.0005849783,0.000018732411,0.0012208213,0.012639614,0.034254476],"study_design_scores_gemma":[0.4669787,0.00037765305,0.000018131726,0.028319547,0.009396908,0.000010072996,0.00003291634,0.0016744967,0.000026025738,0.14080341,0.35182875,0.0005334007],"about_ca_topic_score_codex":0.0000058090427,"about_ca_topic_score_gemma":0.0000053346766,"teacher_disagreement_score":0.48961228,"about_ca_system_score_codex":0.00055982743,"about_ca_system_score_gemma":0.0036015688,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W3009190269","doi":"10.6004/jnccn.2019.7355","title":"Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Depression (economics); Internal medicine; Cancer","score_opus":0.04537247242861947,"score_gpt":0.3190493510386566,"score_spread":0.27367687861003714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009190269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9036654,0.0122553045,0.0026500423,0.076701194,0.0025025643,0.001694792,0.00036974016,0.000042446558,0.000118499986],"genre_scores_gemma":[0.96611446,0.0005252065,0.004203888,0.023253722,0.004573542,0.000080317914,0.000010434346,0.0000554936,0.0011829319],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.997846,0.00006835301,0.0005331102,0.00022539092,0.0010517011,0.0002754566],"domain_scores_gemma":[0.9956766,0.000597579,0.00087557954,0.00011070434,0.0025865478,0.00015300514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012764614,0.00021996268,0.0005018412,0.000051198742,0.0002723358,0.000033970202,0.0002680761,0.00007256164,0.00020819118],"category_scores_gemma":[0.0003606588,0.00013247695,0.00034644236,0.000306976,0.00009887194,0.00015887644,0.000100912206,0.00043379673,0.0000030275235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007258896,0.00006140166,0.28679514,0.00029501828,0.0021974004,0.000016171804,0.0013059587,0.15977612,0.0003414048,0.000036658566,0.53675747,0.0051583657],"study_design_scores_gemma":[0.012950106,0.00044767343,0.89686203,0.0029983069,0.00094524777,0.00013912727,0.00035529348,0.008506295,0.00090166024,0.00021059059,0.075323924,0.00035977107],"about_ca_topic_score_codex":0.000039234223,"about_ca_topic_score_gemma":0.000085577725,"teacher_disagreement_score":0.6100669,"about_ca_system_score_codex":0.00031795248,"about_ca_system_score_gemma":0.000288739,"threshold_uncertainty_score":0.5402253},"labels":[],"label_agreement":null},{"id":"W3009260200","doi":"10.6004/jnccn.2019.7361","title":"Benefits of High-Volume Medical Oncology Care for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University of Manitoba; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Oncology; Adenocarcinoma; Volume (thermodynamics); Internal medicine; Cancer","score_opus":0.061142501798275815,"score_gpt":0.36747636222363167,"score_spread":0.3063338604253559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009260200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95118487,0.015894188,0.0019872433,0.029442616,0.00042529948,0.00071304594,0.00011966041,0.000009140465,0.0002239552],"genre_scores_gemma":[0.9899365,0.0001863711,0.0033848959,0.004669356,0.0016774833,0.0000315891,0.000040354284,0.000014920195,0.00005856037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739057,0.00020713217,0.0007526398,0.00017060562,0.0012413651,0.00023771018],"domain_scores_gemma":[0.9939115,0.001373198,0.0007441774,0.00011024342,0.0035998204,0.0002610369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029633136,0.00013753945,0.0011134543,0.00014712832,0.00014582851,0.0000069699186,0.0002903012,0.00017885485,0.0004075501],"category_scores_gemma":[0.0010252483,0.00009402622,0.0004927226,0.00090729265,0.000116688265,0.000044106466,0.00005164024,0.00039506645,0.00000166516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016899364,0.00008597025,0.76947755,0.0002413958,0.0023156835,0.0000065006225,0.00025605928,0.21313187,0.000026871812,0.0004281818,0.011592713,0.0007472706],"study_design_scores_gemma":[0.0038601302,0.0010027604,0.9458262,0.00028694628,0.0034310468,0.000027106029,0.00015123088,0.041645173,0.00003369094,0.00031574324,0.0033259944,0.00009399875],"about_ca_topic_score_codex":0.00015673605,"about_ca_topic_score_gemma":0.00008465026,"teacher_disagreement_score":0.17634864,"about_ca_system_score_codex":0.00051915116,"about_ca_system_score_gemma":0.002320168,"threshold_uncertainty_score":0.4462388},"labels":[],"label_agreement":null},{"id":"W3010095527","doi":"10.6004/jnccn.2019.7362","title":"Quantifying the Survival Benefits of Oncology Drugs With a Focus on Immunotherapy Using Restricted Mean Survival Time","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Immunotherapy; Oncology; Internal medicine; Survival analysis; Cancer","score_opus":0.1235603526455778,"score_gpt":0.30638243455030495,"score_spread":0.18282208190472715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010095527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95838666,0.01503603,0.0005120108,0.0160251,0.002346332,0.00040159313,0.00022288662,0.000011766963,0.0070576067],"genre_scores_gemma":[0.99430156,0.00083117496,0.00031867472,0.0026218018,0.0018551816,0.0000032488863,0.0000011506669,0.00003102979,0.000036192097],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983935,0.00009929717,0.00086606765,0.00019172112,0.00020148394,0.00024796842],"domain_scores_gemma":[0.99649906,0.00054488156,0.0020809309,0.00013881414,0.0006606911,0.000075645665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041121285,0.00018201613,0.0006782212,0.000084500796,0.00020340702,0.00003867674,0.0005366849,0.00009331819,0.00009923096],"category_scores_gemma":[0.000112451075,0.00012386411,0.00024024249,0.000493148,0.00014189859,0.00017048734,0.00006297698,0.00044067632,0.000009609191],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033245382,0.00010800993,0.016108977,0.000025113939,0.001112858,0.000002854185,0.0019801166,0.8855171,0.00037990927,0.08043098,0.006419313,0.004590204],"study_design_scores_gemma":[0.016913643,0.0045907646,0.6141009,0.0012463774,0.0002896123,0.00008961267,0.0011727801,0.04844135,0.00094971585,0.05198423,0.25836933,0.0018516852],"about_ca_topic_score_codex":0.0001308454,"about_ca_topic_score_gemma":0.000039335628,"teacher_disagreement_score":0.83707577,"about_ca_system_score_codex":0.0004033339,"about_ca_system_score_gemma":0.00034451063,"threshold_uncertainty_score":0.5051032},"labels":[],"label_agreement":null},{"id":"W3011832439","doi":"10.6004/jnccn.2019.7502","title":"CLO20-051: LYMPHA: Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections. A Pilot Study","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lymphedema; NODAL; Cancer; Surgery; Oncology; General surgery; Internal medicine; Breast cancer","score_opus":0.09105522967383024,"score_gpt":0.35077567840027735,"score_spread":0.2597204487264471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011832439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988239,0.0044806036,0.000017502574,0.005295919,0.0010324542,0.0006571338,0.000017468648,0.000007316921,0.0002525844],"genre_scores_gemma":[0.99454105,0.00008756468,0.000040181367,0.0018576315,0.0033793412,0.00003705623,0.0000013885194,0.000019289126,0.000036500867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742025,0.00024799263,0.0008437888,0.00016332799,0.0011258682,0.00019874978],"domain_scores_gemma":[0.9965321,0.00051644567,0.00089387654,0.00010826862,0.0018317696,0.000117586824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023660132,0.00016352278,0.00045328581,0.000071414324,0.00017506623,0.000022095102,0.00029666536,0.000029926865,0.000059820977],"category_scores_gemma":[0.00053220784,0.00009481878,0.00017126129,0.00066957483,0.00007977052,0.00011722679,0.00011781474,0.00006538848,0.0000012351821],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027358343,0.0010246555,0.7300355,0.00027497963,0.00087349926,0.000017696619,0.0049648965,0.24133965,0.0013169269,0.00008706394,0.015869355,0.0014599488],"study_design_scores_gemma":[0.007548263,0.0014723189,0.9786796,0.001675328,0.00044676353,0.00003504417,0.003492398,0.0054189013,0.00011207575,0.00019240733,0.0007601822,0.00016674255],"about_ca_topic_score_codex":0.00027160288,"about_ca_topic_score_gemma":0.000029417764,"teacher_disagreement_score":0.24864408,"about_ca_system_score_codex":0.0005552063,"about_ca_system_score_gemma":0.00065544137,"threshold_uncertainty_score":0.38665977},"labels":[],"label_agreement":null},{"id":"W3012039566","doi":"10.6004/jnccn.2019.7402","title":"CLO20-047: Impact of Treating Physician on Late Treatment Related Morbidity – a Secondary Analysis of a Phase III Randomized Controlled Study in Localized Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Prostate cancer; Randomized controlled trial; Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.04619140862045137,"score_gpt":0.32973219559117256,"score_spread":0.2835407869707212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012039566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885501,0.0076201526,0.000029935238,0.00063870836,0.0003499219,0.0013749694,0.0004802728,0.000004633252,0.00095126114],"genre_scores_gemma":[0.9974167,0.0014674426,0.00002691831,0.00060617743,0.0002995672,0.00008113399,0.000006759189,0.00002115293,0.000074151816],"study_design_codex":"simulation_or_modeling","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965553,0.00023864879,0.0025061616,0.00027179753,0.00017278663,0.0002552956],"domain_scores_gemma":[0.99354744,0.0006528974,0.0049723685,0.00014507941,0.00057811936,0.000104098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471637,0.00028649092,0.0038141827,0.0003925144,0.00007599456,0.000025170963,0.00026783536,0.00008237485,0.00024253438],"category_scores_gemma":[0.00025773983,0.00019956788,0.0017673215,0.0012007748,0.00012895276,0.00019039024,0.000039487637,0.00031790556,0.0000014237855],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121968895,0.0006396332,0.03551722,0.000015986843,0.013575647,0.0000042354854,0.0026860454,0.82338953,0.00007716419,0.0006094392,0.00049048354,0.0010257305],"study_design_scores_gemma":[0.6647649,0.0021864707,0.1422544,0.00028068255,0.0022600098,0.00000109728,0.00025919508,0.1820659,0.00008043299,0.004992639,0.00043044015,0.00042382415],"about_ca_topic_score_codex":0.0014613937,"about_ca_topic_score_gemma":0.00019622885,"teacher_disagreement_score":0.6413236,"about_ca_system_score_codex":0.00091727,"about_ca_system_score_gemma":0.00048481277,"threshold_uncertainty_score":0.81381416},"labels":[],"label_agreement":null},{"id":"W3022049138","doi":"10.6004/jnccn.2020.7531","title":"Letter to the Editor: Radiation for Prior DCIS is a Risk Factor for Death From Invasive Breast Cancer","year":2020,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Risk factor; Cancer; Internal medicine","score_opus":0.030119963393945893,"score_gpt":0.2949070088732546,"score_spread":0.2647870454793087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022049138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007874676,0.010647031,0.0011092479,0.9363092,0.0136032505,0.0017616551,0.035769526,0.00000602207,0.0000065801],"genre_scores_gemma":[0.0048932787,0.0014973505,0.0005571734,0.6987564,0.29336968,0.00059489947,0.00013870516,0.00007021193,0.00012233203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979211,0.00015241335,0.00049290876,0.00043217032,0.0006541519,0.00034723274],"domain_scores_gemma":[0.9954496,0.0006986736,0.0012272391,0.00021927845,0.0023314646,0.00007373479],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007045691,0.0004063041,0.0005006392,0.000044272652,0.00043972966,0.000067164154,0.0006800949,0.00033064996,0.000052105544],"category_scores_gemma":[0.00017783865,0.0002507386,0.0006918739,0.00013826921,0.0000650343,0.000011945231,0.00017840866,0.0006699158,0.0000024607093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007972358,0.000010782903,0.0007812855,0.00003526508,0.0022551576,0.0000010419916,0.00018814059,0.0047341683,0.00023571461,8.02509e-7,0.988481,0.002479444],"study_design_scores_gemma":[0.0013279428,0.00011193659,0.017631402,0.00019205228,0.00059232034,0.000008457042,0.000011474218,0.00004867258,0.00067563984,0.00031175808,0.9788118,0.00027655115],"about_ca_topic_score_codex":0.000088239576,"about_ca_topic_score_gemma":0.00011303882,"teacher_disagreement_score":0.27976644,"about_ca_system_score_codex":0.0004816836,"about_ca_system_score_gemma":0.0007302505,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W3023660975","doi":"10.6004/jnccn.2019.7382","title":"Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Logistic regression; Odds ratio; Proportional hazards model; Clinical trial; Hazard ratio; Opioid; Colorectal cancer; Oncology; Confidence interval; Cancer; Surgery","score_opus":0.13150185525282418,"score_gpt":0.40005083265567326,"score_spread":0.2685489774028491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023660975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890665,0.0018944081,0.00013428433,0.007557327,0.0006345809,0.0005410632,0.00015559622,0.0000051953257,0.0000110379015],"genre_scores_gemma":[0.9913537,0.00026217982,0.0020832997,0.004712711,0.0014748872,0.00001844811,0.000010638725,0.0000246968,0.000059441736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967925,0.0005097085,0.0014156986,0.00020388926,0.00087471213,0.00020348541],"domain_scores_gemma":[0.9928518,0.003931808,0.0011577897,0.000122059144,0.0017499038,0.00018666396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050739676,0.00019025702,0.0010371028,0.00010471372,0.00006804238,0.000018643672,0.00023236738,0.00006438769,0.00012813167],"category_scores_gemma":[0.004163311,0.00011895766,0.00034724615,0.0005270419,0.00010232457,0.00015828425,0.000053935597,0.0005811455,0.0000017339752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013221604,0.00009553382,0.94436485,0.000021764088,0.00020274702,0.0000051407997,0.00017211914,0.031636056,0.00011331712,0.000014718344,0.008826856,0.0013253028],"study_design_scores_gemma":[0.005258387,0.00058220973,0.98375964,0.0013479821,0.00018013049,0.000008490307,0.00004644376,0.0001975651,0.000050091454,0.00007885285,0.008378201,0.000111996655],"about_ca_topic_score_codex":0.00006796311,"about_ca_topic_score_gemma":0.000052715754,"teacher_disagreement_score":0.039394807,"about_ca_system_score_codex":0.00028342713,"about_ca_system_score_gemma":0.0007777467,"threshold_uncertainty_score":0.49841726},"labels":[],"label_agreement":null},{"id":"W3033313243","doi":"10.6004/jnccn.2019.7385","title":"Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Massachusetts General Hospital","keywords":"Medicine; Functional impairment; Activities of daily living; Observational study; Anxiety; Depression (economics); Physical therapy; Bathing; Cancer; Internal medicine; Psychiatry","score_opus":0.03003977940645467,"score_gpt":0.3165171157196245,"score_spread":0.2864773363131698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033313243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840623,0.0024192545,0.000054446136,0.01083613,0.002090616,0.00038099563,0.000056316167,0.000014139887,0.00008578455],"genre_scores_gemma":[0.9863172,0.00063559285,0.00012237258,0.009517658,0.0032389227,0.000019571486,0.000008696986,0.00002621862,0.000113778406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978906,0.00009924794,0.0005560513,0.00022132299,0.0010282532,0.00020451716],"domain_scores_gemma":[0.99649584,0.00025267576,0.0006559066,0.000088402725,0.0022460562,0.0002610882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001071265,0.00020112601,0.0005253419,0.00003926133,0.0001352573,0.000026826738,0.00014431265,0.0000788944,0.00017842362],"category_scores_gemma":[0.00010005424,0.000119934426,0.00030271395,0.00030904694,0.00017494654,0.00015763465,0.000081440405,0.00048785587,0.0000012305283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019616592,0.000043400836,0.96599185,0.000032556814,0.0007999834,0.0000034186467,0.00015666985,0.007921279,0.0000050516555,0.000023255167,0.021603158,0.0014577402],"study_design_scores_gemma":[0.005571107,0.00055313605,0.9743119,0.00031838284,0.00031766962,0.000006665881,0.00007845542,0.00021837633,0.000003333679,0.0000818703,0.018398313,0.00014080944],"about_ca_topic_score_codex":0.000062177205,"about_ca_topic_score_gemma":0.00007533948,"teacher_disagreement_score":0.008320053,"about_ca_system_score_codex":0.00023339235,"about_ca_system_score_gemma":0.00040166482,"threshold_uncertainty_score":0.48907837},"labels":[],"label_agreement":null},{"id":"W3088958758","doi":"10.6004/jnccn.2020.7609","title":"Adjuvant Treatment of Early Ovarian Clear Cell Carcinoma: A Population-Based Study of Whole Abdominal Versus Pelvic Nodal Radiotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"Sanofi","keywords":"Medicine; Internal medicine; Radiation therapy; Hazard ratio; Stage (stratigraphy); Population; Oncology; Chemoradiotherapy; Surgery; Confidence interval","score_opus":0.046528856390585134,"score_gpt":0.32332312424064363,"score_spread":0.2767942678500585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088958758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651576,0.010275324,0.000020242278,0.001510542,0.0011095785,0.00042889683,0.000047813122,0.000003071565,0.00008877035],"genre_scores_gemma":[0.99748707,0.00013947357,0.00094937783,0.00024051384,0.001061861,0.000018242468,0.000008782271,0.000022994363,0.000071661445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979694,0.00018393568,0.00065201253,0.0001876713,0.0008373512,0.0001696684],"domain_scores_gemma":[0.9968025,0.00036805397,0.0008274924,0.000204162,0.00170134,0.0000964621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000836234,0.00018912584,0.0006624254,0.000095540534,0.00009559061,0.0000133079375,0.00011751332,0.000058673606,0.00014911058],"category_scores_gemma":[0.00001983798,0.00013049807,0.00038869708,0.0003913277,0.000036557314,0.00005014557,0.000018858582,0.00014311718,7.551666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013745331,0.0055600265,0.81856805,0.00009892684,0.0021302588,0.00013173628,0.0012556434,0.15108342,0.0015251958,0.00007937741,0.0022048955,0.0036171053],"study_design_scores_gemma":[0.025326999,0.0058835847,0.96381,0.00019219484,0.00079974247,0.000023778925,0.00030052118,0.0007389529,0.0011553764,0.000045244036,0.0016190344,0.0001045355],"about_ca_topic_score_codex":0.00034357942,"about_ca_topic_score_gemma":0.00009071838,"teacher_disagreement_score":0.15034448,"about_ca_system_score_codex":0.0009367832,"about_ca_system_score_gemma":0.0009664122,"threshold_uncertainty_score":0.5321557},"labels":[],"label_agreement":null},{"id":"W3092516330","doi":"10.6004/jnccn.2020.7627","title":"Treatment Outcomes in Chronic Myeloid Leukemia: Does One Size Fit All?","year":2020,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Discontinuation; Adverse effect; Myeloid leukemia; Intensive care medicine; Population; Disease; Quality of life (healthcare); Oncology; Internal medicine","score_opus":0.10120312174648217,"score_gpt":0.38201367040170936,"score_spread":0.2808105486552272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092516330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002621423,0.9927841,0.0000012735841,0.003383661,0.0017097103,0.0014778794,0.00012327422,0.000018432787,0.00023956924],"genre_scores_gemma":[0.00049149216,0.9901199,0.00034473377,0.0014737841,0.0057550785,0.00014437789,0.000024751314,0.00009811953,0.0015477905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955392,0.000347572,0.001715401,0.00045841088,0.0014200006,0.0005194298],"domain_scores_gemma":[0.9947121,0.0018629039,0.0020832277,0.0003368839,0.00074498606,0.0002598904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014405578,0.0007888862,0.0039400635,0.00018459333,0.000108534194,0.00003920205,0.00056596147,0.00039731906,0.00032808978],"category_scores_gemma":[0.00029392983,0.00038883323,0.0018961173,0.00069700123,0.00011762178,0.00010206306,0.00019093431,0.0014319187,0.000035210942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008760481,0.0008326334,0.0017461355,0.012045973,0.030544516,0.0010800441,0.00034607816,0.018842135,0.000021657199,0.00020302199,0.041999478,0.89146227],"study_design_scores_gemma":[0.004668143,0.0004852758,0.0018641578,0.014866605,0.003591719,0.000443865,0.000009138509,0.000088802175,0.000003419254,0.00018036195,0.9734804,0.0003181176],"about_ca_topic_score_codex":0.000076081415,"about_ca_topic_score_gemma":0.00009350607,"teacher_disagreement_score":0.93148094,"about_ca_system_score_codex":0.055257227,"about_ca_system_score_gemma":0.014530042,"threshold_uncertainty_score":0.99985635},"labels":[],"label_agreement":null},{"id":"W3092523695","doi":"10.6004/jnccn.2020.7576","title":"Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bone health and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Internal medicine; Osteoporosis; Bone mineral; Odds ratio; Cohort; Population; Oncology; Cancer","score_opus":0.11882753218401561,"score_gpt":0.36403795378129095,"score_spread":0.24521042159727535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092523695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077594,0.0034604385,0.00008508152,0.0048939083,0.00010628409,0.0005850787,0.000055748373,0.000004893723,0.000032598335],"genre_scores_gemma":[0.9927617,0.000060526894,0.0015690188,0.005221794,0.0002996614,0.000030124787,0.000041060786,0.000011043792,0.000005098183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860626,0.00008597249,0.00065402,0.000117620664,0.0004052146,0.00013093058],"domain_scores_gemma":[0.9967679,0.00046953314,0.0009870017,0.000048732018,0.0016446272,0.00008221803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018009679,0.00010408911,0.0004751115,0.00013549936,0.00008468521,0.000007080425,0.00005400441,0.00004438712,0.000007746705],"category_scores_gemma":[0.0002752911,0.00007472011,0.00018292332,0.0010164962,0.00001925045,0.00007376059,0.000012838655,0.00015311515,5.5757734e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014861119,0.00004560664,0.8306482,0.00004821896,0.000569046,0.0000027896735,0.00013104021,0.16446598,0.0005269374,0.0000057107422,0.0009556239,0.0011147729],"study_design_scores_gemma":[0.0037340082,0.00016559965,0.91858983,0.0002235309,0.00026147717,0.0000029175014,0.000019716146,0.07645713,0.00021009681,0.00013282865,0.00014523168,0.000057607023],"about_ca_topic_score_codex":0.000412593,"about_ca_topic_score_gemma":0.00007378084,"teacher_disagreement_score":0.08800885,"about_ca_system_score_codex":0.00024253604,"about_ca_system_score_gemma":0.00067938335,"threshold_uncertainty_score":0.30469975},"labels":[],"label_agreement":null},{"id":"W3092544457","doi":"10.6004/jnccn.2020.7577","title":"Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Medicine; Chromophobe cell; Nephrectomy; Clear cell; Renal cell carcinoma; Urology; Clear cell carcinoma; Internal medicine; Pathology; Kidney; Carcinoma","score_opus":0.12549440038722112,"score_gpt":0.3378301358079551,"score_spread":0.212335735420734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092544457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305935,0.0012596882,0.00022867491,0.014648104,0.00014034445,0.00058117544,0.000011745269,0.0000061663213,0.00006477012],"genre_scores_gemma":[0.9842875,0.00001435073,0.008354582,0.006211962,0.001058461,0.000014314175,0.000001623114,0.000017651642,0.000039576193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.000116385854,0.00053821335,0.00016046847,0.00083533983,0.00012563771],"domain_scores_gemma":[0.99549115,0.00036814896,0.00055722945,0.00009031262,0.0033292677,0.00016389813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016365024,0.0001569901,0.00041177022,0.00005611977,0.0000651519,0.000017662562,0.00013032166,0.000023854276,0.000036622543],"category_scores_gemma":[0.00032397744,0.000091934024,0.00010970383,0.00040567695,0.000038455044,0.00004469095,0.00005120282,0.00018011281,7.675767e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009612214,0.00040530998,0.33269984,0.00020189838,0.0014015737,0.0001375316,0.0007382014,0.6042399,0.01832759,0.000026171601,0.03155434,0.0006554379],"study_design_scores_gemma":[0.013055876,0.009872116,0.92232287,0.0018591483,0.0017506719,0.0003582079,0.0007740349,0.0038196323,0.028734067,0.00026200808,0.016788727,0.000402643],"about_ca_topic_score_codex":0.000016218473,"about_ca_topic_score_gemma":0.000010963212,"teacher_disagreement_score":0.60042024,"about_ca_system_score_codex":0.00016422084,"about_ca_system_score_gemma":0.0004830712,"threshold_uncertainty_score":0.37489608},"labels":[],"label_agreement":null},{"id":"W3095030832","doi":"10.6004/jnccn.2020.7586","title":"Validating a Patient-Reported Outcomes–Derived Algorithm for Classifying Symptom Complexity Levels Among Patients With Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Algorithm; Checklist; Receiver operating characteristic; Cancer; Cluster (spacecraft); Correlation; Medical record; Data mining; Computer science; Surgery; Internal medicine; Mathematics","score_opus":0.10869672492642961,"score_gpt":0.3338913846029093,"score_spread":0.22519465967647967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095030832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265946,0.0011130732,0.005413436,0.006388018,0.0026233515,0.0012181242,0.00043706,0.000034024717,0.0001134364],"genre_scores_gemma":[0.98339504,0.00002621932,0.0033578028,0.011300431,0.0017366837,0.00007041846,0.000027308308,0.00004924285,0.000036855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972973,0.00010578089,0.0007477553,0.00026292744,0.0012629577,0.00032326538],"domain_scores_gemma":[0.99339914,0.00032728483,0.0013774752,0.00012342674,0.0045349686,0.00023771761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011318868,0.0002649519,0.00064782344,0.000057958903,0.000284771,0.00004554821,0.00022562736,0.0000858413,0.00010845962],"category_scores_gemma":[0.00015582962,0.00017150135,0.0003745471,0.00047140438,0.0001435004,0.00017602766,0.00009131924,0.00048166374,4.749119e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016475198,0.00017008063,0.9203452,0.00021140672,0.003005306,0.000014363473,0.0020475949,0.025079805,0.00038339815,0.00006205262,0.022420451,0.02461283],"study_design_scores_gemma":[0.006316906,0.00047968572,0.97045904,0.00095142843,0.0006040987,0.000015881484,0.0003371303,0.0077576875,0.0003331991,0.00026912807,0.0121508585,0.00032493979],"about_ca_topic_score_codex":0.00010153498,"about_ca_topic_score_gemma":0.00009732575,"teacher_disagreement_score":0.050113864,"about_ca_system_score_codex":0.00055773853,"about_ca_system_score_gemma":0.00060288346,"threshold_uncertainty_score":0.69936216},"labels":[],"label_agreement":null},{"id":"W3095519987","doi":"10.6004/jnccn.2020.7580","title":"Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostatectomy; Absolute risk reduction; Prostate cancer; Logistic regression; Stage (stratigraphy); Internal medicine; Urology; Cancer; Gynecology; Confidence interval","score_opus":0.057011787398923534,"score_gpt":0.32328416312974895,"score_spread":0.2662723757308254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095519987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96816987,0.0057235733,0.0000036638676,0.024371136,0.00070049794,0.00061847625,0.00025391363,0.000006460872,0.000152404],"genre_scores_gemma":[0.9907533,0.0056637996,0.00006293036,0.0027756742,0.0005950586,0.00004156046,0.000017460581,0.000017086144,0.00007316332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861085,0.00009316572,0.00038081492,0.00019684459,0.0005240206,0.0001943233],"domain_scores_gemma":[0.9980379,0.00017245334,0.0005478222,0.00006700259,0.0010310605,0.0001437932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068970265,0.00015789292,0.00033124164,0.000047386293,0.00007297785,0.000023406694,0.00010201079,0.00004632912,0.000041877283],"category_scores_gemma":[0.00008651859,0.00010872082,0.000087928136,0.0003706495,0.00009645328,0.00012217653,0.000047556892,0.00029533223,0.0000012966885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004477376,0.00013655976,0.93264294,0.00010106085,0.00041320425,0.000008815081,0.0013732881,0.034832824,0.0001643741,0.000046014655,0.023141766,0.002661766],"study_design_scores_gemma":[0.006815913,0.00036984088,0.96587706,0.00035712292,0.00007099148,0.000001931392,0.00015178847,0.0014565524,0.00025511155,0.000071901086,0.024454372,0.0001174213],"about_ca_topic_score_codex":0.000044928234,"about_ca_topic_score_gemma":0.00012672278,"teacher_disagreement_score":0.033376273,"about_ca_system_score_codex":0.00073568255,"about_ca_system_score_gemma":0.00039252685,"threshold_uncertainty_score":0.44335064},"labels":[],"label_agreement":null},{"id":"W3097339274","doi":"10.6004/jnccn.2020.0052","title":"Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada; Genentech; Bayer HealthCare; Boston Pharmaceuticals; Agios Pharmaceuticals; SK Life Science; Arbor Pharmaceuticals; AstraZeneca; Cancer Research Institute; Novocure; National Comprehensive Cancer Network; Ipsen; Takeda Pharmaceuticals North America; Jazz Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; BeiGene; Varian Medical Systems; Karyopharm Therapeutics; University of Pennsylvania; National Cancer Institute; Gilead Sciences; INOVIO Pharmaceuticals; Novartis Pharmaceuticals Corporation; National Cancer Research Institute; Bristol-Myers Squibb; Johns Hopkins University; Amgen","keywords":"Medicine; Central nervous system; Radiation therapy; Clinical Practice; Oncology; Radiation oncology; Disease; Internal medicine; Pathology; Family medicine","score_opus":0.10996868575068654,"score_gpt":0.43327070406139073,"score_spread":0.3233020183107042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097339274","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39700013,0.05075266,0.000094447125,0.53525114,0.01215019,0.0011769213,0.00006419804,0.000037404592,0.0034729044],"genre_scores_gemma":[0.93931836,0.0027814533,0.0034498584,0.04539389,0.008996214,0.000010851957,0.0000043904492,0.000018759245,0.000026251373],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756444,0.00028532968,0.0009997579,0.00017571216,0.0007476176,0.00022716846],"domain_scores_gemma":[0.9946876,0.0007795354,0.0008861855,0.00007983185,0.0033463326,0.0002204831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033744876,0.0001393392,0.0005229993,0.000040004656,0.000081124825,0.00001483802,0.00018164534,0.00010959364,0.00004556077],"category_scores_gemma":[0.0012170752,0.00009066445,0.00029552233,0.00041666496,0.000052642354,0.00010253323,0.00007845645,0.0005123628,0.000008383919],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024457339,0.00015723634,0.03232382,0.00005411323,0.0005823477,0.00051092874,0.00012815013,0.21822147,0.00011055927,0.00021913563,0.73755264,0.0076938407],"study_design_scores_gemma":[0.0053833295,0.0007371152,0.13514388,0.0008312172,0.00043699073,0.0006919291,0.00044967097,0.0083850715,0.000043892054,0.000042516345,0.8477436,0.00011079715],"about_ca_topic_score_codex":0.00008538025,"about_ca_topic_score_gemma":0.0000292185,"teacher_disagreement_score":0.5423182,"about_ca_system_score_codex":0.0017088971,"about_ca_system_score_gemma":0.0013833607,"threshold_uncertainty_score":0.44687063},"labels":[],"label_agreement":null},{"id":"W3110827616","doi":"10.6004/jnccn.2020.7605","title":"Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based Analysis","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Sunnybrook Health Science Centre; McGill University Health Centre; Health Sciences Centre; McGill University; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Ipsen; Ipsen Biopharmaceuticals; Cancer Care Ontario","keywords":"Medicine; Pancreatic cancer; Receipt; Adenocarcinoma; Cancer; Cancer registry; Population; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Environmental health; Confidence interval","score_opus":0.057721419217144666,"score_gpt":0.37160609218805907,"score_spread":0.3138846729709144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110827616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172354,0.0059901597,0.0002927021,0.0013794091,0.000092008384,0.00034593846,0.00008649821,0.0000032798039,0.00008646936],"genre_scores_gemma":[0.9976544,0.00014267935,0.0007440365,0.00084234215,0.0005674236,0.000011228098,0.000019376497,0.0000098814835,0.000008654037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986061,0.00012967047,0.00039233375,0.00012752606,0.0005827298,0.00016162983],"domain_scores_gemma":[0.99605,0.0010926164,0.00043288476,0.00007783882,0.0022057046,0.00014094071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014408393,0.00011838621,0.00067803037,0.00016881009,0.00011508727,0.000009431112,0.00011477596,0.00006415914,0.000051770083],"category_scores_gemma":[0.000233982,0.00007462308,0.00059389125,0.0006372615,0.000072815594,0.000036949477,0.000022049384,0.00021368734,2.497224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017284618,0.00004041789,0.8909927,0.000090601956,0.0023318152,0.000001977886,0.0000876443,0.10339255,0.000064713764,0.000033237986,0.0011377747,0.000098129705],"study_design_scores_gemma":[0.002155518,0.0010519366,0.9742684,0.00014371121,0.0020695305,0.0000046358496,0.00006869691,0.019947505,0.000012632993,0.00012714513,0.00008886165,0.00006144755],"about_ca_topic_score_codex":0.00016098833,"about_ca_topic_score_gemma":0.000014506037,"teacher_disagreement_score":0.08344504,"about_ca_system_score_codex":0.00022536774,"about_ca_system_score_gemma":0.0005942562,"threshold_uncertainty_score":0.3043041},"labels":[],"label_agreement":null},{"id":"W3112260348","doi":"10.6004/jnccn.2020.7603","title":"Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Docetaxel; Chemotherapy; Breast cancer; Mucositis; Relative risk; Regimen; Neutropenia; Cyclophosphamide; Randomized controlled trial; Surgery; Cohort; Chemotherapy regimen; Cancer; Oncology; Confidence interval","score_opus":0.030091181871559795,"score_gpt":0.32712837232886705,"score_spread":0.29703719045730725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112260348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987207,0.0053256843,0.000012033793,0.0049651614,0.0011502068,0.0011245223,0.00010590845,0.0000049511136,0.000104511],"genre_scores_gemma":[0.9936043,0.002499541,0.000017463015,0.0016603207,0.0020938695,0.000043808574,0.0000011729298,0.00002052542,0.00005901455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99802965,0.00019062677,0.00065147167,0.00016427442,0.00077305804,0.000190919],"domain_scores_gemma":[0.9975084,0.00043994896,0.00072011683,0.00008660845,0.0010968917,0.00014802253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026658556,0.00019690662,0.0011951907,0.00007545074,0.000047702488,0.000017531518,0.00016278599,0.00007832138,0.00015081142],"category_scores_gemma":[0.00007113955,0.00012189704,0.000572794,0.00041541347,0.0000813906,0.00007115636,0.000027433063,0.00042877856,3.3960086e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91287196,0.00017141776,0.04137682,0.000063950625,0.0005855794,0.000008116927,0.00084948464,0.039917458,0.00049423287,0.000022852999,0.002732964,0.00090518413],"study_design_scores_gemma":[0.6441663,0.0013555962,0.34901738,0.0013957951,0.00022944443,0.00001803714,0.000086168606,0.0024105588,0.00006771922,0.000096989446,0.00096340646,0.0001926108],"about_ca_topic_score_codex":0.00039061415,"about_ca_topic_score_gemma":0.000080579026,"teacher_disagreement_score":0.30764055,"about_ca_system_score_codex":0.00027560766,"about_ca_system_score_gemma":0.0006231704,"threshold_uncertainty_score":0.49708173},"labels":[],"label_agreement":null},{"id":"W3119615054","doi":"10.6004/jnccn.2020.7613","title":"Patterns and Trends of Cancer Screening in Canada: Results From a Contemporary National Survey","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Cohort; Mammography; Breast cancer; Logistic regression; Cancer screening; Cancer; Cervical cancer; Breast cancer screening; Cohort study; Odds ratio; Family medicine; Colorectal cancer; Demography; Gynecology; Internal medicine","score_opus":0.09546180959103533,"score_gpt":0.32963157749240524,"score_spread":0.2341697679013699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119615054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98076373,0.013822654,0.000050644132,0.0032552127,0.00090257445,0.00006640147,0.0007970101,0.000002709618,0.0003390858],"genre_scores_gemma":[0.99714625,0.00034152693,0.00016844143,0.0013780628,0.0008231482,0.0000044620638,0.00003360114,0.00000946206,0.000095061136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980278,0.00019925312,0.00058006175,0.0001570791,0.0009157076,0.00012008297],"domain_scores_gemma":[0.99605703,0.0007333806,0.00058899284,0.000062429004,0.0024849176,0.00007324863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028626007,0.00010798533,0.0003576088,0.00009936019,0.000056617995,0.000010455371,0.000085515545,0.000049188202,0.00004736059],"category_scores_gemma":[0.000315812,0.00008502456,0.000090578185,0.000578307,0.000029808722,0.000069051544,0.00005775809,0.0003529014,3.8914063e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007594054,0.000033062486,0.8938013,0.000024256302,0.00046759308,0.000028954802,0.0001343307,0.061487135,0.00031679127,0.000009521421,0.028452827,0.007650192],"study_design_scores_gemma":[0.002537781,0.00007696938,0.99073917,0.0007670647,0.000032806216,0.000036890222,0.000081677805,0.0027240762,0.00046534036,0.00009560185,0.0023657158,0.00007691577],"about_ca_topic_score_codex":0.5560495,"about_ca_topic_score_gemma":0.81370443,"teacher_disagreement_score":0.2576549,"about_ca_system_score_codex":0.00064922275,"about_ca_system_score_gemma":0.0038989664,"threshold_uncertainty_score":0.69165987},"labels":[],"label_agreement":null},{"id":"W3119952631","doi":"10.6004/jnccn.2020.7606","title":"Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"","keywords":"Medicine; Underweight; Overweight; Body mass index; Breast cancer; Hazard ratio; Weight change; Internal medicine; Weight loss; Obesity; Cancer; Weight gain; Randomization; Oncology; Randomized controlled trial; Confidence interval; Body weight","score_opus":0.02822923941213263,"score_gpt":0.2893308653753342,"score_spread":0.2611016259632016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119952631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297273,0.0031817672,0.000009699051,0.0022604621,0.0009489838,0.0003690939,0.00022315058,0.0000020066425,0.00003209704],"genre_scores_gemma":[0.9962104,0.0006553805,0.000019102461,0.0015158332,0.0015194947,0.000024079956,0.000007180041,0.0000150588385,0.000033487173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811316,0.00017590336,0.00043901306,0.00016825696,0.0009301418,0.00017351081],"domain_scores_gemma":[0.99673647,0.00013928805,0.0006925494,0.00013292949,0.0022126695,0.00008610236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011573293,0.00015431576,0.000545729,0.00016464086,0.00009133003,0.000018335984,0.00014073912,0.00007133577,0.000057263587],"category_scores_gemma":[0.000020655358,0.00008675534,0.00024351674,0.0014526412,0.00011818397,0.00011063149,0.00006999621,0.00039805754,1.2385313e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009846035,0.00012342291,0.9799915,0.000016711057,0.001818797,0.00000512665,0.00039450594,0.0056450255,0.000049068134,0.000018301324,0.0009729564,0.0011185702],"study_design_scores_gemma":[0.012635257,0.0001662675,0.98407364,0.00051330664,0.0009063423,0.0000057436296,0.000065902714,0.00030301898,0.00004851596,0.00004997052,0.001137187,0.00009483455],"about_ca_topic_score_codex":0.00039983407,"about_ca_topic_score_gemma":0.00070872303,"teacher_disagreement_score":0.0053420067,"about_ca_system_score_codex":0.00044798083,"about_ca_system_score_gemma":0.0005896316,"threshold_uncertainty_score":0.353778},"labels":[],"label_agreement":null},{"id":"W3121783725","doi":"10.6004/jnccn.2020.7618","title":"Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radiodensity; Hazard ratio; Internal medicine; Cancer; Surgery; Confidence interval; Radiography","score_opus":0.04174486441706441,"score_gpt":0.38466337339758033,"score_spread":0.3429185089805159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121783725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974377,0.0020603603,0.000011256979,0.0073937755,0.0004246339,0.00022585239,0.000046416946,0.0000032463677,0.00009071546],"genre_scores_gemma":[0.99443877,0.0008587042,0.0017582438,0.002365358,0.00048843154,0.000008387982,0.0000072268767,0.0000122211895,0.000062641986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984858,0.00010834604,0.00054878136,0.000113092,0.00060597167,0.00013803365],"domain_scores_gemma":[0.9961824,0.0003559037,0.00066486717,0.00006476281,0.0026496395,0.0000824618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001402064,0.00009373303,0.00046504373,0.00005537833,0.00007265845,0.000008306535,0.00006352608,0.00004970871,0.00003835148],"category_scores_gemma":[0.00013458355,0.00005764878,0.00010014879,0.00031305835,0.000082793944,0.00008070507,0.000029641787,0.00033557494,1.4245148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023436655,0.00012006927,0.99336153,0.000036724407,0.00026983823,0.0000038021658,0.0000797765,0.00368696,0.000014806206,0.000079399404,0.0007958602,0.0013168772],"study_design_scores_gemma":[0.0066781174,0.0002121479,0.988788,0.00090312323,0.00010958684,0.000006494448,0.000051974537,0.000100597674,0.000005824405,0.00021739518,0.0028614488,0.00006525946],"about_ca_topic_score_codex":0.000026882783,"about_ca_topic_score_gemma":0.00010127846,"teacher_disagreement_score":0.006443751,"about_ca_system_score_codex":0.00023470243,"about_ca_system_score_gemma":0.00057526573,"threshold_uncertainty_score":0.2350849},"labels":[],"label_agreement":null},{"id":"W3126744606","doi":"10.6004/jnccn.2020.7645","title":"Barriers to Optimal End-of-Life Care for Adolescents and Young Adults With Cancer: Bereaved Caregiver Perspectives","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"National Institute of Nursing Research; Cambia Health Foundation; National Institutes of Health; National Palliative Care Research Center","keywords":"Medicine; Regret; Palliative care; End-of-life care; Medicaid; Distress; Family caregivers; Quality of life (healthcare); Family medicine; Qualitative research; Gerontology; Young adult; Nursing; Health care; Clinical psychology","score_opus":0.02403699953910725,"score_gpt":0.3178969813034805,"score_spread":0.2938599817643732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126744606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9459883,0.042752173,0.00018926094,0.008741162,0.0012992475,0.00066944346,0.00025682317,0.00000861501,0.000094985044],"genre_scores_gemma":[0.9908687,0.0008764753,0.0018560102,0.004046418,0.002214703,0.000030333895,0.000005519054,0.000031972053,0.000069909554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789053,0.00012364707,0.00047553764,0.00027522928,0.0009850968,0.00024995016],"domain_scores_gemma":[0.9923372,0.00019311476,0.00054470944,0.00014613318,0.0063786665,0.00040016783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012644725,0.00020685402,0.0006023557,0.0000783579,0.00020381884,0.000023345918,0.00018181062,0.00007175776,0.000066545035],"category_scores_gemma":[0.00039845958,0.00015390283,0.00023439078,0.0003546297,0.00015698058,0.000097224445,0.000089116336,0.00031450478,1.8959501e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03348258,0.0002662346,0.46000993,0.003514848,0.005094487,0.00005389389,0.22564293,0.18808703,0.0013791583,0.00065255305,0.078164175,0.0036521622],"study_design_scores_gemma":[0.023540633,0.0015902794,0.717163,0.019368783,0.0014328639,0.00043248324,0.18812478,0.000660124,0.0020540515,0.00017329387,0.044579733,0.0008799708],"about_ca_topic_score_codex":0.00020576139,"about_ca_topic_score_gemma":0.0008931592,"teacher_disagreement_score":0.25715306,"about_ca_system_score_codex":0.0005423206,"about_ca_system_score_gemma":0.0028677373,"threshold_uncertainty_score":0.6275975},"labels":[],"label_agreement":null},{"id":"W3126783535","doi":"10.6004/jnccn.2020.7637","title":"Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Lung; Metastasis; Internal medicine; Upper urinary tract; Urology; Urinary system; Lymph node; Oncology; Cancer","score_opus":0.026734438216476173,"score_gpt":0.27663128568627277,"score_spread":0.2498968474697966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126783535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434185,0.0039919848,0.0000041061785,0.0010611757,0.00017548745,0.00022264919,0.00011414015,0.0000011815805,0.00008744352],"genre_scores_gemma":[0.9991025,0.00016055928,0.00003632758,0.0004743208,0.00015752233,0.000007701091,0.000020388816,0.000006626317,0.000034050954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865925,0.0002274821,0.00034067334,0.000104686595,0.00054737565,0.000120513054],"domain_scores_gemma":[0.9989093,0.00021626,0.00024125587,0.000071220165,0.0005290462,0.000032926775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115995856,0.0001103498,0.00032097552,0.000044510558,0.000051830946,0.0000114070135,0.00009169288,0.000040036863,0.000028977527],"category_scores_gemma":[0.000041336694,0.00005634015,0.00008398367,0.0003405218,0.00009832941,0.000068249916,0.000025480265,0.00026878557,1.379926e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084983377,0.0005205002,0.99595016,0.000024970343,0.0001708058,0.000054968907,0.00036922353,0.0010519226,0.000031788204,0.00008923724,0.00046762204,0.00041898468],"study_design_scores_gemma":[0.0039814776,0.00048629154,0.99371314,0.00029451755,0.00014401713,0.00012279046,0.00014407004,0.00004408065,0.00009061554,0.0005496652,0.00037463327,0.00005471311],"about_ca_topic_score_codex":0.00003653542,"about_ca_topic_score_gemma":0.000013717727,"teacher_disagreement_score":0.0047606714,"about_ca_system_score_codex":0.00013648093,"about_ca_system_score_gemma":0.0002959864,"threshold_uncertainty_score":0.22974847},"labels":[],"label_agreement":null},{"id":"W3131489629","doi":"10.6004/jnccn.2020.7677","title":"Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Kingston Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Occupational Cancer Research Centre; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interim; Interim analysis; Clinical trial; Clinical endpoint; Surrogate endpoint; Internal medicine; Cancer drugs; Quality of life (healthcare); Oncology; Cancer","score_opus":0.4597360644743093,"score_gpt":0.4807494730049917,"score_spread":0.021013408530682398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131489629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.679156,0.20442338,0.016637975,0.09477629,0.0038408872,0.000658732,0.00018868054,0.000007249035,0.00031082882],"genre_scores_gemma":[0.98463815,0.0014779043,0.0046726675,0.006924421,0.0021685704,0.000016170297,9.436714e-7,0.000022432509,0.00007871664],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9960211,0.0005555446,0.0024703883,0.0002135563,0.0005028747,0.0002365512],"domain_scores_gemma":[0.9868574,0.0040601008,0.006445854,0.00032194276,0.0022577445,0.00005695158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004655661,0.00015434819,0.0007024247,0.00008773589,0.00038899115,0.000055711873,0.00056245027,0.00009755302,0.00012207068],"category_scores_gemma":[0.0017585031,0.00009322672,0.00024228064,0.0007362299,0.00022547593,0.00036106101,0.000104423976,0.00047330777,0.0000017468744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008995159,0.000031069427,0.063505135,0.00013498716,0.00042718547,3.5078216e-7,0.0010694732,0.87114793,0.00005171102,0.05675154,0.006619916,0.00017076026],"study_design_scores_gemma":[0.001483344,0.00015320741,0.5828554,0.014557576,0.00036170837,0.00011010319,0.004777428,0.09623776,0.00025546734,0.27324694,0.025379742,0.0005813118],"about_ca_topic_score_codex":0.0009017133,"about_ca_topic_score_gemma":0.00014383056,"teacher_disagreement_score":0.77491015,"about_ca_system_score_codex":0.0012921193,"about_ca_system_score_gemma":0.0015510607,"threshold_uncertainty_score":0.3801675},"labels":[],"label_agreement":null},{"id":"W3134747077","doi":"10.6004/jnccn.2020.7654","title":"Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interquartile range; Hazard ratio; Diffuse large B-cell lymphoma; Internal medicine; Proportional hazards model; Rituximab; Population; Confidence interval; Cohort; Lymphoma; Surgery","score_opus":0.028263567137291393,"score_gpt":0.3030276553712567,"score_spread":0.2747640882339653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134747077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921141,0.0019246071,0.000011816298,0.0048724073,0.00045768218,0.00034983386,0.00013353472,0.0000064564006,0.00012955992],"genre_scores_gemma":[0.99106544,0.00021587811,0.00015734724,0.007838504,0.00038014734,0.00009364749,0.00005472113,0.000025234025,0.0001690502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978262,0.00020851809,0.0005932709,0.00024908173,0.0007774457,0.0003454363],"domain_scores_gemma":[0.99778146,0.0005198157,0.00041722442,0.00017221854,0.00096931896,0.0001399536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001593219,0.00024323801,0.0006200494,0.00013668709,0.00008180206,0.00004119337,0.00012491186,0.00010188767,0.000103788945],"category_scores_gemma":[0.00013958296,0.00016058589,0.000266024,0.0005627088,0.000017901939,0.00008002748,0.00005731716,0.00016556898,0.0000024250567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006459463,0.006346977,0.9807843,0.000017680082,0.00034431907,0.0003609471,0.00019581155,0.007888064,0.000014893014,0.000047766764,0.003063096,0.00029021033],"study_design_scores_gemma":[0.030204153,0.00031309953,0.9600165,0.0013907652,0.00014900415,0.00003315561,0.0000530368,0.00095573184,0.00023142765,0.00007642914,0.006423885,0.00015279895],"about_ca_topic_score_codex":0.0001615233,"about_ca_topic_score_gemma":0.002512776,"teacher_disagreement_score":0.029558206,"about_ca_system_score_codex":0.0031262988,"about_ca_system_score_gemma":0.00094786054,"threshold_uncertainty_score":0.81751627},"labels":[],"label_agreement":null},{"id":"W3135800774","doi":"10.6004/jnccn.2020.7656","title":"Status of Cancer Care at Network Sites of the Nation’s Academic Cancer Centers","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Medicine; Workforce; Family medicine; Pharmacy; Cancer; Certification; Health care; Nursing; Political science","score_opus":0.12344401835775279,"score_gpt":0.3938842738240449,"score_spread":0.27044025546629213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7684888,0.22003944,0.000015160343,0.006729322,0.0035591736,0.00030579927,0.0002008519,0.0000059766085,0.0006554644],"genre_scores_gemma":[0.9790231,0.012058551,0.00020201941,0.0050582327,0.0031971578,0.000017161672,0.000008093928,0.00001958147,0.000416083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99668825,0.00018073616,0.0008111718,0.0001916885,0.0017192883,0.0004088805],"domain_scores_gemma":[0.9914039,0.0002798681,0.0014380189,0.00018731119,0.006553304,0.00013764919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015038559,0.000194481,0.0005356238,0.000052159623,0.00022801184,0.000010310889,0.00038310693,0.00014166911,0.0003231977],"category_scores_gemma":[0.00021607005,0.00012418283,0.0004652454,0.0009081793,0.00018997636,0.000117685435,0.00024578537,0.0007262455,5.9928857e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052967435,0.000015515869,0.54687214,0.00012308602,0.0005209186,0.0000042455194,0.0004875668,0.3620797,0.0054770247,0.00020128967,0.0825738,0.0011150627],"study_design_scores_gemma":[0.0023558899,0.0001083616,0.85030276,0.0052851276,0.00075806136,0.00011282549,0.00070615014,0.0006419566,0.01034724,0.000955667,0.12819229,0.00023370564],"about_ca_topic_score_codex":0.00046246068,"about_ca_topic_score_gemma":0.001218062,"teacher_disagreement_score":0.36143774,"about_ca_system_score_codex":0.0018235022,"about_ca_system_score_gemma":0.0023037244,"threshold_uncertainty_score":0.50640285},"labels":[],"label_agreement":null},{"id":"W3164222140","doi":"10.6004/jnccn.2021.0024","title":"Open Notes Are Here: Are We Ready?","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Research Data Management Practices","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"University of California, San Francisco; American Society of Clinical Oncology; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; V Foundation for Cancer Research; Pancreatic Cancer Action Network; Lustgarten Foundation; National Cancer Institute; Conquer Cancer Foundation","keywords":"Medicine; MEDLINE","score_opus":0.2708778978010283,"score_gpt":0.43010282397491123,"score_spread":0.15922492617388295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164222140","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072273775,0.06433335,0.07231852,0.83162624,0.011380847,0.0011447938,0.00014231041,0.000065767315,0.011760787],"genre_scores_gemma":[0.7536555,0.05155688,0.09378039,0.07482926,0.013227825,0.00009758748,0.00002088708,0.00010226048,0.012729423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971138,0.00051283865,0.00040305255,0.00027778585,0.001429114,0.00026337523],"domain_scores_gemma":[0.9935432,0.0011265016,0.0012368539,0.00045752357,0.003533212,0.00010269326],"candidate_categories":["scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0006533711,0.00013049708,0.00026804436,0.000067989175,0.00030914674,0.0020334176,0.004866472,0.00004116392,0.000046798294],"category_scores_gemma":[0.0009051078,0.00009320283,0.00012267152,0.0009550945,0.000056660905,0.008107511,0.0032895652,0.000495333,0.000009924215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013505876,0.00017455666,0.012238226,0.000077373275,0.0006792563,0.00025919918,0.00009793512,0.15639298,0.00032838993,0.093757436,0.72884285,0.00701674],"study_design_scores_gemma":[0.00067465514,0.000037820304,0.04272851,0.00059174706,0.000029806304,0.00013563278,0.00019239639,0.0032009892,0.00028511183,0.018161768,0.9337814,0.00018019136],"about_ca_topic_score_codex":0.000016187787,"about_ca_topic_score_gemma":0.000058428635,"teacher_disagreement_score":0.756797,"about_ca_system_score_codex":0.00024218646,"about_ca_system_score_gemma":0.00059389067,"threshold_uncertainty_score":0.9990026},"labels":[],"label_agreement":null},{"id":"W3165196335","doi":"10.6004/jnccn.2020.7666","title":"Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors: A Population-Based Analysis","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Manitoba; Health Sciences Centre; Occupational Cancer Research Centre; Manitoba Health; University of Toronto; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care; EMD Serono; Ipsen; Ipsen Biopharmaceuticals","keywords":"Medicine; Interquartile range; Cancer; Internal medicine; Population; Hazard ratio; Cause of death; Oncology; Cohort; Colorectal cancer; Proportional hazards model; Cohort study; Disease; Confidence interval; Environmental health","score_opus":0.03210202073306971,"score_gpt":0.34300445236499677,"score_spread":0.31090243163192705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165196335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926397,0.00420338,0.00021959154,0.0017518869,0.00036513436,0.00053786166,0.0002508343,0.000007746839,0.00002381888],"genre_scores_gemma":[0.9953615,0.0008461617,0.0019923158,0.00089750113,0.0006950723,0.000058836842,0.000038526214,0.000029091418,0.000080989696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726635,0.00021232577,0.00064433477,0.00023816213,0.0013411014,0.00029774243],"domain_scores_gemma":[0.9909235,0.0012210456,0.0011342331,0.00019827648,0.0063803196,0.00014259992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007639254,0.00018663131,0.0006465319,0.00022807873,0.00015407181,0.00002180916,0.0002199099,0.000007974392,0.00009453559],"category_scores_gemma":[0.00058012904,0.00012231848,0.0004932944,0.0014705302,0.00006582956,0.00010046049,0.000049348033,0.00036103386,2.5708908e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013234896,0.00017659219,0.6816166,0.000057121957,0.0008951199,0.00009057806,0.0000069501966,0.31291342,0.000087926586,0.000042274445,0.0024801148,0.00030980105],"study_design_scores_gemma":[0.0044193217,0.0005160783,0.9823014,0.00037892684,0.0010372675,0.00006503885,0.000019327874,0.0024152522,0.0011255073,0.00035470125,0.0072517325,0.00011545943],"about_ca_topic_score_codex":0.000111248264,"about_ca_topic_score_gemma":0.00023636091,"teacher_disagreement_score":0.31049815,"about_ca_system_score_codex":0.00031797626,"about_ca_system_score_gemma":0.0006618998,"threshold_uncertainty_score":0.49880028},"labels":[],"label_agreement":null},{"id":"W3166972402","doi":"10.6004/jnccn.2020.7681","title":"Racial Background and Health Behaviors Among Adults With Cancer in Canada: Results of a National Survey","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Socioeconomic status; Logistic regression; Odds ratio; Cancer; Gerontology; Public health; Young adult; National Health Interview Survey; Odds; Environmental health; Population; Internal medicine","score_opus":0.0695991807844237,"score_gpt":0.3459992550002257,"score_spread":0.27640007421580204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166972402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820615,0.01189301,0.000004626637,0.0040554903,0.0011258681,0.00018887143,0.0005532328,0.0000016574786,0.0001157371],"genre_scores_gemma":[0.9960489,0.000998106,0.00004536935,0.0020925477,0.00068086974,0.000009408472,0.000025069345,0.000013128329,0.00008654434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975372,0.0002094628,0.00061488093,0.00017116548,0.0012713431,0.000195981],"domain_scores_gemma":[0.9945485,0.00029376047,0.00072277593,0.00007431489,0.004235866,0.00012480892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042057084,0.00013213934,0.0004414489,0.000070939626,0.00007657208,0.000011296294,0.000105927174,0.000046130175,0.000048098747],"category_scores_gemma":[0.00007132901,0.00009583179,0.0000733039,0.0006388017,0.000086907436,0.00008013728,0.000045782304,0.00039205467,4.962851e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040091877,0.00007658503,0.9198653,0.0001331963,0.00026419156,0.00003591692,0.0010134557,0.037654694,0.000035051846,0.000056304878,0.034721334,0.0021347646],"study_design_scores_gemma":[0.0030659274,0.00011234483,0.9921735,0.0013983144,0.00003126849,0.000065664244,0.0005217415,0.00017981732,0.00004662468,0.000046877194,0.0022654668,0.000092476716],"about_ca_topic_score_codex":0.5829111,"about_ca_topic_score_gemma":0.98805684,"teacher_disagreement_score":0.40514576,"about_ca_system_score_codex":0.0019983458,"about_ca_system_score_gemma":0.014519999,"threshold_uncertainty_score":0.99106675},"labels":[],"label_agreement":null},{"id":"W3177118749","doi":"10.6004/jnccn.2021.7042","title":"Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Guideline; Survivorship curve; Intensive care medicine; Adverse effect; Population; Quality of life (healthcare); Regimen; Hodgkin lymphoma; Clinical trial; Lymphoma; Environmental health; Internal medicine; Pathology","score_opus":0.11784780182124671,"score_gpt":0.40992001889445234,"score_spread":0.29207221707320563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177118749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003089372,0.9893456,0.00005052933,0.0044790017,0.0019686655,0.00095626456,0.00004033952,0.0000063476346,0.000063888285],"genre_scores_gemma":[0.0016050648,0.9861705,0.00029370416,0.002477018,0.009156785,0.000055162804,0.000021317031,0.00004568215,0.00017479072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99590594,0.00097295287,0.0015434873,0.0002509737,0.0010979865,0.00022868835],"domain_scores_gemma":[0.9906239,0.0038566075,0.0026614147,0.0003202598,0.0024465502,0.00009128572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008243065,0.0004340561,0.0017704817,0.00013388967,0.00027403756,0.000056665074,0.00041997287,0.00017643975,0.000013957458],"category_scores_gemma":[0.00074117485,0.00018567075,0.0010834113,0.00079026865,0.00015908956,0.00007582376,0.00014768881,0.00047936334,8.9987753e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025999144,0.00023110074,0.0010766183,0.0055241175,0.00588162,0.000028090371,0.001482903,0.010618789,0.000008374009,0.00063936657,0.094764434,0.8794846],"study_design_scores_gemma":[0.0018551591,0.00038671133,0.0098999515,0.02085452,0.007014418,0.0005039043,0.00016735127,0.00025050493,0.0000058414184,0.00083116797,0.9579522,0.0002782476],"about_ca_topic_score_codex":0.00009239464,"about_ca_topic_score_gemma":0.00023831653,"teacher_disagreement_score":0.87920636,"about_ca_system_score_codex":0.0006825068,"about_ca_system_score_gemma":0.0019031131,"threshold_uncertainty_score":0.7571433},"labels":[],"label_agreement":null},{"id":"W3187036481","doi":"10.6004/jnccn.2021.7016","title":"Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Conflict of interest; Clinical trial; Internal medicine; Clinical Oncology; Alternative medicine; Publication; Oncology; Family medicine; Cancer; Pathology; Law","score_opus":0.4962882298497098,"score_gpt":0.5624177617003119,"score_spread":0.06612953185060205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187036481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79978883,0.030883485,0.000019920557,0.03159161,0.13571705,0.0008426093,0.0005532447,0.00001421862,0.000589031],"genre_scores_gemma":[0.93002677,0.0018778654,0.00009577466,0.0043138694,0.06316684,0.00004635629,0.000007221636,0.000028797063,0.0004364868],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967591,0.0008663708,0.0011146073,0.00022430805,0.0005829176,0.00045266649],"domain_scores_gemma":[0.99118024,0.0017366719,0.0012894471,0.00010758858,0.0053857756,0.0003002726],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013143428,0.0002326979,0.00063413364,0.000113680195,0.00024615246,0.00004298109,0.00044256944,0.0008912053,0.0008398531],"category_scores_gemma":[0.0004903301,0.00017205112,0.00021019146,0.00077215093,0.0002125039,0.00021710829,0.000096460186,0.0038578063,0.0000012822939],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061570248,0.00060153176,0.059087567,0.0004205108,0.0024840294,0.00005961326,0.0016628504,0.3167694,0.01860296,0.0058040926,0.5847037,0.0036467267],"study_design_scores_gemma":[0.006972693,0.00020696828,0.008112293,0.0017956068,0.00039946503,0.00008598035,0.00045409953,0.0007158741,0.018152703,0.007132081,0.9556551,0.00031716624],"about_ca_topic_score_codex":0.000034183355,"about_ca_topic_score_gemma":0.00006539775,"teacher_disagreement_score":0.37095135,"about_ca_system_score_codex":0.0005437445,"about_ca_system_score_gemma":0.001853885,"threshold_uncertainty_score":0.9984403},"labels":[],"label_agreement":null},{"id":"W3188488521","doi":"10.6004/jnccn.2020.7796","title":"Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Xiangya Hospital, Central South University; Central South University; National Natural Science Foundation of China","keywords":"Durvalumab; Medicine; Etoposide; Oncology; Chemotherapy; Lung cancer; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Stage (stratigraphy); Cancer; Immunotherapy","score_opus":0.1077639222556304,"score_gpt":0.4199083928252948,"score_spread":0.3121444705696644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188488521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.917766,0.07312397,0.00015186326,0.0068105143,0.00053715974,0.0011872973,0.00014866248,0.0000037243906,0.00027083087],"genre_scores_gemma":[0.9819421,0.015411249,0.00011253707,0.0015013193,0.00065316015,0.00011519305,0.000007929053,0.000019392037,0.00023707775],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9974191,0.00038395918,0.0006416184,0.00020627158,0.0010920316,0.0002569791],"domain_scores_gemma":[0.9930056,0.0013608165,0.00077231927,0.00024231781,0.004561151,0.000057838013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003966047,0.00020462935,0.001016309,0.00021960659,0.00011018864,0.000012210912,0.00025771483,0.00006374373,0.00012193189],"category_scores_gemma":[0.00013244183,0.000116672774,0.00062624144,0.0019092568,0.00016363339,0.00004868999,0.00005502431,0.00028338324,1.635451e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028725283,0.00051493244,0.1415136,0.00041560797,0.0076868734,0.00005830424,0.0020227658,0.8388548,0.0020142014,0.000059593905,0.002660153,0.0013266257],"study_design_scores_gemma":[0.010010502,0.0005164151,0.94867307,0.0011073769,0.002926059,0.000026103518,0.00059477484,0.012851782,0.008809582,0.00011396373,0.014203111,0.00016726348],"about_ca_topic_score_codex":0.0003647015,"about_ca_topic_score_gemma":0.0008310743,"teacher_disagreement_score":0.826003,"about_ca_system_score_codex":0.0018495927,"about_ca_system_score_gemma":0.0013329681,"threshold_uncertainty_score":0.48366207},"labels":[],"label_agreement":null},{"id":"W3194832450","doi":"10.6004/jnccn.2021.7070","title":"Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Izaak Walton Killam Health Centre; University of Alberta Hospital; Alberta Hospital Edmonton; BC Children's Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Wilms' tumor; Oncology; Internal medicine; Chemotherapy; Clinical trial; Cog; Metastasis; Radiation therapy; Cancer","score_opus":0.2680173121637455,"score_gpt":0.5386201233560011,"score_spread":0.27060281119225554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194832450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026210982,0.99036103,0.000055523233,0.00050358544,0.0052993163,0.00088341814,0.00021801583,9.455947e-7,0.000057056437],"genre_scores_gemma":[0.0014235484,0.9852582,0.000333434,0.0012144822,0.011595104,0.00003245337,0.00006223404,0.00003013653,0.000050398798],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933048,0.0027366634,0.002975986,0.00028795362,0.00051866076,0.00017596119],"domain_scores_gemma":[0.9861826,0.0029136154,0.008144652,0.00025771215,0.0024257835,0.00007567922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030546584,0.000274719,0.0020705462,0.000043823693,0.00012205041,0.000013948746,0.0006012409,0.00056282996,0.000012470427],"category_scores_gemma":[0.0047045914,0.00013261107,0.0045938445,0.00024948054,0.0002264218,0.0000075750795,0.00014680161,0.00088025036,3.2400575e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027131045,0.0010558094,0.00082794216,0.0008378392,0.021209817,0.0000041230264,0.000015594676,0.06879386,0.0001990287,0.00029787197,0.62317413,0.28087085],"study_design_scores_gemma":[0.0014126317,0.0021107618,0.0007316197,0.003709758,0.0021223268,0.00018788817,0.000003979735,0.000039653314,0.000033718254,0.000037882066,0.98945147,0.00015830093],"about_ca_topic_score_codex":0.000007772103,"about_ca_topic_score_gemma":0.0000087398585,"teacher_disagreement_score":0.3662773,"about_ca_system_score_codex":0.0002533922,"about_ca_system_score_gemma":0.003192649,"threshold_uncertainty_score":0.5663622},"labels":[],"label_agreement":null},{"id":"W3195154633","doi":"10.6004/jnccn.2021.7049","title":"Pancreatic Cancer Progression in a Patient With Lynch Syndrome Receiving Immunotherapy: A Cautionary Tale","year":2021,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; Jewish General Hospital; McGill University and Génome Québec Innovation Centre; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Cancer Research Society; McGill University","keywords":"Microsatellite instability; PMS2; Medicine; Pembrolizumab; Cancer research; Cancer; Metastasis; MSH2; Oncology; Immunotherapy; DNA mismatch repair; Pathology; Internal medicine; Colorectal cancer; Biology; Microsatellite; Allele; Genetics","score_opus":0.049536194037718785,"score_gpt":0.3671157661308216,"score_spread":0.3175795720931028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195154633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008962272,0.98730224,0.0000059498184,0.0004552381,0.0018475478,0.0012613061,0.000045630735,0.0000090081285,0.00011079347],"genre_scores_gemma":[0.0057527833,0.99095863,0.00087449024,0.0007355828,0.0010219748,0.00038729783,0.000017547947,0.000088968736,0.00016274115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594665,0.0004956877,0.0011895632,0.00036619898,0.001612774,0.00038911833],"domain_scores_gemma":[0.9953227,0.0005614883,0.0018258672,0.0002491475,0.0019189887,0.00012177878],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023259637,0.00048502686,0.0021071231,0.00024538315,0.00014379785,0.00003689464,0.0003490805,0.00027241875,0.00034264446],"category_scores_gemma":[0.0001093614,0.00028307977,0.0006556646,0.0013523806,0.00014274198,0.00007937925,0.00014706352,0.0013464674,0.0000017199133],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012784309,0.0005373714,0.0042038225,0.010644942,0.00551873,0.001335307,0.0005705369,0.032960724,0.000041120486,0.000029476383,0.028834784,0.91404474],"study_design_scores_gemma":[0.0012829696,0.00062735064,0.0053769797,0.17564695,0.0012182001,0.008546468,0.000045205452,0.00007031106,0.000005527852,0.000075320924,0.8066877,0.00041698388],"about_ca_topic_score_codex":0.000033607048,"about_ca_topic_score_gemma":0.00003849778,"teacher_disagreement_score":0.91362774,"about_ca_system_score_codex":0.0030889008,"about_ca_system_score_gemma":0.0049786516,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W3196892055","doi":"10.6004/jnccn.2020.7803","title":"Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"Eisai; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; GlaxoSmithKline; Ontario Ministry of Health and Long-Term Care; AstraZeneca","keywords":"Medicine; Palliative care; Quality of life (healthcare); Depression (economics); Mood; Cancer; Internal medicine; Patient satisfaction; Physical therapy; Surgery; Nursing; Psychiatry","score_opus":0.08735327822484144,"score_gpt":0.41545993695869005,"score_spread":0.3281066587338486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196892055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811017,0.01597386,0.0007699275,0.0005477071,0.00056313205,0.00068440917,0.00027912646,0.0000045904785,0.000075568845],"genre_scores_gemma":[0.98781586,0.00075920793,0.009566701,0.00054331456,0.00112546,0.000046183774,0.000042646167,0.000027339205,0.00007326108],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99815196,0.0000756538,0.0004981532,0.00016148305,0.0009228175,0.00018992943],"domain_scores_gemma":[0.986974,0.0004203791,0.001109656,0.00010297664,0.011309111,0.00008388512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006215104,0.00017699861,0.00062496547,0.00006601499,0.00013942811,0.000007054348,0.00013535537,0.00005929311,0.000030577263],"category_scores_gemma":[0.0001864904,0.00010778561,0.00022324553,0.00044674508,0.00010648694,0.0001106614,0.000040751795,0.00023887304,5.930907e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4484422,0.002478695,0.2982872,0.0008936372,0.008740502,0.000025625328,0.010854463,0.19584984,0.002988371,0.00030970003,0.010017505,0.021112254],"study_design_scores_gemma":[0.5747518,0.038439218,0.23571518,0.029249042,0.0029455384,0.000010080493,0.0037815836,0.0008513404,0.02346406,0.0004538622,0.089506425,0.00083185814],"about_ca_topic_score_codex":0.000018358256,"about_ca_topic_score_gemma":0.00003132871,"teacher_disagreement_score":0.1949985,"about_ca_system_score_codex":0.00022525106,"about_ca_system_score_gemma":0.00084405026,"threshold_uncertainty_score":0.43953693},"labels":[],"label_agreement":null},{"id":"W3197461520","doi":"10.6004/jnccn.2021.7015","title":"Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Censoring (clinical trials); Medicine; Discontinuation; Internal medicine; Logistic regression; Clinical trial; Confidence interval; Standard error; Oncology; Statistics; Pathology","score_opus":0.572503393295862,"score_gpt":0.5838695199751416,"score_spread":0.011366126679279609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197461520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663571,0.0037651153,0.000088815024,0.02778971,0.0014297118,0.00027515285,0.000010828197,0.0000021675476,0.00028137732],"genre_scores_gemma":[0.9931564,0.0013667347,0.0016061799,0.0020603726,0.0011740269,0.0000065779295,0.0000010233837,0.0000122639385,0.0006164694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964232,0.00080886064,0.0012116433,0.00017374796,0.0011833656,0.00019917145],"domain_scores_gemma":[0.97260195,0.02080266,0.000796583,0.00011927708,0.0055422722,0.00013726656],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040743817,0.00010028908,0.00076025166,0.00012090752,0.00008001264,0.000022934822,0.00017124598,0.00012303013,0.00004486877],"category_scores_gemma":[0.024839478,0.00007085059,0.00020533237,0.00053293805,0.00018514895,0.00006887491,0.00016971894,0.0011361662,9.569542e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076844683,0.0003954047,0.8949378,0.00038966004,0.0012751534,0.00020109714,0.003668439,0.034201246,0.017761271,0.018115561,0.017139578,0.004230335],"study_design_scores_gemma":[0.010242174,0.00053029606,0.94038934,0.0058045485,0.00023861822,0.00022786764,0.0010171877,0.0003137402,0.00405041,0.025229199,0.011751986,0.00020462039],"about_ca_topic_score_codex":0.00006092387,"about_ca_topic_score_gemma":0.0011097116,"teacher_disagreement_score":0.045451567,"about_ca_system_score_codex":0.00031040914,"about_ca_system_score_gemma":0.0022929513,"threshold_uncertainty_score":0.9833747},"labels":[],"label_agreement":null},{"id":"W3198724220","doi":"10.6004/jnccn.2021.7014","title":"Trajectories of Suffering in the Last Year of Life Among Patients With a Solid Metastatic Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"Duke-NUS Medical School","keywords":"Medicine; Cancer; Confounding; Odds ratio; Cohort; Prospective cohort study; Cohort study; Pediatrics; Internal medicine","score_opus":0.09487665685362046,"score_gpt":0.386034090513386,"score_spread":0.29115743365976554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198724220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912027,0.0077414126,0.000032932072,0.00041241822,0.00031157615,0.00012555296,0.000036963662,0.000001013397,0.00013544521],"genre_scores_gemma":[0.99798256,0.0007281062,0.00048020345,0.00044069666,0.00033371703,0.0000058107103,0.0000029955545,0.000008942092,0.00001699644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984906,0.00013329739,0.0004536902,0.0000710269,0.00074299425,0.000108428394],"domain_scores_gemma":[0.99615747,0.00047216975,0.000646081,0.00007972689,0.0026088844,0.000035657034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013446271,0.000092904214,0.00043673784,0.000057999976,0.000028111888,0.0000044896524,0.00013569485,0.000024993256,0.00004134381],"category_scores_gemma":[0.00025841442,0.000050955863,0.00013031777,0.00047256378,0.00012550708,0.00006351236,0.000028780672,0.00021501591,8.759857e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005309964,0.00011045248,0.9447454,0.00016925136,0.0006142986,0.000004614666,0.001905343,0.049058132,0.0003058713,0.00010825655,0.0023224798,0.00012489044],"study_design_scores_gemma":[0.0019317311,0.00015972357,0.99025416,0.0027090565,0.00019580801,0.0000035682758,0.0012114256,0.00010824307,0.0015107681,0.00017976863,0.001675963,0.000059760125],"about_ca_topic_score_codex":0.000071484676,"about_ca_topic_score_gemma":0.00022907279,"teacher_disagreement_score":0.04894989,"about_ca_system_score_codex":0.000092607035,"about_ca_system_score_gemma":0.00053394615,"threshold_uncertainty_score":0.20779198},"labels":[],"label_agreement":null},{"id":"W3201171945","doi":"10.6004/jnccn.2021.7003","title":"Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Postmarketing surveillance; Clinical trial; Adverse effect; Internal medicine; Oncology","score_opus":0.038686617396315556,"score_gpt":0.29488366663683363,"score_spread":0.25619704924051806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201171945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730817,0.01742649,0.000005243487,0.006797368,0.00026364488,0.00013342388,0.000243643,9.3740186e-7,0.0020475364],"genre_scores_gemma":[0.9948638,0.002594195,0.0001877966,0.0018118988,0.00030511143,0.0000063286498,0.0000020343994,0.000010763192,0.00021805796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985324,0.00016704525,0.00087415037,0.00014525552,0.00013049634,0.00015062137],"domain_scores_gemma":[0.9951025,0.002422192,0.0017433969,0.00009190254,0.0006105511,0.000029420646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018967899,0.00010831335,0.00050385226,0.000046125075,0.000168533,0.000032515843,0.0001905658,0.00006408546,0.00006392331],"category_scores_gemma":[0.00078585144,0.00006618564,0.00015442011,0.0002241239,0.00021533247,0.00011521686,0.00011042651,0.00029569084,5.1353544e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003666244,0.000036678663,0.9887035,0.000018259123,0.00037552,0.0000010205547,0.00082922715,0.004165595,0.000006612329,0.0030018585,0.0013304551,0.0011646834],"study_design_scores_gemma":[0.00080608885,0.000033567332,0.99306023,0.00014620516,0.00004521113,0.00001316904,0.000340651,0.00048468477,0.0000066884113,0.002944073,0.0020378702,0.0000815546],"about_ca_topic_score_codex":0.00008356743,"about_ca_topic_score_gemma":0.0003553996,"teacher_disagreement_score":0.021782102,"about_ca_system_score_codex":0.00017496708,"about_ca_system_score_gemma":0.00018854346,"threshold_uncertainty_score":0.26989722},"labels":[],"label_agreement":null},{"id":"W3217732564","doi":"10.6004/jnccn.2021.5109","title":"Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Immunovaccine (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Diffuse large B-cell lymphoma; Oncology; Internal medicine; Disease; Intensive care medicine","score_opus":0.03837105324427232,"score_gpt":0.31363689596042993,"score_spread":0.2752658427161576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217732564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83174115,0.14888744,0.00028910208,0.013892813,0.003605059,0.00076141884,0.0001696087,0.000019988662,0.0006334145],"genre_scores_gemma":[0.97719234,0.0062601836,0.0015819757,0.011397689,0.0027429967,0.000053092575,0.000018887895,0.00003004897,0.0007227956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853885,0.00008547912,0.00037430355,0.00016655297,0.00059862906,0.00023620711],"domain_scores_gemma":[0.99669105,0.00048178041,0.0004200509,0.00014697349,0.0020743872,0.00018578403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000109225315,0.00016279527,0.00033655664,0.00004322649,0.00022224935,0.000032212476,0.00013066256,0.000056405835,0.000062369116],"category_scores_gemma":[0.000101140286,0.00010377156,0.00052073936,0.0002019841,0.0000349076,0.000088080866,0.00005161932,0.00011768244,0.0000024072594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011714047,0.028053744,0.085807204,0.0003312355,0.004131294,0.00063947914,0.0005900104,0.03686408,0.0033984715,0.003299537,0.8093354,0.015835505],"study_design_scores_gemma":[0.06988123,0.00042810058,0.2509582,0.0008055459,0.00062303914,0.00018775169,0.00010336786,0.0012057206,0.0022410227,0.0020731902,0.6712169,0.00027592317],"about_ca_topic_score_codex":0.000001775867,"about_ca_topic_score_gemma":0.0000015686607,"teacher_disagreement_score":0.165151,"about_ca_system_score_codex":0.0005924775,"about_ca_system_score_gemma":0.0011341255,"threshold_uncertainty_score":0.42316815},"labels":[],"label_agreement":null},{"id":"W4200025323","doi":"10.6004/jnccn.2021.7066","title":"Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center","keywords":"Medicine; Adverse effect; Randomized controlled trial; Internal medicine; Dexamethasone; Quality of life (healthcare); Population; Cancer; Physical therapy","score_opus":0.09430723708718246,"score_gpt":0.40363802345610855,"score_spread":0.3093307863689261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200025323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784409,0.010870134,0.000238187,0.0055453186,0.0020684723,0.0027035328,0.00003546382,0.00000770106,0.000090301735],"genre_scores_gemma":[0.99556535,0.0017659118,0.000096335694,0.00047879072,0.0015823415,0.0002855171,0.000007668097,0.000018304863,0.00019976878],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979998,0.00037779065,0.0005518558,0.00017080185,0.00073986663,0.00015987095],"domain_scores_gemma":[0.9927839,0.0019010522,0.001141276,0.00010043512,0.003987636,0.00008570425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005423786,0.00017939016,0.001328879,0.000079134305,0.00016929541,0.00001960969,0.000105068226,0.00009959882,0.00004683106],"category_scores_gemma":[0.000252367,0.00011595602,0.00075913157,0.00040234442,0.00014377771,0.00010070852,0.000039848903,0.000341793,4.9548657e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98140776,0.0011163562,0.000021074095,0.000046004083,0.0021540457,0.0000016605965,0.0007058807,0.0027952832,0.005237978,0.0011490333,0.0009793706,0.004385538],"study_design_scores_gemma":[0.98137987,0.0011500859,0.00017355967,0.00029218246,0.0006981301,0.000018658735,0.000049153754,0.00693427,0.0045004166,0.0018314697,0.0028615545,0.00011066345],"about_ca_topic_score_codex":0.000050043243,"about_ca_topic_score_gemma":0.0000373153,"teacher_disagreement_score":0.017124474,"about_ca_system_score_codex":0.00021116922,"about_ca_system_score_gemma":0.00096077565,"threshold_uncertainty_score":0.47285494},"labels":[],"label_agreement":null},{"id":"W4200032080","doi":"10.6004/jnccn.2021.7093","title":"Sustainability of Tobacco Treatment Programs in the Cancer Center Cessation Initiative","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, University of North Carolina at Chapel Hill; National Cancer Institute; School of Medicine, University of Maryland; Robert H. Lurie Comprehensive Cancer Center; Norris Cotton Cancer Center; University of North Carolina at Chapel Hill; National Institute on Drug Abuse; Dartmouth College; York University; UVA Cancer Center; Memorial Sloan-Kettering Cancer Center; University of South Carolina; Comprehensive Cancer Center, City of Hope; Hollings Cancer Center, Medical University of South Carolina; Feinberg School of Medicine; School of Medicine and Public Health, University of Wisconsin-Madison; Washington University in St. Louis; Stanford Cancer Institute; University of Wisconsin-Madison; Northwestern University; Beckman Research Institute, City of Hope","keywords":"Medicine; Smoking cessation; Center (category theory); Sustainability; Tobacco use; Environmental health; Oncology","score_opus":0.5908350087493385,"score_gpt":0.6198646113209496,"score_spread":0.029029602571611135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200032080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86842483,0.00092363113,0.00009867593,0.12637618,0.0018752464,0.001410985,0.000099992954,0.0000052602823,0.00078516646],"genre_scores_gemma":[0.9786339,0.0003127153,0.00014315509,0.019621056,0.0009925079,0.00020115572,0.0000040497766,0.0000071743207,0.00008431543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952708,0.0023387044,0.001020325,0.00014456699,0.0008808552,0.000344746],"domain_scores_gemma":[0.99023664,0.0022626887,0.001296312,0.00014718375,0.005995637,0.00006156691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011884805,0.00011090243,0.000274847,0.00006668024,0.00036450895,0.000013252225,0.0003459852,0.00006122723,0.0001902585],"category_scores_gemma":[0.0007779547,0.00006254959,0.000120761906,0.0011660191,0.0001143244,0.00017878706,0.000082190505,0.00042164596,0.0000013628579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018665488,0.0001586319,0.9230568,0.0001039859,0.00009036866,0.00000364817,0.022536358,0.015732437,0.000027649769,0.0012505535,0.03202419,0.004828752],"study_design_scores_gemma":[0.0018169779,0.00009333893,0.853358,0.00040933263,0.000027818493,0.000005193317,0.009709089,0.00006422518,0.00004604844,0.004456927,0.12993424,0.0000788713],"about_ca_topic_score_codex":0.0002430508,"about_ca_topic_score_gemma":0.0011842208,"teacher_disagreement_score":0.11020901,"about_ca_system_score_codex":0.0022743007,"about_ca_system_score_gemma":0.0049101925,"threshold_uncertainty_score":0.871047},"labels":[],"label_agreement":null},{"id":"W4200423910","doi":"10.6004/jnccn.2021.7094","title":"Implementation Science to Improve Tobacco Cessation Services in Oncology Care","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Agency for Healthcare Research and Quality; National Institute of General Medical Sciences; National Institute on Drug Abuse; National Center for Advancing Translational Sciences; Partenariat Canadien Contre Le Cancer","keywords":"Medicine; Context (archaeology); Psychological intervention; Smoking cessation; Tobacco use; Tobacco control; Family medicine; Nursing; Environmental health; Public health","score_opus":0.3224241705783949,"score_gpt":0.6467473961898564,"score_spread":0.32432322561146154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200423910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516544,0.00047790562,0.0001086471,0.03978951,0.0055402042,0.0007808808,0.00006781837,0.00000826076,0.0015724042],"genre_scores_gemma":[0.92930067,0.00008024372,0.001525365,0.067215286,0.0017289702,0.00007688227,0.0000030295068,0.000009327258,0.000060249884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616057,0.00079127075,0.0010750609,0.000225414,0.0012436173,0.00050409476],"domain_scores_gemma":[0.9899962,0.0011115131,0.0010788598,0.00013042953,0.0075024045,0.00018058148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014488148,0.00010581953,0.0002455296,0.00023154468,0.00081382017,0.000029766288,0.00052504824,0.00006573708,0.00030205853],"category_scores_gemma":[0.00045604972,0.000083382874,0.00005889085,0.0021278968,0.00007950921,0.000445534,0.00027757025,0.0004903883,0.000016770065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003907633,0.00007417428,0.64481956,0.0004829223,0.00008390764,0.000015204921,0.08720507,0.09256759,0.04007843,0.0063293744,0.076710865,0.051242117],"study_design_scores_gemma":[0.001843293,0.0001072601,0.7059169,0.00034831863,0.00001588231,0.000009081363,0.031677082,0.00013930906,0.0011974417,0.0015153103,0.25709742,0.00013271639],"about_ca_topic_score_codex":0.00025920628,"about_ca_topic_score_gemma":0.004469479,"teacher_disagreement_score":0.18038656,"about_ca_system_score_codex":0.0034134253,"about_ca_system_score_gemma":0.00880996,"threshold_uncertainty_score":0.9968092},"labels":[],"label_agreement":null},{"id":"W4200560749","doi":"10.6004/jnccn.2021.7092","title":"Telehealth Delivery of Tobacco Cessation Treatment in Cancer Care: An Ongoing Innovation Accelerated by the COVID-19 Pandemic","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Partenariat Canadien Contre Le Cancer; Agency for Healthcare Research and Quality; University of Louisville","keywords":"Telehealth; Medicine; Pandemic; Phone; Telemedicine; Smoking cessation; Health care; Family medicine; Ambulatory care; Medical emergency; Nursing; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.24013154498539743,"score_gpt":0.46350132809787736,"score_spread":0.22336978311247993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200560749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587806,0.016319716,0.000048778526,0.023691515,0.00064651266,0.00039490024,0.000060920385,0.00000773113,0.000049360857],"genre_scores_gemma":[0.96614593,0.0042245127,0.00006530763,0.028359652,0.0010574985,0.00002161994,0.000041472245,0.000014018072,0.00007000921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978627,0.0003302553,0.0007385929,0.00016025812,0.00069180306,0.0002163825],"domain_scores_gemma":[0.9943457,0.00057650625,0.0008575494,0.0001354204,0.0039552464,0.0001295389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003408126,0.00014454006,0.00037177154,0.00014740265,0.0001984818,0.000022122727,0.00014192186,0.00009841343,0.000069610236],"category_scores_gemma":[0.00032792526,0.0000901992,0.00009608214,0.0014034938,0.00005748836,0.00015722105,0.00003173979,0.00038041826,2.5277637e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013704854,0.00022831034,0.74129677,0.00026994417,0.0003049311,0.00001539353,0.0031316963,0.17652966,0.007943547,0.0002073645,0.024835093,0.04386679],"study_design_scores_gemma":[0.0071924906,0.0007486223,0.84512424,0.00095539493,0.00023203288,0.00023342377,0.0019041513,0.0011795257,0.0019470878,0.00071976,0.13952033,0.00024293251],"about_ca_topic_score_codex":0.0023051684,"about_ca_topic_score_gemma":0.0041910214,"teacher_disagreement_score":0.17535014,"about_ca_system_score_codex":0.0045360792,"about_ca_system_score_gemma":0.00893579,"threshold_uncertainty_score":0.99928534},"labels":[],"label_agreement":null},{"id":"W4200614899","doi":"10.6004/jnccn.2021.7090","title":"Involving Family and Social Support Systems in Tobacco Cessation Treatment for Patients With Cancer","year":2021,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Family Support in Illness","field":"Social Sciences","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; School of Medicine and Public Health, University of Wisconsin-Madison; University of North Carolina at Chapel Hill; Agency for Healthcare Research and Quality; Norris Cotton Cancer Center; Partenariat Canadien Contre Le Cancer; Memorial Sloan-Kettering Cancer Center; University of South Carolina; Dartmouth College; University of Arizona; Massachusetts General Hospital; Virginia Commonwealth University; University of Wisconsin-Madison","keywords":"Social support; Medicine; Smoking cessation; Psychological intervention; Family medicine; Tobacco control; Family support; Cancer; Support group; Nursing; Public health; Psychiatry; Psychotherapist; Psychology; Physical therapy","score_opus":0.059081919316286216,"score_gpt":0.331173806866866,"score_spread":0.2720918875505798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200614899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989104,0.004492125,0.000022576944,0.0025673225,0.0028902423,0.00046158515,0.00008916345,0.0000054663346,0.00036757335],"genre_scores_gemma":[0.9962919,0.0006325791,0.00011855019,0.0009969779,0.0016785727,0.00006213831,0.0000095710275,0.000012222759,0.00019753356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983291,0.00029143275,0.00033226112,0.00013289394,0.00070141855,0.00021289995],"domain_scores_gemma":[0.9964918,0.00048770022,0.00046831658,0.00003923436,0.0024676125,0.00004536781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031002122,0.00010600907,0.00024653,0.000050541967,0.00058488245,0.000079050405,0.00013575137,0.00007004848,0.000020774185],"category_scores_gemma":[0.00008309907,0.00007573055,0.00007514782,0.0003184109,0.00010290554,0.00022801138,0.00002884657,0.00015339554,1.7979477e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043777894,0.00018749511,0.88558203,0.00005681823,0.0003588853,0.000006119813,0.011851436,0.058305446,0.00006535073,0.0050194035,0.033186067,0.0049431934],"study_design_scores_gemma":[0.0029903396,0.000119729855,0.8264597,0.0003298218,0.00009594728,0.0000025563477,0.008120387,0.00022145042,0.000011862122,0.0012388745,0.16019021,0.00021911642],"about_ca_topic_score_codex":0.0006542326,"about_ca_topic_score_gemma":0.0020988877,"teacher_disagreement_score":0.12700413,"about_ca_system_score_codex":0.0011420792,"about_ca_system_score_gemma":0.0013666537,"threshold_uncertainty_score":0.4498502},"labels":[],"label_agreement":null},{"id":"W4210617548","doi":"10.6004/jnccn.2021.7114","title":"Incident Cancer Detection During the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Manitoba; Princess Margaret Cancer Centre; Women's College Hospital; Cancer Care Ontario; Institute of Health Services and Policy Research; Queen's University; University of Toronto; Associated Medical Services; Ontario Institute for Cancer Research; North Pacific Marine Science Organization; Manitoba Health","funders":"","keywords":"Medicine; Incidence (geometry); Cancer; Pandemic; Population; Cervical cancer; Rate ratio; Lung cancer; Cohort; Demography; Coronavirus disease 2019 (COVID-19); Internal medicine; Environmental health; Disease","score_opus":0.13858145724569573,"score_gpt":0.4264038682847975,"score_spread":0.2878224110391018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210617548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91813374,0.015131638,0.00010836777,0.06251595,0.0035234557,0.00047824907,0.00003684293,0.000021065702,0.000050686704],"genre_scores_gemma":[0.9343784,0.001082224,0.000011693212,0.06044416,0.003679709,0.00005270768,9.664913e-7,0.00001593621,0.0003342141],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99758905,0.0003068728,0.00044472824,0.00013127357,0.0012823527,0.0002457475],"domain_scores_gemma":[0.99747384,0.00057059096,0.00068504957,0.00012564768,0.0009358185,0.00020903007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005348592,0.00012412167,0.0002540289,0.00010421045,0.0010908149,0.000019904408,0.0002741583,0.00004256357,0.0004524219],"category_scores_gemma":[0.00040331658,0.00007535519,0.00023113392,0.0005700822,0.00006813819,0.00006771697,0.0001773342,0.0009916612,0.0000011969194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021211212,0.000051166848,0.21370426,0.00016232983,0.00037472328,0.000027762919,0.0009373274,0.72263557,0.0046071378,0.000060406786,0.052896976,0.002421201],"study_design_scores_gemma":[0.001740064,0.00015180944,0.585253,0.000096977485,0.00012905417,0.0014029482,0.00023216387,0.00065094687,0.00008802926,0.0010532556,0.4090982,0.0001035717],"about_ca_topic_score_codex":0.00053437584,"about_ca_topic_score_gemma":0.000499851,"teacher_disagreement_score":0.7219846,"about_ca_system_score_codex":0.005354732,"about_ca_system_score_gemma":0.0026313076,"threshold_uncertainty_score":0.9984635},"labels":[],"label_agreement":null},{"id":"W4210627757","doi":"10.6004/jnccn.2022.0009","title":"NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Astellas Pharma; Seagen","keywords":"Medicine; Myelodysplastic syndromes; Multidisciplinary approach; Intensive care medicine; Malignancy; MEDLINE; Clinical Practice; Family medicine; Internal medicine","score_opus":0.0733164020931557,"score_gpt":0.35871192283820913,"score_spread":0.2853955207450534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210627757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83975744,0.065141656,0.00036846378,0.07574984,0.013596786,0.0014023175,0.00017351212,0.00006411094,0.0037458462],"genre_scores_gemma":[0.9669274,0.0014651392,0.0012891014,0.020897472,0.0055462816,0.000047862897,0.000026054415,0.0000622032,0.0037384625],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960595,0.00029021033,0.000665113,0.00019175668,0.0025000533,0.00029340104],"domain_scores_gemma":[0.99498075,0.0005089698,0.0005807305,0.00017833678,0.003591284,0.00015993245],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000430274,0.00017135491,0.00039975485,0.00023129758,0.00058685226,0.00002122707,0.0005540081,0.00005701867,0.0013568003],"category_scores_gemma":[0.00047185208,0.00011923763,0.0003084589,0.0010880815,0.00009926458,0.00011225027,0.00053238973,0.0013226353,0.000016203727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079883885,0.000057604862,0.0013021809,0.00002876101,0.00037172897,0.00008045768,0.000074332725,0.19660287,0.001957625,0.00031683376,0.79782844,0.0005803377],"study_design_scores_gemma":[0.0033477964,0.00050048623,0.021656502,0.00027938586,0.00019621741,0.0023356285,0.00026489093,0.010005943,0.00009754567,0.0018510375,0.9592875,0.00017701607],"about_ca_topic_score_codex":0.0000141226155,"about_ca_topic_score_gemma":0.0000021128292,"teacher_disagreement_score":0.18659692,"about_ca_system_score_codex":0.0026629267,"about_ca_system_score_gemma":0.0019692832,"threshold_uncertainty_score":0.9995561},"labels":[],"label_agreement":null},{"id":"W4210725270","doi":"10.6004/jnccn.2021.7118","title":"Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About","year":2022,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Perioperative; Disease; Cancer; Radiation therapy; Intensive care medicine; Chemotherapy; Biomarker; General surgery; Surgery; Internal medicine","score_opus":0.25093225683797515,"score_gpt":0.41021314871403736,"score_spread":0.1592808918760622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210725270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098671095,0.98109233,0.0000039825595,0.015239444,0.0010285635,0.0021519118,0.00025895558,0.000006258565,0.00011988908],"genre_scores_gemma":[0.0006058547,0.9825226,0.00015159648,0.012636144,0.002597522,0.0006875006,0.000020751815,0.00005741872,0.00072059967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959212,0.0007314657,0.0007714853,0.000419932,0.001687257,0.00046869364],"domain_scores_gemma":[0.99673533,0.0009561048,0.00080499414,0.00025382623,0.00091883447,0.00033088814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040536805,0.0005061223,0.0015037094,0.00015084747,0.0005740437,0.00020885926,0.0005937899,0.000113953785,0.00060854614],"category_scores_gemma":[0.00008492051,0.00024900594,0.00070395006,0.0006549267,0.00021012795,0.00023171262,0.00044246257,0.0016261728,0.0000049868563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011132644,0.00021973254,0.00034127152,0.00247389,0.009134434,0.00016718892,0.0030912522,0.0072587966,5.2925617e-7,0.00048966997,0.15909816,0.8166118],"study_design_scores_gemma":[0.0009088711,0.0006953612,0.0009824149,0.006617909,0.0014605268,0.0005676588,0.00026293364,0.000041765477,0.000003925703,0.0001258615,0.9881414,0.00019137461],"about_ca_topic_score_codex":0.000043292806,"about_ca_topic_score_gemma":0.00002835178,"teacher_disagreement_score":0.8290432,"about_ca_system_score_codex":0.0019836633,"about_ca_system_score_gemma":0.0025560942,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W4210729420","doi":"10.6004/jnccn.2021.7113","title":"Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Adverse effect; Cancer; Common Terminology Criteria for Adverse Events; Internal medicine; Cohort; Prospective cohort study; Observational study; Cohort study; Clinical trial","score_opus":0.04286418073360021,"score_gpt":0.3641078119557966,"score_spread":0.3212436312221964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210729420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930908,0.002573418,0.00003834532,0.0028662297,0.00064405554,0.0005398483,0.00016323001,0.000007022471,0.00007704207],"genre_scores_gemma":[0.9513548,0.000028972729,0.00007010561,0.04785497,0.00047294633,0.00010069643,0.000012157521,0.000021408674,0.00008393642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967638,0.00018572804,0.00064088515,0.00019130814,0.0019990536,0.00021922388],"domain_scores_gemma":[0.99618566,0.0001909461,0.001062205,0.00016248171,0.0023059852,0.00009273846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002881798,0.00015792665,0.00035657734,0.00013034958,0.00019832187,0.000005628359,0.0002405654,0.000045848657,0.00026089253],"category_scores_gemma":[0.0001887443,0.000108291606,0.0001894993,0.00068107864,0.000053805692,0.00010566318,0.00011922644,0.00051032857,7.0154107e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028467236,0.000620641,0.86693966,0.00013274471,0.0010963056,0.00008491275,0.00024160922,0.012814016,0.0022738036,0.000013787963,0.08691609,0.00039916203],"study_design_scores_gemma":[0.011455629,0.001429432,0.62876236,0.00032188685,0.00039505056,0.00022758485,0.0001228358,0.00052115397,0.001145225,0.00038439495,0.3550012,0.00023326193],"about_ca_topic_score_codex":0.00009247974,"about_ca_topic_score_gemma":0.00005137702,"teacher_disagreement_score":0.26808512,"about_ca_system_score_codex":0.0011514986,"about_ca_system_score_gemma":0.0026991516,"threshold_uncertainty_score":0.47881794},"labels":[],"label_agreement":null},{"id":"W4221042784","doi":"10.6004/jnccn.2021.7278","title":"HSR22-173: Treatment Patterns, Healthcare Resource Use and Costs Among Patients With EGFR-Mutated Non-Small Cell Lung Cancer Following Discontinuation of Osimertinib and Platinum-Based Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Osimertinib; Medicine; Discontinuation; Lung cancer; Chemotherapy; Oncology; Internal medicine; Intensive care medicine; Cancer; Adenocarcinoma","score_opus":0.0178787720146668,"score_gpt":0.3003399990160326,"score_spread":0.2824612270013658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221042784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361515,0.003053007,0.000054739627,0.0019558866,0.0002386191,0.0008922915,0.00017125513,0.000005500537,0.000013531309],"genre_scores_gemma":[0.9976725,0.0001610612,0.0002574133,0.0014652789,0.00016681351,0.00009189922,0.00006131333,0.000029199204,0.00009454493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985316,0.00012789562,0.00039967903,0.0001855055,0.0005824787,0.00017287956],"domain_scores_gemma":[0.99811625,0.00023828153,0.00075846125,0.000092603404,0.0006922041,0.000102181206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082491264,0.0001827907,0.0003657257,0.00008954914,0.00029025628,0.000029754832,0.000070185335,0.000035227942,0.000022213113],"category_scores_gemma":[0.00001124067,0.00011966005,0.00011620751,0.00023788495,0.000042102067,0.00010760052,0.000032958433,0.00019528974,2.2847118e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010211484,0.00019666458,0.9543753,0.00004801005,0.0006743208,0.0000052662576,0.0008458575,0.03963446,0.00009597665,0.0000021672752,0.0009479685,0.00215286],"study_design_scores_gemma":[0.011062439,0.00086033734,0.9821019,0.0007846203,0.00063371053,0.000005297772,0.0002685561,0.002867718,0.00026985136,0.0000062573563,0.0010136327,0.00012565855],"about_ca_topic_score_codex":0.00075438543,"about_ca_topic_score_gemma":0.0002933508,"teacher_disagreement_score":0.036766738,"about_ca_system_score_codex":0.0012721946,"about_ca_system_score_gemma":0.00046066786,"threshold_uncertainty_score":0.4879595},"labels":[],"label_agreement":null},{"id":"W4221104422","doi":"10.6004/jnccn.2021.7268","title":"CLO22-052: A Tale of Two Schedules: A Study of the Efficacy and Toxicity Outcomes of Extended Durvalumab Dosing in Patients with Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Durvalumab; Dosing; Toxicity; Oncology; Stage (stratigraphy); Internal medicine; Lung cancer; non-small cell lung cancer (NSCLC); Cancer; Immunotherapy","score_opus":0.020011767071446553,"score_gpt":0.30492830326985554,"score_spread":0.284916536198409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221104422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449277,0.0037113335,0.000011371127,0.00020246884,0.000444932,0.0010228184,0.00006261777,0.0000018459415,0.000049825943],"genre_scores_gemma":[0.99923456,0.00009648675,0.000107365995,0.0003482479,0.00009583944,0.000023418086,0.0000012030358,0.000017691456,0.00007519587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757385,0.0002638289,0.00072455505,0.00015964183,0.0010936382,0.00018449318],"domain_scores_gemma":[0.99712193,0.00029953642,0.0013748093,0.00018270926,0.0009804079,0.00004061176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037852355,0.00016528108,0.0005945318,0.00012866686,0.00016716674,0.000007830258,0.0002959118,0.000031214026,0.00007612461],"category_scores_gemma":[0.000033206492,0.00009787321,0.00016195378,0.0007093427,0.00014190887,0.00006681289,0.00019081532,0.00041685347,1.2635458e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011197106,0.0012766733,0.87807935,0.00014030184,0.0008949386,0.0000018326695,0.001667296,0.101515144,0.004683919,0.000009200111,0.0002890569,0.0002452059],"study_design_scores_gemma":[0.025566688,0.00097604195,0.96912,0.0006923039,0.00022576848,0.0000038168264,0.0009869093,0.0006685312,0.0015560996,0.000021326545,0.0000800834,0.00010240251],"about_ca_topic_score_codex":0.00058187725,"about_ca_topic_score_gemma":0.00026037518,"teacher_disagreement_score":0.10084661,"about_ca_system_score_codex":0.0004629088,"about_ca_system_score_gemma":0.00067829585,"threshold_uncertainty_score":0.39911538},"labels":[],"label_agreement":null},{"id":"W4255357567","doi":"10.6004/jnccn.2007.0060","title":"Point: Active Surveillance for Favorable Risk Prostate Cancer","year":2007,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Disease; Comorbidity; Cancer; Intervention (counseling); Prostate; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.4769247467430893,"score_gpt":0.5108862904012774,"score_spread":0.0339615436581881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255357567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003722771,0.9819272,0.0005653848,0.0044184206,0.0059820022,0.002017313,0.0046303687,0.000012319511,0.0004097751],"genre_scores_gemma":[0.00005110154,0.98433167,0.0010410692,0.0056794547,0.0074957116,0.00031222598,0.000035379355,0.00009540553,0.0009580046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99092895,0.0008191165,0.0067133466,0.00052657834,0.00039639097,0.000615645],"domain_scores_gemma":[0.9697147,0.0068888655,0.020865647,0.00030706183,0.0020354926,0.000188244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010889373,0.00048587806,0.0035900732,0.00038323624,0.0004962873,0.00009940579,0.00088735705,0.00035333322,0.00019691447],"category_scores_gemma":[0.0036856972,0.00041858992,0.0013019466,0.0006721296,0.00012186171,0.00036179423,0.00011256848,0.0010296237,0.00006530252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002629465,0.00011365918,0.0017334027,0.011677429,0.0037650964,0.0000016609267,0.000564472,0.046093695,5.5735324e-8,0.010806588,0.82735246,0.09762855],"study_design_scores_gemma":[0.0006860067,0.000053238633,0.0006466814,0.0053017917,0.00013360774,0.000020392163,0.00005131202,0.00032989666,1.2754653e-7,0.012092448,0.98027915,0.00040535638],"about_ca_topic_score_codex":0.00021917032,"about_ca_topic_score_gemma":0.00016632349,"teacher_disagreement_score":0.1529267,"about_ca_system_score_codex":0.0037681132,"about_ca_system_score_gemma":0.002056538,"threshold_uncertainty_score":0.9998266},"labels":[],"label_agreement":null},{"id":"W4281858263","doi":"10.6004/jnccn.2022.5020","title":"The Future of Telemedicine in Oncology","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Telemedicine; Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Socioeconomic status; Telehealth; Health care; Family medicine; Medical emergency; Nursing; Internal medicine; Economic growth; Environmental health; Population","score_opus":0.06411557709359854,"score_gpt":0.4187124715446378,"score_spread":0.35459689445103926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281858263","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41026407,0.08908118,0.000015795818,0.49022236,0.008698977,0.0006935372,0.000028659855,0.0000062549975,0.0009891618],"genre_scores_gemma":[0.9684201,0.00205856,0.00006794373,0.02466674,0.004598959,0.000011046206,0.0000012574654,0.000008707004,0.00016669769],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981282,0.0002475603,0.00051509804,0.00006735193,0.00086674583,0.00017505231],"domain_scores_gemma":[0.9971828,0.0009537946,0.0006165675,0.00008928786,0.001084566,0.00007299974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006371866,0.00007358966,0.00030425712,0.00008766846,0.00023153368,0.0000030467334,0.00023151272,0.000037983944,0.00012875863],"category_scores_gemma":[0.00018356729,0.000039995462,0.00013284496,0.0005438685,0.00008178538,0.000025394158,0.00009957037,0.0008091181,2.8796538e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005543892,0.00025055755,0.077577375,0.00014036534,0.00040830276,0.00007545999,0.0014153302,0.12113227,0.0010923584,0.0038115566,0.72964096,0.058911603],"study_design_scores_gemma":[0.0014783887,0.0004992149,0.25517836,0.00010114583,0.000033667817,0.00020901191,0.0005438604,0.00020458242,0.000014926139,0.0020856431,0.7396192,0.000032030413],"about_ca_topic_score_codex":0.000041825948,"about_ca_topic_score_gemma":0.00014578848,"teacher_disagreement_score":0.558156,"about_ca_system_score_codex":0.0010778414,"about_ca_system_score_gemma":0.0021613457,"threshold_uncertainty_score":0.38341346},"labels":[],"label_agreement":null},{"id":"W4283014330","doi":"10.6004/jnccn.2022.7014","title":"Frailty in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hazard ratio; Interquartile range; Proportional hazards model; Population; Diffuse large B-cell lymphoma; Internal medicine; Comorbidity; Retrospective cohort study; Lymphoma; Rituximab; Confidence interval","score_opus":0.030460634555253694,"score_gpt":0.2936127694747425,"score_spread":0.2631521349194888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283014330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576944,0.0013323207,0.0000083922505,0.0012836889,0.0005401412,0.0009729743,0.00004384061,0.000007525129,0.000041663916],"genre_scores_gemma":[0.99552655,0.000035023462,0.000118475626,0.0038364297,0.00025263955,0.00014594824,0.000022598328,0.00002410671,0.000038240585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737686,0.00034441167,0.0004957309,0.00019955402,0.0013486673,0.00023477688],"domain_scores_gemma":[0.99766594,0.0004557147,0.00066436775,0.00014534962,0.0009829708,0.00008565282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018786552,0.0001992984,0.00041071378,0.0001358888,0.0003313312,0.000025449861,0.00019352684,0.000028518167,0.00012244855],"category_scores_gemma":[0.000054897668,0.00012216353,0.00018021425,0.00055330945,0.000017509365,0.00008773423,0.00007862457,0.00023408716,7.9022436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002097264,0.0113700805,0.92864007,0.0000060555703,0.00026178564,0.000030655046,0.0003851117,0.05344093,0.0000034109923,0.000013472989,0.0027769345,0.00097423635],"study_design_scores_gemma":[0.058243774,0.0013214234,0.9361234,0.0001547437,0.0000831569,0.00000481914,0.00027751687,0.000650871,0.000009403149,0.00005323629,0.0029583452,0.00011932417],"about_ca_topic_score_codex":0.00013620146,"about_ca_topic_score_gemma":0.00010119774,"teacher_disagreement_score":0.05614651,"about_ca_system_score_codex":0.001847751,"about_ca_system_score_gemma":0.00048438396,"threshold_uncertainty_score":0.49816844},"labels":[],"label_agreement":null},{"id":"W4283032396","doi":"10.6004/jnccn.2021.7107","title":"Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Jewish General Hospital; Mount Sinai Hospital; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; STK11; Germline mutation; KRAS; Pancreatic cancer; Asymptomatic; Adenocarcinoma; Cancer; Internal medicine; Oncology; Surgical oncology; Gastroenterology; Colorectal cancer; Mutation; Gene","score_opus":0.07576385808459944,"score_gpt":0.37832339655324315,"score_spread":0.3025595384686437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283032396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97479105,0.015105216,0.000068468544,0.007326098,0.00083188317,0.001309058,0.00046756823,0.000009419683,0.00009122117],"genre_scores_gemma":[0.9865447,0.0029798918,0.001297295,0.005217386,0.0013999711,0.0009256478,0.000010101568,0.000047750586,0.0015772198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621546,0.00039463583,0.0008138745,0.0003203996,0.0016883211,0.0005673178],"domain_scores_gemma":[0.99615747,0.0011634638,0.0007626888,0.0001894176,0.0015784958,0.00014845691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000644371,0.00026830204,0.0010518907,0.00024697479,0.00042831083,0.000026034471,0.0004518225,0.000084218555,0.00084001984],"category_scores_gemma":[0.0002080716,0.00016738551,0.00022502246,0.0011060456,0.00021460412,0.00006818,0.00015997254,0.0007054519,0.0000012347319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029274584,0.00019476847,0.85143363,0.00016605064,0.0010610067,0.000042040963,0.0007163315,0.096738085,0.0000753407,0.000031907737,0.045905016,0.00070833677],"study_design_scores_gemma":[0.0059180195,0.0013891491,0.95686835,0.0007485564,0.00051420147,0.00048414615,0.0006703111,0.007535129,0.000019883335,0.00026411127,0.02534778,0.00024034649],"about_ca_topic_score_codex":0.00042972382,"about_ca_topic_score_gemma":0.00038517773,"teacher_disagreement_score":0.10543471,"about_ca_system_score_codex":0.0016754073,"about_ca_system_score_gemma":0.0035999336,"threshold_uncertainty_score":0.9197628},"labels":[],"label_agreement":null},{"id":"W4285099105","doi":"10.6004/jnccn.2022.7007","title":"Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Imatinib; Medical prescription; Pharmacist; Advertising; Quarter (Canadian coin); Certification; Family medicine; Internet privacy; Business; Internal medicine; Pharmacology","score_opus":0.18536691750635576,"score_gpt":0.4807106139900732,"score_spread":0.29534369648371744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285099105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336476,0.0020540247,0.00014154344,0.013139264,0.0008589818,0.00019921681,0.00006634475,0.000008005645,0.00016784444],"genre_scores_gemma":[0.98136544,0.000158178,0.00059037685,0.016438553,0.001381903,0.0000070421875,0.000012372033,0.000010277898,0.000035867146],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9976506,0.00034521113,0.0006161936,0.0001117708,0.0011427775,0.00013343875],"domain_scores_gemma":[0.9974717,0.00026390763,0.00080431486,0.00010167417,0.0012645154,0.00009388123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072667573,0.00009138661,0.00029015625,0.000049503862,0.00017719154,0.0000079383535,0.00032634885,0.000020249638,0.00083866017],"category_scores_gemma":[0.00011833969,0.00006584014,0.00016979077,0.0003428582,0.00009943997,0.00014120231,0.00009208432,0.0005695134,2.8583855e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02709815,0.011644833,0.20498897,0.0011373105,0.004166259,0.00003696271,0.005123975,0.27433577,0.14487082,0.0037189545,0.14425634,0.17862165],"study_design_scores_gemma":[0.017688874,0.0011198379,0.5914038,0.0006919465,0.0007325573,0.00058031,0.0014261131,0.107001506,0.009175397,0.018763652,0.25095236,0.00046362338],"about_ca_topic_score_codex":0.000013705907,"about_ca_topic_score_gemma":0.0000024933506,"teacher_disagreement_score":0.38641483,"about_ca_system_score_codex":0.00029873173,"about_ca_system_score_gemma":0.0005123389,"threshold_uncertainty_score":0.9182741},"labels":[],"label_agreement":null},{"id":"W4290958807","doi":"10.6004/jnccn.2022.7033","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Frailty Among Older Adults With Blood Cancers","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Dana-Farber/Harvard Cancer Center; National Institute on Aging; National Cancer Institute; National Institutes of Health; Brigham and Women's Hospital; U.S. Department of Veterans Affairs","keywords":"Medicine; Polypharmacy; Odds ratio; Anticholinergic; Odds; Comorbidity; Beers Criteria; Geriatric oncology; Internal medicine; Geriatrics; Cross-sectional study; Cancer; Logistic regression; Psychiatry","score_opus":0.04049587474737516,"score_gpt":0.33943084726148176,"score_spread":0.2989349725141066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290958807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98727924,0.0025135155,0.000065817476,0.008959952,0.00044611545,0.0004230472,0.000035786994,0.000005265719,0.00027128225],"genre_scores_gemma":[0.9959837,0.00038720842,0.00042802183,0.0025514984,0.0003936641,0.000020709207,0.000004723013,0.000012444232,0.00021801866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979908,0.00015818693,0.00033527124,0.00010952987,0.0012630088,0.00014318894],"domain_scores_gemma":[0.99707174,0.00032848166,0.001208287,0.00006372235,0.0012270645,0.000100726764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000250286,0.0001015469,0.00025193047,0.000063458065,0.00022001824,0.000010198864,0.00013012171,0.00002681179,0.00020232351],"category_scores_gemma":[0.000061494895,0.000061704166,0.000074581745,0.0003733764,0.0000846992,0.00013583586,0.000067587396,0.00056201447,1.2364904e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047664912,0.00028353784,0.9023434,0.00014720044,0.0036453053,0.000016088366,0.00096721156,0.07588531,0.00040783678,0.00012135607,0.010109261,0.0013070212],"study_design_scores_gemma":[0.011630061,0.0007535064,0.96212727,0.0006618321,0.002418344,0.00023939622,0.0005081633,0.0036058829,0.00026039153,0.00014479377,0.017475108,0.00017522763],"about_ca_topic_score_codex":0.0000719574,"about_ca_topic_score_gemma":0.000029562741,"teacher_disagreement_score":0.07227942,"about_ca_system_score_codex":0.00032597902,"about_ca_system_score_gemma":0.0005956599,"threshold_uncertainty_score":0.2516223},"labels":[],"label_agreement":null},{"id":"W4290959419","doi":"10.6004/jnccn.2022.7029","title":"Regional Variations in Clinical Trial Outcomes in Oncology","year":2022,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Subgroup analysis; Random effects model; Internal medicine; High income countries; Clinical endpoint; Cohort; Clinical trial; Demography; Oncology; Confidence interval; Meta-analysis; Developing country","score_opus":0.5530678697641415,"score_gpt":0.5571093237104976,"score_spread":0.004041453946356133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290959419","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018521315,0.9905278,0.0000062512136,0.0026953034,0.004925128,0.00094195525,0.000025296402,0.000004150756,0.0006888819],"genre_scores_gemma":[0.00015865643,0.989759,0.00036841116,0.0048052305,0.004586225,0.000108207736,0.00001558842,0.000024348334,0.0001743261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441135,0.0012107292,0.0025258267,0.00026083633,0.0013054843,0.00028577106],"domain_scores_gemma":[0.9933558,0.0034155096,0.0023293449,0.00016776563,0.0006231843,0.00010835772],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016369731,0.0002650666,0.0024355005,0.00034055562,0.000103907914,0.000015701684,0.00054817734,0.00031062734,0.00035232995],"category_scores_gemma":[0.0010968047,0.00017539522,0.0013769945,0.0010993956,0.00009681245,0.000086912834,0.00019111948,0.0026103263,0.0000033798062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019112805,0.0011657932,0.010967701,0.0011642413,0.00233658,0.00042458109,0.00016581167,0.015803795,8.202369e-8,0.0023918822,0.19167624,0.7547905],"study_design_scores_gemma":[0.011931242,0.0004764559,0.006945045,0.004461769,0.00047449148,0.00030794967,0.000026034115,0.00003998871,2.8400866e-9,0.00086590846,0.97433096,0.00014012161],"about_ca_topic_score_codex":0.000051877487,"about_ca_topic_score_gemma":0.00013026952,"teacher_disagreement_score":0.78265476,"about_ca_system_score_codex":0.0030971258,"about_ca_system_score_gemma":0.006388089,"threshold_uncertainty_score":0.9996907},"labels":[],"label_agreement":null},{"id":"W4294982915","doi":"10.6004/jnccn.2022.7028","title":"Prevalence of Breast Cancer Survivors Among Canadian Women","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Cancer; Demography; Gerontology; Internal medicine","score_opus":0.021276924556063274,"score_gpt":0.27881312476170383,"score_spread":0.25753620020564055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294982915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824736,0.00761358,0.0000034548423,0.0039956425,0.004284814,0.0002522698,0.0007473648,0.0000057993534,0.0006234359],"genre_scores_gemma":[0.9933696,0.00048471283,0.000012512867,0.0034902992,0.0014443022,0.000057687692,0.00000232596,0.00002115504,0.0011174008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976674,0.0001889603,0.00045412758,0.0001450431,0.0012236083,0.00032086918],"domain_scores_gemma":[0.9969035,0.00013927103,0.00061179727,0.00014108003,0.0019558792,0.00024852145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034701664,0.00014055788,0.00034546512,0.00015826564,0.00027008323,0.000010674607,0.0003963329,0.00004428721,0.0023650303],"category_scores_gemma":[0.000030284433,0.00010937604,0.00023777953,0.0007019405,0.00012592426,0.00008607414,0.00011357441,0.0005740215,5.699989e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008603347,0.00006470942,0.7845871,0.00026130566,0.00059113867,0.000018385912,0.001981654,0.15710917,0.0002688389,0.00019609946,0.05282334,0.0012379481],"study_design_scores_gemma":[0.0007304501,0.000119031676,0.94216394,0.00031829954,0.00012856827,0.00020022858,0.0008171697,0.00028630343,0.000032003725,0.0004157292,0.05465062,0.0001376303],"about_ca_topic_score_codex":0.038140163,"about_ca_topic_score_gemma":0.048280217,"teacher_disagreement_score":0.15757689,"about_ca_system_score_codex":0.002283098,"about_ca_system_score_gemma":0.0023430623,"threshold_uncertainty_score":0.99854696},"labels":[],"label_agreement":null},{"id":"W4294982963","doi":"10.6004/jnccn.2022.7038","title":"Healthcare Cost Trajectories in the Last 2 Years of Life Among Patients With a Solid Metastatic Cancer: A Prospective Cohort Study","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"","keywords":"Medicine; Health care; Cohort; Cancer; Trajectory; Life expectancy; Cohort study; Cost effectiveness; Demography; Gerontology; Environmental health; Internal medicine; Population; Risk analysis (engineering)","score_opus":0.0341766775942928,"score_gpt":0.2792527583144628,"score_spread":0.24507608072016998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294982963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222195,0.004330069,0.000014832772,0.0007034753,0.0009519906,0.0011537264,0.00038864426,0.0000023706466,0.00023296238],"genre_scores_gemma":[0.9978864,0.00017549624,0.000029236211,0.0012761191,0.0003451662,0.00024415425,0.0000028395777,0.000017783428,0.00002280529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835616,0.00013078234,0.00081143517,0.00018458432,0.00029627734,0.00022073799],"domain_scores_gemma":[0.9973654,0.00020612928,0.0016846298,0.0001290531,0.00056194566,0.000052798627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025992,0.00013398442,0.0005822871,0.0001346647,0.0002092699,0.000031055264,0.00046896256,0.000022568349,0.00008794354],"category_scores_gemma":[0.000110442335,0.000102524624,0.00012910037,0.00061867136,0.00011128897,0.00020131336,0.00008107399,0.0004790174,7.558184e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000256212,0.00018078077,0.8883735,0.00001035967,0.00028745978,0.0000013670286,0.0016531022,0.105341285,7.3972465e-8,0.001574295,0.0021851957,0.00013639264],"study_design_scores_gemma":[0.0017020552,0.0003615404,0.9898625,0.00004112542,0.00003036361,0.0000019518063,0.00083144003,0.00012477701,3.2562235e-7,0.0032964528,0.0036328856,0.000114561895],"about_ca_topic_score_codex":0.0009718865,"about_ca_topic_score_gemma":0.0016875329,"teacher_disagreement_score":0.1052165,"about_ca_system_score_codex":0.00082314416,"about_ca_system_score_gemma":0.00043532538,"threshold_uncertainty_score":0.41808328},"labels":[],"label_agreement":null},{"id":"W4294983054","doi":"10.6004/jnccn.2022.7041","title":"FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute","keywords":"Medicine; Neoadjuvant therapy; Internal medicine; Adenocarcinoma; Oncology; Nat; Multivariate analysis; Pancreatic ductal adenocarcinoma; Univariate analysis; Odds ratio; Complete response; Gastroenterology; Pancreatic cancer; Cancer; Chemotherapy","score_opus":0.04880449726578326,"score_gpt":0.35505449688932406,"score_spread":0.3062499996235408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294983054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9599986,0.029165784,0.000023360217,0.009321786,0.00059624796,0.00055526255,0.0000288954,0.0000074452814,0.00030261124],"genre_scores_gemma":[0.99198127,0.003051195,0.0006659548,0.0027445527,0.00069939625,0.0000735277,0.000004931539,0.000024493993,0.0007546651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634564,0.0011336843,0.00062380626,0.00020909743,0.0013332565,0.00035448791],"domain_scores_gemma":[0.9964723,0.0017303205,0.00041303094,0.00015897994,0.0010760134,0.00014934344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014703028,0.0001704485,0.00066826836,0.00020154465,0.00031497315,0.000015697087,0.00028408546,0.000049065657,0.00025491594],"category_scores_gemma":[0.00056589715,0.00011994889,0.00012681812,0.0006641606,0.00017421787,0.00008504497,0.00020107573,0.0009901535,7.96474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071937576,0.0004124312,0.83218586,0.00006890207,0.0007821724,0.00051235623,0.00084406027,0.06411171,0.0045978636,0.00028296158,0.021436429,0.002827669],"study_design_scores_gemma":[0.008860431,0.0017998415,0.961435,0.00030132695,0.00008560266,0.0010019323,0.00046663632,0.0060366406,0.000027467948,0.001352243,0.01850785,0.00012500945],"about_ca_topic_score_codex":0.000047918445,"about_ca_topic_score_gemma":0.000028733451,"teacher_disagreement_score":0.12924914,"about_ca_system_score_codex":0.00066919846,"about_ca_system_score_gemma":0.0017176354,"threshold_uncertainty_score":0.48913738},"labels":[],"label_agreement":null},{"id":"W4308772617","doi":"10.6004/jnccn.2022.7052","title":"Association Between Frailty and Time Alive and At Home After Cancer Surgery Among Older Adults: A Population-Based Analysis","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; Health Sciences Centre; University of Toronto; University of Manitoba; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ipsen; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research","keywords":"Medicine; Interquartile range; Hazard ratio; Proportional hazards model; Cancer; Perioperative; Surgery; Population; Retrospective cohort study; Breast cancer; Cohort; Cohort study; Internal medicine; Confidence interval","score_opus":0.019034249641618747,"score_gpt":0.2800684600469516,"score_spread":0.2610342104053328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308772617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98709714,0.0054812147,0.0000134065185,0.006369701,0.00043582584,0.00027301742,0.00030538178,0.000009969598,0.000014319878],"genre_scores_gemma":[0.994903,0.00015195768,0.00008838771,0.0028617715,0.0011184631,0.00008465747,0.000060921837,0.000021577487,0.00070921105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974169,0.0002820505,0.00055501633,0.00022558632,0.0012759302,0.00024448786],"domain_scores_gemma":[0.99616313,0.0013911515,0.0010071651,0.000107222055,0.0011905752,0.00014073364],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040565475,0.00017483845,0.0005943092,0.000260964,0.00032165184,0.000028411314,0.00010154208,0.00008259569,0.001013414],"category_scores_gemma":[0.00017201777,0.00014026526,0.00031335422,0.0008362437,0.000054265274,0.00012108675,0.00013307217,0.00043747126,8.8875686e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003793557,0.000023294046,0.93480796,0.00003479757,0.001970063,0.000005254714,0.00017563507,0.03440209,0.000008303953,9.1842367e-7,0.027784146,0.00040818652],"study_design_scores_gemma":[0.0012449921,0.000038130747,0.98980004,0.00030801966,0.001688012,0.000012057757,0.000027472961,0.0045631747,0.000007984173,0.000102743,0.0020612068,0.00014617732],"about_ca_topic_score_codex":0.00027864423,"about_ca_topic_score_gemma":0.00018987045,"teacher_disagreement_score":0.054992072,"about_ca_system_score_codex":0.0018852823,"about_ca_system_score_gemma":0.00024254691,"threshold_uncertainty_score":0.9998998},"labels":[],"label_agreement":null},{"id":"W4308937667","doi":"10.6004/jnccn.2022.7075","title":"Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake","year":2022,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Women's College Hospital; Cancer Care Ontario; Queen's University; Institute of Health Services and Policy Research; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Clearance; Pandemic; Incidence (geometry); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Cancer; Population; Seismology; Virology; Internal medicine; Environmental health; Geology; Optics","score_opus":0.06427195668621836,"score_gpt":0.37535593275086876,"score_spread":0.3110839760646504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308937667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9197933,0.012112588,0.00006142038,0.0656612,0.0017936735,0.000496576,0.000051843686,0.000007983699,0.000021407079],"genre_scores_gemma":[0.970926,0.00066378067,0.000015628117,0.02594436,0.0021779714,0.00008075956,9.889592e-7,0.000017034095,0.00017351391],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99738944,0.00041335044,0.0005343925,0.00012956843,0.0012954484,0.00023782885],"domain_scores_gemma":[0.99672216,0.0010696794,0.0007953209,0.0001811978,0.0010788856,0.00015278121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059061614,0.00013660053,0.00028138852,0.00009233746,0.00082325836,0.000018635292,0.00030249398,0.000041668354,0.00036028223],"category_scores_gemma":[0.0006042456,0.00007109373,0.00028655873,0.00052546995,0.00013496843,0.00006818072,0.00020123424,0.00081269647,7.131773e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006754586,0.00010341532,0.101376735,0.00030355158,0.00064473884,0.000034164867,0.0032916055,0.8633881,0.0038521942,0.000079790145,0.016730852,0.0034402204],"study_design_scores_gemma":[0.0015331826,0.0001673918,0.89736545,0.00016928434,0.00014669767,0.0003200557,0.00057581626,0.0017769127,0.00034080824,0.00088531745,0.096627355,0.00009170465],"about_ca_topic_score_codex":0.00066774135,"about_ca_topic_score_gemma":0.0011506692,"teacher_disagreement_score":0.86161125,"about_ca_system_score_codex":0.0015264101,"about_ca_system_score_gemma":0.0018008456,"threshold_uncertainty_score":0.6331921},"labels":[],"label_agreement":null},{"id":"W4320892900","doi":"10.6004/jnccn.2022.7087","title":"Patient-Reported Symptom Complexity and Acute Care Utilization Among Patients With Cancer: A Population-Based Study Using a Novel Symptom Complexity Algorithm and Observational Data","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Emergency department; Observational study; Logistic regression; Odds; Retrospective cohort study; Ambulatory; Odds ratio; Population; Health care; Cohort; Diagnosis code; Emergency medicine; Cancer; Algorithm; Internal medicine; Psychiatry","score_opus":0.19698948836998023,"score_gpt":0.37252836190708705,"score_spread":0.17553887353710682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320892900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949885,0.00095095934,0.0005446312,0.00044346447,0.0008875413,0.00091815746,0.0012323286,0.00002748995,0.0000069159164],"genre_scores_gemma":[0.99607116,0.000052467603,0.0015495189,0.00088003004,0.0005263044,0.00002331059,0.00085482665,0.0000340405,0.000008368367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971824,0.000131295,0.0006320516,0.00037293762,0.0014387235,0.00024258588],"domain_scores_gemma":[0.99480027,0.0002169332,0.0009367698,0.00026138846,0.0036344645,0.00015015718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016301981,0.00025277512,0.0004888062,0.0001584118,0.00045315525,0.00006828164,0.0002026946,0.00007397512,0.00002728484],"category_scores_gemma":[0.000059656824,0.000186826,0.000076214295,0.00094274106,0.00017196061,0.0003032304,0.00022750275,0.00031661408,1.1640255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004435861,0.000121071884,0.9737959,0.00006081163,0.0007023572,0.0000050835924,0.0006648606,0.02203523,0.000009730993,0.000026127016,0.0006025506,0.0015327071],"study_design_scores_gemma":[0.0033629176,0.00020667697,0.9350668,0.00054335786,0.0006293895,0.000015641739,0.00054822286,0.058809213,0.0000022643515,0.00013205345,0.00049922086,0.00018424744],"about_ca_topic_score_codex":0.0015801378,"about_ca_topic_score_gemma":0.0015629663,"teacher_disagreement_score":0.03872909,"about_ca_system_score_codex":0.00051827665,"about_ca_system_score_gemma":0.00060581084,"threshold_uncertainty_score":0.76185435},"labels":[],"label_agreement":null},{"id":"W4320893540","doi":"10.6004/jnccn.2022.7083","title":"Androgen Deprivation Therapy and Risk of Cardiovascular Disease in Patients With Prostate Cancer Based on Existence of Cardiovascular Risk","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Internal medicine; Hazard ratio; Interquartile range; Proportional hazards model; Vitamin K antagonist; Oncology; Cancer; Confidence interval","score_opus":0.035489812507363626,"score_gpt":0.28799455768787524,"score_spread":0.25250474518051164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320893540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96128565,0.037499133,0.000016941294,0.00020402714,0.00013927874,0.00068212237,0.00015617344,0.0000041640296,0.000012482363],"genre_scores_gemma":[0.9626285,0.036963865,0.000093247654,0.00006453259,0.00016712933,0.000040300973,0.000012146038,0.000017663064,0.000012628367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756765,0.00026059934,0.00033966708,0.00017992409,0.0014761438,0.00017599453],"domain_scores_gemma":[0.9973637,0.00018573318,0.00041517275,0.00020881905,0.0017361027,0.00009045778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044967627,0.00013812215,0.00047234204,0.00017796514,0.00008340046,0.0000072606344,0.00011350544,0.000038459446,0.000006646365],"category_scores_gemma":[0.00009479074,0.00007995582,0.0003692153,0.00076059165,0.0001390521,0.000068990805,0.00003301577,0.0002603133,2.0775416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036941187,0.000055316406,0.51498485,0.00005291931,0.0022677088,0.0000047808776,0.00006712407,0.4740637,0.000004298204,0.000001978828,0.00012349105,0.0046797064],"study_design_scores_gemma":[0.0075352625,0.00036585072,0.98334384,0.0008156363,0.00066742586,6.977613e-7,0.000018056991,0.004716093,0.0002106257,0.00018548161,0.002060107,0.000080942475],"about_ca_topic_score_codex":0.00021214806,"about_ca_topic_score_gemma":0.0000055673404,"teacher_disagreement_score":0.4693476,"about_ca_system_score_codex":0.000225501,"about_ca_system_score_gemma":0.0004766166,"threshold_uncertainty_score":0.32605037},"labels":[],"label_agreement":null},{"id":"W4320914516","doi":"10.6004/jnccn.2022.7089","title":"Small Cell Lung Cancer in Light/Never Smokers – A Role for Molecular Testing?","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; Chemotherapy; Oncology; Disease; Cancer; Internal medicine; Incidence (geometry); Cancer research","score_opus":0.06197872644611645,"score_gpt":0.37007329462359173,"score_spread":0.30809456817747527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320914516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8498585,0.085037634,0.0001321395,0.054273877,0.0038642713,0.0028539721,0.00013782221,0.000070318594,0.0037714436],"genre_scores_gemma":[0.9825959,0.0016986419,0.0012557869,0.008066009,0.00397822,0.00037726364,0.0000045303327,0.00008059985,0.0019430494],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980019,0.00008439272,0.00043561365,0.00019077308,0.00086542097,0.00042193878],"domain_scores_gemma":[0.99615854,0.00061376306,0.00035359082,0.00011102305,0.0026530637,0.000110031564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450488,0.00016861632,0.00039329962,0.0002014501,0.00014388368,0.00002219384,0.0002776043,0.00006727328,0.00002965415],"category_scores_gemma":[0.00042358492,0.00011791349,0.00023800253,0.0012105075,0.00006246344,0.000083463994,0.00011668011,0.0004638744,0.0000019703584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011927444,0.000092477836,0.12840825,0.0005426728,0.0009817102,0.00007075741,0.00055655406,0.47758934,0.027730713,0.00020099002,0.36117187,0.0014618994],"study_design_scores_gemma":[0.01491439,0.00074929255,0.59869313,0.0063136555,0.00093306124,0.00010916164,0.0006731727,0.059233386,0.011956618,0.00879323,0.2968146,0.0008163208],"about_ca_topic_score_codex":0.00007441809,"about_ca_topic_score_gemma":0.000051057188,"teacher_disagreement_score":0.47028488,"about_ca_system_score_codex":0.0010030048,"about_ca_system_score_gemma":0.0011092632,"threshold_uncertainty_score":0.48083726},"labels":[],"label_agreement":null},{"id":"W4320932490","doi":"10.6004/jnccn.2022.7096","title":"Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice","year":2023,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Profiling (computer programming); Endometrial cancer; Categorization; Clinical trial; Adjuvant; Disease; Oncology; Bioinformatics; Computational biology; Internal medicine; Cancer; Computer science; Artificial intelligence","score_opus":0.25901739956103037,"score_gpt":0.5116208674045226,"score_spread":0.25260346784349225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320932490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024532722,0.9877934,0.000039504066,0.0012977578,0.008606206,0.0013499701,0.0004290268,0.000012713558,0.00022613234],"genre_scores_gemma":[0.00012508011,0.9789012,0.0024174652,0.0025130431,0.015722465,0.00010877342,0.000028221297,0.00008018571,0.00010358537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99392736,0.0007396596,0.002483295,0.00038391212,0.0021386927,0.0003270632],"domain_scores_gemma":[0.9852693,0.006718338,0.0034037663,0.00026389523,0.004040424,0.00030424923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079021015,0.00041423787,0.0031020287,0.00039447926,0.00008377154,0.000026827967,0.00058667414,0.00033541897,0.00013181308],"category_scores_gemma":[0.0053391247,0.0002501268,0.0020659189,0.0029300984,0.000091683054,0.00008570569,0.00027154808,0.0012633385,0.000019617311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006992869,0.00074332993,0.0009085516,0.0064270375,0.029796062,0.0002943786,0.00006570495,0.011340664,0.000032527267,0.00034880303,0.055764217,0.8872858],"study_design_scores_gemma":[0.0033322661,0.00046445234,0.00042722584,0.022552824,0.007544675,0.00005258921,0.000015605423,0.000009949128,0.000029314797,0.0004096367,0.9649296,0.00023187595],"about_ca_topic_score_codex":0.00012862879,"about_ca_topic_score_gemma":0.000006112012,"teacher_disagreement_score":0.9091654,"about_ca_system_score_codex":0.0009793782,"about_ca_system_score_gemma":0.002854139,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W4323823168","doi":"10.6004/jnccn.2022.7095","title":"Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; Institute of Aging; University of Victoria; Princess Margaret Cancer Centre; Women's College Hospital; McMaster University; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coaching; Cancer; Intensive care medicine; Patient education; Nursing; Internal medicine; Psychotherapist","score_opus":0.04298865649454445,"score_gpt":0.3445372463943131,"score_spread":0.3015485898997686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943292,0.00286621,0.000050859748,0.0010894743,0.00082131766,0.0006769783,0.000020736787,0.000008408024,0.00013679834],"genre_scores_gemma":[0.9973354,0.0015434937,0.00009508149,0.00054885773,0.00033457106,0.000093380746,0.000005431976,0.000009531573,0.000034275236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918455,0.0000999984,0.00020458583,0.000117518044,0.00030063355,0.000092730625],"domain_scores_gemma":[0.9985745,0.00045512876,0.00025832633,0.000058058235,0.0006156012,0.000038392332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001807594,0.00009531541,0.00021382298,0.00009636064,0.00011357991,0.000011929365,0.000037341048,0.000027214734,0.000002401797],"category_scores_gemma":[0.000020773368,0.00006592416,0.00008316961,0.00019765222,0.00003071983,0.000057368467,0.000025807418,0.000076443284,5.1723756e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020974796,0.0014447898,0.3538468,0.008811518,0.005648964,0.0000053644976,0.01416901,0.29028463,0.005221744,0.018348202,0.014909053,0.26633516],"study_design_scores_gemma":[0.0033771861,0.000915255,0.9635792,0.0039683618,0.00045166523,0.000014287261,0.001999853,0.002189149,0.002713983,0.008934995,0.011686476,0.00016963243],"about_ca_topic_score_codex":0.00007480747,"about_ca_topic_score_gemma":0.00002870024,"teacher_disagreement_score":0.6097324,"about_ca_system_score_codex":0.0006873768,"about_ca_system_score_gemma":0.00016561252,"threshold_uncertainty_score":0.26883093},"labels":[],"label_agreement":null},{"id":"W4323823189","doi":"10.6004/jnccn.2022.7097","title":"Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"DOD Prostate Cancer Research Program; South African Medical Research Council; Medical Research Council; University of Sydney; Cancer Association of South Africa; National Health and Medical Research Council; Johns Hopkins University","keywords":"Prostate cancer; CHEK2; Germline; Medicine; Genetic testing; Cancer; Family history; Oncology; PALB2; Germline mutation; Disease; Internal medicine; Genetics; Gene; Mutation; Biology","score_opus":0.12616336662457778,"score_gpt":0.38977934067146486,"score_spread":0.2636159740468871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323823189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851156,0.006899963,0.0000035939854,0.0067489003,0.0004279692,0.00058059965,0.00006923269,0.000021403303,0.00013273011],"genre_scores_gemma":[0.9947725,0.0010216493,0.0013472701,0.001255593,0.0010547352,0.00016856061,0.000006258618,0.000036893285,0.00033652727],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9979614,0.00009972378,0.0005103634,0.00020297129,0.0008902734,0.00033527304],"domain_scores_gemma":[0.9966863,0.0005226378,0.00067481847,0.000103680664,0.001915519,0.00009703975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031252505,0.00018974133,0.00040928737,0.00012991959,0.00013773,0.000023285147,0.000142178,0.000038750353,0.000039612158],"category_scores_gemma":[0.00017527546,0.00011327769,0.00011237803,0.0012532357,0.00007916747,0.000092318645,0.00006194794,0.00034870248,0.0000040248196],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010559928,0.00007414637,0.24980114,0.00008211668,0.00030860878,0.000064540516,0.001106086,0.7211644,0.0018966158,0.000015809192,0.0013989579,0.023031592],"study_design_scores_gemma":[0.006885577,0.0010424723,0.96682054,0.0057447585,0.0003061742,0.00014661675,0.0013527907,0.0113176,0.00056955504,0.0012482528,0.004268186,0.00029747566],"about_ca_topic_score_codex":0.00007677169,"about_ca_topic_score_gemma":0.00007306971,"teacher_disagreement_score":0.7170194,"about_ca_system_score_codex":0.000687892,"about_ca_system_score_gemma":0.00083014026,"threshold_uncertainty_score":0.461933},"labels":[],"label_agreement":null},{"id":"W4362469831","doi":"10.6004/jnccn.2022.7199","title":"CLO23-056: Risk of Second Malignancy Among Non-Metastatic Seminoma Patients Treated With Radiation Therapy and Chemotherapy in Manitoba","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Malignancy; Radiation therapy; Chemotherapy; Seminoma; Oncology; Internal medicine; Cancer","score_opus":0.025859424793628853,"score_gpt":0.2705497157981843,"score_spread":0.24469029100455547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362469831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695635,0.0019454394,0.000003819957,0.00024836382,0.0002188105,0.00043689707,0.00004832982,0.0000050978315,0.00013686567],"genre_scores_gemma":[0.9945899,0.0037200705,0.00012412264,0.0011203856,0.0003029067,0.000013252063,0.000016796692,0.000021188771,0.00009137449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998658,0.00010368485,0.0004582995,0.000135548,0.00047760477,0.00016687156],"domain_scores_gemma":[0.9981557,0.00024579247,0.00072957785,0.00008767662,0.00071716576,0.000064082466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017677103,0.0001482133,0.00039280383,0.00017886204,0.00006824034,0.000011120688,0.00010253651,0.00004775919,0.00008723517],"category_scores_gemma":[0.000025565258,0.00009552691,0.000104147104,0.000579727,0.00009097823,0.00013665657,0.000017268922,0.00026543965,6.1583887e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014882443,0.00005893959,0.9716079,0.000053567317,0.00041800112,0.000007756258,0.00034147952,0.0071956157,0.0003287125,0.000003912305,0.007972912,0.010522945],"study_design_scores_gemma":[0.0073045786,0.0004057397,0.98766136,0.0003451644,0.000060899063,0.000013560293,0.00008831521,0.0015194167,0.00044732238,0.000121466255,0.0019395589,0.00009262875],"about_ca_topic_score_codex":0.00007290451,"about_ca_topic_score_gemma":0.00011870605,"teacher_disagreement_score":0.016053434,"about_ca_system_score_codex":0.0002414335,"about_ca_system_score_gemma":0.00023603458,"threshold_uncertainty_score":0.38954747},"labels":[],"label_agreement":null},{"id":"W4362471859","doi":"10.6004/jnccn.2022.7118","title":"QIM23-129: Impact of the COVID Pandemic on Oncology Education, Mentorship, and Networking—A National Survey","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Mentorship; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus Infections; Oncology; Internal medicine; Family medicine; Virology; Medical education","score_opus":0.11052315370529352,"score_gpt":0.48096082175558696,"score_spread":0.37043766805029343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362471859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9435412,0.017222596,0.00008651743,0.019056786,0.016429555,0.00089414115,0.00009854916,0.000028340142,0.0026422911],"genre_scores_gemma":[0.97962934,0.0034582578,0.00009755898,0.010644874,0.005507571,0.000012516322,0.000009265244,0.000017453262,0.00062314945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807566,0.0004885362,0.000443284,0.00013029872,0.00067941967,0.00018281002],"domain_scores_gemma":[0.9944638,0.0023979046,0.0008069877,0.00009863961,0.002143903,0.00008877439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091379875,0.00013498332,0.0003546997,0.000105233754,0.000229577,0.0000070951805,0.0002403868,0.00012702415,0.000055060147],"category_scores_gemma":[0.0005501345,0.0000730706,0.00022078345,0.00069770816,0.0002930128,0.000056319393,0.000055985987,0.00051264244,0.0000015441127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013851228,0.00013978331,0.43600854,0.000018695782,0.000655012,0.0000013246446,0.00018978072,0.12696078,0.00014866561,0.0005220187,0.43054616,0.003424084],"study_design_scores_gemma":[0.0013243088,0.00040182928,0.8569453,0.00020846326,0.00005998613,0.00019187905,0.000031324078,0.00055195333,0.000009355209,0.009037687,0.1311593,0.00007863643],"about_ca_topic_score_codex":0.000019327455,"about_ca_topic_score_gemma":0.000044875538,"teacher_disagreement_score":0.42093673,"about_ca_system_score_codex":0.0012764954,"about_ca_system_score_gemma":0.0033445426,"threshold_uncertainty_score":0.5933075},"labels":[],"label_agreement":null},{"id":"W4362473019","doi":"10.6004/jnccn.2022.7109","title":"CLO23-025: Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-Term Data","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Nova Scotia Cancer Centre; Centre hospitalier universitaire de Québec; McGill University Health Centre; Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Prostate cancer; Term (time); Oncology; Cancer; Internal medicine; Clinical trial; Prostate","score_opus":0.32030928530987374,"score_gpt":0.5348290192169047,"score_spread":0.214519733907031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362473019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832048,0.012260729,0.000028577322,0.0019911358,0.0013038628,0.00083744683,0.00036160942,0.0000063101415,0.0000055546716],"genre_scores_gemma":[0.9870034,0.012029581,0.0000610018,0.00012011313,0.00060491706,0.000029390721,0.00009340249,0.000016734217,0.000041499992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966925,0.0005385071,0.0014636012,0.00024261232,0.000785628,0.00027716337],"domain_scores_gemma":[0.995973,0.0012595142,0.0016581671,0.00018730815,0.00082477037,0.00009726319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015974964,0.00017895178,0.0010650009,0.00035093536,0.0000867851,0.000027011578,0.00029911724,0.000054924647,0.000029591172],"category_scores_gemma":[0.00047429014,0.000114005714,0.00012752772,0.00069386483,0.00019715045,0.00018462293,0.0002165793,0.0005604625,7.0639993e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002719625,0.0002265837,0.9485725,0.00012445042,0.00046653033,0.00001693319,0.00054579723,0.018254263,0.0012486371,0.000028114002,0.002635546,0.025161019],"study_design_scores_gemma":[0.0213582,0.00017568424,0.93720526,0.0015043146,0.0002768035,0.000008691149,0.00021114243,0.038104776,0.00035420904,0.00027923106,0.0004069681,0.00011471958],"about_ca_topic_score_codex":0.00032202865,"about_ca_topic_score_gemma":0.000444766,"teacher_disagreement_score":0.0250463,"about_ca_system_score_codex":0.000616811,"about_ca_system_score_gemma":0.00072527863,"threshold_uncertainty_score":0.46490183},"labels":[],"label_agreement":null},{"id":"W4375853356","doi":"10.6004/jnccn.2022.7256","title":"Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University Health Network; University of Toronto; Toronto General Hospital; Toronto Public Health; Institute of Health Services and Policy Research","funders":"Government of Ontario","keywords":"Medicine; Prostate cancer; Population; Cohort; Cancer registry; Retrospective cohort study; Cancer; Cohort study; Emergency medicine; Internal medicine; Environmental health","score_opus":0.04607041986331676,"score_gpt":0.3821461362965448,"score_spread":0.33607571643322803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375853356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942562,0.0021536578,0.0000024031413,0.0008732209,0.0005064179,0.0018483046,0.0003343664,0.000013989321,0.000011417531],"genre_scores_gemma":[0.998186,0.0004486134,0.00005183601,0.00035869476,0.00040018972,0.0004969148,0.000021433443,0.000022736964,0.000013584755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680454,0.0004795154,0.0010620682,0.00026317185,0.001118435,0.00027224683],"domain_scores_gemma":[0.9959909,0.00082987046,0.0014252473,0.00017891028,0.0014514511,0.00012364799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061320764,0.00019897512,0.00071787706,0.00030990515,0.00015539982,0.000013680841,0.00017953296,0.00005219266,0.000017582004],"category_scores_gemma":[0.00039476575,0.00014623688,0.00020158966,0.001706266,0.000034052293,0.00007284494,0.00008278162,0.00035173295,8.575329e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014825424,0.00015312973,0.729344,0.00019430018,0.00024125764,0.0000058332466,0.0010908273,0.2652236,0.00013326821,0.000004928151,0.000117933276,0.0020083466],"study_design_scores_gemma":[0.0038900268,0.00024965036,0.99264914,0.0009292895,0.000059089674,9.728028e-7,0.0011554955,0.00009674455,0.0006349999,0.00006140515,0.00013885404,0.00013435233],"about_ca_topic_score_codex":0.0013700376,"about_ca_topic_score_gemma":0.0017906296,"teacher_disagreement_score":0.26512685,"about_ca_system_score_codex":0.0017567879,"about_ca_system_score_gemma":0.0005875877,"threshold_uncertainty_score":0.5963367},"labels":[],"label_agreement":null},{"id":"W4383874089","doi":"10.6004/jnccn.2023.7023","title":"Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Mace; Health equity; Social determinants of health; Gerontology; Demography; Cancer; Internal medicine; Public health; Myocardial infarction; Percutaneous coronary intervention; Pathology","score_opus":0.07557736132578949,"score_gpt":0.42169939000989776,"score_spread":0.34612202868410824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95699656,0.006110208,3.7641004e-7,0.034860425,0.0017269226,0.00018121954,0.000060970004,0.0000035685196,0.000059766764],"genre_scores_gemma":[0.9898731,0.0061684153,0.000007339667,0.002529967,0.0013228258,0.00001183149,6.273385e-7,0.0000066019443,0.00007929311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978465,0.0005371523,0.0005485583,0.00008433901,0.000643852,0.0003395893],"domain_scores_gemma":[0.99865556,0.00037543577,0.00048415194,0.000026976033,0.00038157793,0.0000762948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096924754,0.000078251636,0.00041181222,0.00011246344,0.00032490323,0.000011270419,0.00018163491,0.00006313853,0.00001358257],"category_scores_gemma":[0.00009727702,0.000062932566,0.000102276565,0.0006174548,0.0001405646,0.00013446517,0.000062181025,0.00022298998,3.0220528e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074934156,0.000012680481,0.9806695,0.000081468,0.000017844142,7.9033714e-7,0.0036064878,0.0017913497,6.4934477e-7,0.0010744402,0.01000927,0.0026605614],"study_design_scores_gemma":[0.00037273866,0.0000076074366,0.98843634,0.000443197,0.000004485926,8.5191243e-7,0.001232354,0.00006827248,5.0465553e-7,0.0033242237,0.006052265,0.00005717014],"about_ca_topic_score_codex":0.0074271923,"about_ca_topic_score_gemma":0.008468477,"teacher_disagreement_score":0.032876555,"about_ca_system_score_codex":0.00050183333,"about_ca_system_score_gemma":0.0014420487,"threshold_uncertainty_score":0.99918246},"labels":[],"label_agreement":null},{"id":"W4387568217","doi":"10.6004/jnccn.2023.7046","title":"Machine Learning–Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for Cancer","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Vector Institute; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Ipsen; Eisai; Incyte; Princess Margaret Cancer Foundation; Pfizer; University of Toronto; Exelixis; Eli Lilly and Company","keywords":"Medicine; Cohort; Acute care; Emergency department; Emergency medicine; Regimen; Retrospective cohort study; Population; Cancer; Intensive care medicine; Health care; Internal medicine","score_opus":0.13972691780023644,"score_gpt":0.40064150056042064,"score_spread":0.2609145827601842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387568217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8895902,0.1021985,0.00046807164,0.0024465013,0.0030085982,0.0020302183,0.00018994714,0.000051464238,0.00001651609],"genre_scores_gemma":[0.98978984,0.006503951,0.00009181517,0.00053527625,0.0022094217,0.00051983545,0.00005411169,0.000044618737,0.00025110875],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99855256,0.00008533512,0.0004256224,0.00016500433,0.0005353931,0.00023605529],"domain_scores_gemma":[0.99584407,0.00049887813,0.0006340833,0.00007896439,0.0028731057,0.0000708892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015127253,0.00016718265,0.0004124868,0.00012790802,0.00036265515,0.000039022707,0.0001249,0.00007319831,0.000011241936],"category_scores_gemma":[0.00007683921,0.00010934462,0.000349787,0.00037491816,0.000021860817,0.00006129884,0.000018743935,0.00018845378,0.0000010406762],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014019383,0.00003896473,0.09291537,0.0003185994,0.0014698419,0.0000047954763,0.00040040963,0.89449906,0.0008783469,0.000058607202,0.00704695,0.0009671129],"study_design_scores_gemma":[0.027558766,0.002005847,0.6108177,0.00872638,0.0023009544,0.00017269245,0.0009241283,0.21579653,0.003259732,0.00020522968,0.1276404,0.0005916833],"about_ca_topic_score_codex":0.000036105714,"about_ca_topic_score_gemma":0.000005692802,"teacher_disagreement_score":0.67870253,"about_ca_system_score_codex":0.0006696317,"about_ca_system_score_gemma":0.000322563,"threshold_uncertainty_score":0.44589442},"labels":[],"label_agreement":null},{"id":"W4388450013","doi":"10.6004/jnccn.2023.7092","title":"Authors’ Reply to the Letter to the Editor by Nguyen et al","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine","score_opus":0.04729631797960049,"score_gpt":0.35786615185020604,"score_spread":0.31056983387060555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388450013","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013604818,0.0013474385,0.00030782892,0.9756421,0.008171033,0.0004279221,0.000043319884,0.000015585852,0.00043998103],"genre_scores_gemma":[0.08339313,0.00024781955,0.00021435035,0.89624226,0.018536573,0.0000386844,0.0000058571636,0.000019407089,0.0013019416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981278,0.00017656905,0.00035395595,0.00013358069,0.000966582,0.00024149092],"domain_scores_gemma":[0.9971293,0.0013460306,0.00019250448,0.00016366281,0.0010255211,0.00014296279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005443697,0.00012051132,0.00023381856,0.00004146543,0.0002366585,0.000043166783,0.0003848141,0.000049445553,0.00008868605],"category_scores_gemma":[0.0015472069,0.000051312978,0.00018021464,0.00065836095,0.00004975744,0.00003479446,0.00016050553,0.00054787926,0.000084204534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014184986,0.000020158457,0.0006832877,0.0000036745068,0.00007862484,0.0000058959085,0.00016422995,0.03176919,0.000077158926,0.00022259093,0.96660477,0.00022859318],"study_design_scores_gemma":[0.000321643,0.00012787733,0.020682307,0.00014642061,0.00003953137,0.00002710164,0.000073370575,0.00033650684,0.000021498532,0.0008115748,0.9773449,0.00006732402],"about_ca_topic_score_codex":0.000013479253,"about_ca_topic_score_gemma":0.00001146357,"teacher_disagreement_score":0.07939983,"about_ca_system_score_codex":0.000094017356,"about_ca_system_score_gemma":0.00016672198,"threshold_uncertainty_score":0.23802933},"labels":[],"label_agreement":null},{"id":"W4388450064","doi":"10.6004/jnccn.2023.7089","title":"Letter to the Editor: Disaggregating Asian Prostate Cancer Cohorts Can Help Us Improve Care for All Patients With Prostate Cancer","year":2023,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Prostate; Oncology; Internal medicine; Family medicine","score_opus":0.021454705010819797,"score_gpt":0.255855868657141,"score_spread":0.2344011636463212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388450064","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016226325,0.020379907,0.000040033578,0.8764303,0.06082277,0.0049705068,0.020705502,0.00004297738,0.00038170294],"genre_scores_gemma":[0.027938208,0.0022631185,0.00023412166,0.7737128,0.18959227,0.0018148526,0.00024961086,0.0003803656,0.0038146356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962521,0.00006879395,0.001474947,0.0007035768,0.0004976574,0.0010028887],"domain_scores_gemma":[0.9927281,0.00032201482,0.0037544747,0.00038407417,0.0026397815,0.00017151303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003485956,0.00065370323,0.0012608675,0.00023047352,0.0005783195,0.00032044415,0.0010806646,0.00042587772,0.000066393855],"category_scores_gemma":[0.00016466157,0.00045418955,0.00053890946,0.0004793227,0.00017412887,0.0003495743,0.00021856849,0.0015787934,0.000015311038],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034125184,0.000013812838,0.023811102,0.00019707977,0.00078510505,0.0000042964953,0.001334002,0.044442207,8.0092855e-7,0.000038700135,0.92766047,0.0013711818],"study_design_scores_gemma":[0.00137868,0.00020737195,0.028951429,0.0009363536,0.00015318365,0.0000021062258,0.00006373124,0.00011521557,0.0000066359703,0.0011573819,0.9663986,0.00062931055],"about_ca_topic_score_codex":0.0010678184,"about_ca_topic_score_gemma":0.0023358113,"teacher_disagreement_score":0.1287695,"about_ca_system_score_codex":0.0025966163,"about_ca_system_score_gemma":0.00084371003,"threshold_uncertainty_score":0.99979097},"labels":[],"label_agreement":null},{"id":"W4390033373","doi":"10.6004/jnccn.2023.7069","title":"Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma","year":2023,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Jiangxi Provincial Department of Science and Technology; National Natural Science Foundation of China","keywords":"Nomogram; Medicine; Hepatocellular carcinoma; Concordance; Hepatectomy; Internal medicine; Cohort; Retrospective cohort study; Oncology; Surgery; Resection","score_opus":0.09559302608642728,"score_gpt":0.3015228849217186,"score_spread":0.2059298588352913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390033373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963102,0.0020440684,0.000026624319,0.0008737496,0.0002327929,0.00047247764,0.000011275462,0.000004827641,0.00002403922],"genre_scores_gemma":[0.9981995,0.00011753316,0.0012625469,0.00009931689,0.0002231322,0.00003024308,0.0000098894825,0.000011468847,0.00004631774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989445,0.00007608269,0.00039421118,0.000111828136,0.00034098193,0.00013238231],"domain_scores_gemma":[0.9985481,0.00030138873,0.00026985677,0.000040742514,0.00078273326,0.000057189347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034919556,0.00010149227,0.00027729763,0.00012441493,0.000095643634,0.000013195633,0.000050191877,0.00005397262,0.0000026077494],"category_scores_gemma":[0.0000890373,0.00007285514,0.00007720126,0.00032968508,0.00004712599,0.000070726346,0.00004426647,0.00013984327,1.7685682e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033771415,0.000025707537,0.99508846,0.000062566825,0.00014398084,0.000010501018,0.0012609805,0.00038429935,0.0013891316,0.000094890805,0.00022451657,0.0009772783],"study_design_scores_gemma":[0.0025631932,0.0002788074,0.97828406,0.00041302384,0.00011806255,0.000038079757,0.0002571982,0.01143477,0.004211819,0.0003290969,0.0019840326,0.00008785933],"about_ca_topic_score_codex":0.000019168117,"about_ca_topic_score_gemma":0.000007977336,"teacher_disagreement_score":0.016804375,"about_ca_system_score_codex":0.0001152221,"about_ca_system_score_gemma":0.00022792968,"threshold_uncertainty_score":0.29709464},"labels":[],"label_agreement":null},{"id":"W4393991649","doi":"10.6004/jnccn.2023.7280","title":"BPI24-011: Impact of Obesity on Sentinel Lymph Node Mapping in Patients With Endometrial Intraepithelial Neoplasia Undergoing Robotic Surgery","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Lymph node; Robotic surgery; General surgery; Sentinel lymph node; Sentinel node; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.036651504712202534,"score_gpt":0.30249376782122034,"score_spread":0.2658422631090178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393991649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948123,0.002247439,0.000070697664,0.00060395745,0.0018409167,0.0002537634,0.000025664487,0.000009316926,0.0001359251],"genre_scores_gemma":[0.99715257,0.00024169603,0.000115363466,0.0004464331,0.0019748546,0.0000052261926,0.000008198494,0.000024379631,0.000031302858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975653,0.000141576,0.00068781537,0.00019042175,0.0011401189,0.00027473617],"domain_scores_gemma":[0.99616474,0.0022463764,0.0004843692,0.00010036603,0.0008898201,0.000114312075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027587303,0.00021641617,0.0006889188,0.00054640946,0.000068493726,0.0000307606,0.00013614664,0.000077326644,0.00009377495],"category_scores_gemma":[0.0003965381,0.00012327505,0.0005334486,0.0017909333,0.00006320118,0.0001229539,0.000046697507,0.00039105013,0.0000030947333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043675774,0.00032039115,0.87599736,0.00015816787,0.0012558647,0.000028468394,0.000056264107,0.11422882,0.0001164076,0.000040887993,0.0015119304,0.00191784],"study_design_scores_gemma":[0.0062536076,0.00023213241,0.98929214,0.002852395,0.0001982284,0.000029186098,0.000008809804,0.00047112207,0.00005506128,0.0004182161,0.00007760675,0.000111500856],"about_ca_topic_score_codex":0.00005883634,"about_ca_topic_score_gemma":0.000003988141,"teacher_disagreement_score":0.1137577,"about_ca_system_score_codex":0.0013593737,"about_ca_system_score_gemma":0.0011712511,"threshold_uncertainty_score":0.5027011},"labels":[],"label_agreement":null},{"id":"W4394859738","doi":"10.6004/jnccn.2023.7097","title":"The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; Interpace Diagnostics; National Cancer Institute; Amazon Web Services; FibroGen; AstraZeneca Canada; Teva Pharmaceutical Industries; AstraZeneca; Bristol-Myers Squibb","keywords":"Medicine; Cohort; Odds ratio; Pancreatic cancer; Internal medicine; Cohort study; Endoscopic ultrasound; Cancer; Oncology; Surgery","score_opus":0.025498185788854745,"score_gpt":0.36077265637153755,"score_spread":0.3352744705826828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394859738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552763,0.0056954105,0.00049874187,0.005180316,0.0018505568,0.0010723363,0.000049906947,0.000019853514,0.0001052611],"genre_scores_gemma":[0.99517345,0.00079757866,0.00017656306,0.0010866746,0.0023204407,0.0001657484,7.806542e-7,0.000024544368,0.00025422435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967065,0.00043015796,0.0007662329,0.0003009284,0.0013642452,0.00043192258],"domain_scores_gemma":[0.9966819,0.0011801507,0.00030829178,0.00017190629,0.0014797115,0.00017800415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013966971,0.00023189049,0.00055567315,0.00020238225,0.00048705484,0.00014101443,0.0003204949,0.00009343956,0.00008864856],"category_scores_gemma":[0.00041152583,0.00014073901,0.00021918635,0.0014812121,0.00011873946,0.00016818452,0.00014038084,0.0009803895,0.000014927025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090197683,0.00008539949,0.9753943,0.0000306709,0.001050216,0.000029109438,0.0011699499,0.0034692858,0.00019038146,0.00002854363,0.0046927556,0.012957385],"study_design_scores_gemma":[0.0017150212,0.0006368906,0.98596495,0.00075550925,0.0006525416,0.00011631589,0.00036250192,0.004527958,0.00013678499,0.0015966671,0.0033986557,0.00013622508],"about_ca_topic_score_codex":0.0018616063,"about_ca_topic_score_gemma":0.0016897571,"teacher_disagreement_score":0.01282116,"about_ca_system_score_codex":0.0019062138,"about_ca_system_score_gemma":0.00083667133,"threshold_uncertainty_score":0.573917},"labels":[],"label_agreement":null},{"id":"W4399215381","doi":"10.6004/jnccn.2024.5019","title":"Updates in Clinical Management of Pancreatic Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nautilus Biosciences (Canada)","funders":"","keywords":"Medicine; Pancreatic cancer; Radiation therapy; Oncology; Chemotherapy; Intensive care medicine; Internal medicine; Cancer","score_opus":0.10393018519792709,"score_gpt":0.4601177103225228,"score_spread":0.3561875251245957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399215381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92351806,0.061766718,0.00006628782,0.009033869,0.0018721246,0.0004009897,0.000015556105,0.000006900134,0.0033194744],"genre_scores_gemma":[0.9793716,0.015631782,0.0010839743,0.0011687726,0.001530222,0.00002205718,0.0000013554377,0.000013016112,0.0011772317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981398,0.00016197407,0.0007511784,0.00011713599,0.00065794535,0.00017197996],"domain_scores_gemma":[0.998206,0.00065555633,0.00024250384,0.000086351436,0.00074035005,0.00006924112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061493175,0.00009134742,0.0005010961,0.00010843959,0.000034555836,0.000009345689,0.00017737116,0.00006957538,0.0002784388],"category_scores_gemma":[0.00006490919,0.000055401862,0.00022721823,0.0004935013,0.00015098743,0.000050859104,0.0000736109,0.00048426032,0.000004467345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001414369,0.00023906116,0.81815076,0.0009212873,0.0035866294,0.00019109975,0.00017226755,0.01128364,0.00017421058,0.0050583077,0.14702752,0.011780854],"study_design_scores_gemma":[0.0015340829,0.00018734594,0.9494886,0.00464144,0.0005940799,0.00008105586,0.00009521282,0.0050884564,0.000030921517,0.0045619267,0.03362518,0.00007174021],"about_ca_topic_score_codex":0.000026051883,"about_ca_topic_score_gemma":0.000012162709,"teacher_disagreement_score":0.1313378,"about_ca_system_score_codex":0.00031240465,"about_ca_system_score_gemma":0.00066463323,"threshold_uncertainty_score":0.30487093},"labels":[],"label_agreement":null},{"id":"W4399369708","doi":"10.6004/jnccn.2024.7011","title":"Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Renal cell carcinoma; Proportional hazards model; Internal medicine; Nephrectomy; Clear cell renal cell carcinoma; Surgery; Oncology; Kidney; Confidence interval","score_opus":0.07271995487144732,"score_gpt":0.30501299002645355,"score_spread":0.2322930351550062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399369708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912546,0.004987465,0.00007934906,0.0008738046,0.00063807314,0.0007427889,0.0000637285,0.0000132433015,0.0013469463],"genre_scores_gemma":[0.9979132,0.000045232933,0.0005902878,0.0007648563,0.0003589414,0.000028756847,0.000042576186,0.000047150763,0.0002090337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974774,0.00064076425,0.00056585204,0.0002013849,0.00084296754,0.0002715972],"domain_scores_gemma":[0.9967977,0.0013511486,0.0004527187,0.00019169746,0.0010638541,0.00014289677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023208329,0.00030676447,0.00056425325,0.00021156506,0.00017800635,0.000048092723,0.00019213087,0.00005937062,0.000028785164],"category_scores_gemma":[0.000023923705,0.00018030018,0.0003108209,0.0005252755,0.00010197023,0.00014739459,0.000051913536,0.00078676187,0.000002734026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06303412,0.009838995,0.4629137,0.003290384,0.0065138624,0.001602393,0.0056411806,0.40203983,0.015791917,0.00020176083,0.024740363,0.0043914993],"study_design_scores_gemma":[0.046374105,0.015495045,0.8879296,0.0037721745,0.0019025397,0.00012555413,0.0012984396,0.011084794,0.020064559,0.00066744577,0.010450754,0.000834999],"about_ca_topic_score_codex":0.00020389374,"about_ca_topic_score_gemma":0.00012356133,"teacher_disagreement_score":0.4250159,"about_ca_system_score_codex":0.0022785587,"about_ca_system_score_gemma":0.0022449815,"threshold_uncertainty_score":0.7352428},"labels":[],"label_agreement":null},{"id":"W4399521570","doi":"10.6004/jnccn.2024.7042","title":"Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing","year":2024,"lang":"en","type":"letter","venue":"Journal of the National Comprehensive Cancer Network","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Ovarian cancer; Medicine; Olaparib; Genetic testing; PARP inhibitor; Oncology; Germline; Cancer; BRCA mutation; Internal medicine; Germline mutation; Breast cancer; PALB2; Gynecology; Mutation; Genetics; Gene; Biology","score_opus":0.06058403225475431,"score_gpt":0.3355404807866882,"score_spread":0.2749564485319339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399521570","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04974999,0.5344553,0.0033006507,0.40314862,0.007154451,0.0014525652,0.00030714294,0.00002473753,0.00040653057],"genre_scores_gemma":[0.060413085,0.070796244,0.18237484,0.5501787,0.1266554,0.00078003685,0.00025647285,0.0005158735,0.008029328],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839765,0.00015367057,0.00051793706,0.0003370591,0.00035699486,0.00023670742],"domain_scores_gemma":[0.9980934,0.00013441373,0.0006783339,0.00014675679,0.0009073327,0.00003976221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009071229,0.00030399195,0.00034994844,0.000057626206,0.00018526854,0.00009117726,0.00020546713,0.0003030951,0.000018263061],"category_scores_gemma":[0.000055205244,0.00022254983,0.00016271869,0.00019592776,0.0001252845,0.00001160363,0.00015539388,0.00053586834,6.5257257e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070057475,0.000017686349,0.00045274274,0.00026597487,0.0014623229,0.000020447373,0.00021676243,0.22138768,0.0026962545,0.000012999393,0.7684757,0.004921352],"study_design_scores_gemma":[0.0014025122,0.0003758991,0.0034109,0.0017268744,0.001032966,0.0006258059,0.000037318343,0.0027834848,0.0004168747,0.008028583,0.9796584,0.00050034095],"about_ca_topic_score_codex":0.000031144828,"about_ca_topic_score_gemma":0.000027712258,"teacher_disagreement_score":0.46365908,"about_ca_system_score_codex":0.00043008596,"about_ca_system_score_gemma":0.00094206596,"threshold_uncertainty_score":0.90753186},"labels":[],"label_agreement":null},{"id":"W4400060993","doi":"10.6004/jnccn.2024.7003","title":"Changes in New Patient Consultations During the COVID-19 Pandemic at a Canadian Comprehensive Cancer Center","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Saskatchewan; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cancer; Center (category theory); Health care; Family medicine; Healthcare system; Medical emergency; Virology; Disease; Internal medicine; Infectious disease (medical specialty); Economic growth","score_opus":0.1308255174835729,"score_gpt":0.4122198450496803,"score_spread":0.2813943275661074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400060993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6858441,0.04302485,0.000012830439,0.26616672,0.0035020895,0.0009636252,0.00030120707,0.000027568025,0.00015695783],"genre_scores_gemma":[0.9069371,0.0041318447,0.00003098664,0.0856354,0.0024994654,0.00003137901,0.0000085814445,0.000027433223,0.0006977767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979034,0.00018567596,0.0005107386,0.00021167252,0.00074471807,0.00044378257],"domain_scores_gemma":[0.9967561,0.0010458055,0.00029454165,0.00013351899,0.001124193,0.0006458406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015678492,0.00020500693,0.00035744533,0.00030218408,0.00040287897,0.000051099774,0.00021305651,0.00010310625,0.0003921414],"category_scores_gemma":[0.00032138228,0.00012568245,0.0001847901,0.00082287844,0.00011690846,0.00008361049,0.00008432857,0.0007630591,0.0000075482385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0012525683,0.00005368524,0.34161016,0.00072879094,0.0008400844,0.00031388388,0.008011298,0.1406961,0.001180952,0.0004063807,0.5004112,0.004494866],"study_design_scores_gemma":[0.0015291572,0.00007880878,0.29587936,0.0011188238,0.00009113656,0.00084723317,0.00025555855,0.0005617604,0.000021459091,0.0004214679,0.69906044,0.00013478224],"about_ca_topic_score_codex":0.030294815,"about_ca_topic_score_gemma":0.40671042,"teacher_disagreement_score":0.3764156,"about_ca_system_score_codex":0.007749867,"about_ca_system_score_gemma":0.010037797,"threshold_uncertainty_score":0.9960592},"labels":[],"label_agreement":null},{"id":"W4401640830","doi":"10.6004/jnccn.2024.7051","title":"Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma","year":2024,"lang":"en","type":"review","venue":"Journal of the National Comprehensive Cancer Network","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oncology; Telomerase; Anaplastic lymphoma kinase; Liquid biopsy; Biomarker; Internal medicine; Neuroblastoma; Disease; Immunotherapy; Bioinformatics; Cancer research; Cancer; Gene; Biology; Lung cancer","score_opus":0.10500773361077949,"score_gpt":0.4606522043830703,"score_spread":0.35564447077229083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401640830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047117355,0.9963652,0.000014948803,0.00037158089,0.0014112523,0.0010615913,0.0002681807,0.0000085480215,0.000027506036],"genre_scores_gemma":[0.0012330565,0.99617,0.000076824355,0.00008589847,0.0022494248,0.000065770146,0.00001942266,0.0000489312,0.000050670737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997926,0.00022256828,0.00060843886,0.00025978644,0.00074023975,0.0002429407],"domain_scores_gemma":[0.9971151,0.0007476466,0.00090766285,0.00013294916,0.000927306,0.00016935961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019708938,0.00033091888,0.0008580542,0.00027545934,0.00015947857,0.00006853446,0.0001740403,0.00008291388,0.000013705516],"category_scores_gemma":[0.00016879622,0.00016747232,0.0009614302,0.000465706,0.00006598275,0.00005949402,0.000060578095,0.000840299,0.0000060200214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075948634,0.00013295574,0.000038618782,0.0058158287,0.0038442821,0.000019590196,0.000017451704,0.0008689652,0.0000057049197,0.00009922742,0.11486917,0.8735287],"study_design_scores_gemma":[0.000938317,0.0009406688,0.0013150944,0.027973078,0.0035881363,0.00041640393,0.000003791207,0.00052486575,0.0000029469377,0.0010398093,0.96308976,0.0001671232],"about_ca_topic_score_codex":0.000002023835,"about_ca_topic_score_gemma":0.0000013250958,"teacher_disagreement_score":0.8733616,"about_ca_system_score_codex":0.00054199365,"about_ca_system_score_gemma":0.0009861424,"threshold_uncertainty_score":0.6829323},"labels":[],"label_agreement":null},{"id":"W4403461604","doi":"10.6004/jnccn.2024.7028","title":"Sympathetic Blockade for Pain Associated With Nonaxial Bone Lesions in Patients With Cancer: An Uncontrolled Cohort","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Retrospective cohort study; Blockade; Cancer; Visual analogue scale; Cancer pain; Multimodal therapy; Anesthesia; Internal medicine; Surgery","score_opus":0.023184458604149603,"score_gpt":0.3193258889044194,"score_spread":0.2961414303002698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403461604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98677176,0.006342406,0.00006221334,0.0042796307,0.0011133595,0.001225532,0.00013303295,0.000016329623,0.000055740296],"genre_scores_gemma":[0.99587995,0.00017958508,0.00011780781,0.0018635866,0.0014289715,0.00015327969,0.000033410037,0.00003140401,0.00031201774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984388,0.00017996899,0.00036434442,0.00017739699,0.00059794314,0.00024155401],"domain_scores_gemma":[0.9975478,0.0006269193,0.0002924859,0.000064971195,0.0013652395,0.00010255848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000329775,0.00017541583,0.0004664901,0.00012297687,0.000116415875,0.000022667571,0.00010430496,0.000071271104,0.00008004554],"category_scores_gemma":[0.00005136016,0.00009817444,0.00014998108,0.0004500545,0.000070122325,0.00008720012,0.000015206838,0.0003417282,3.3582953e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014561198,0.0012315656,0.7186147,0.00010983843,0.00490682,0.000064981476,0.00052670715,0.20101018,0.00026178945,0.00013301277,0.051004913,0.007574268],"study_design_scores_gemma":[0.027809914,0.004412937,0.9275929,0.0029278523,0.0021458147,0.000035561043,0.00004849496,0.012623529,0.00005281664,0.0006910987,0.021356005,0.0003031294],"about_ca_topic_score_codex":0.000041328185,"about_ca_topic_score_gemma":0.00047709857,"teacher_disagreement_score":0.20897813,"about_ca_system_score_codex":0.001042241,"about_ca_system_score_gemma":0.0010308446,"threshold_uncertainty_score":0.40034375},"labels":[],"label_agreement":null},{"id":"W4404401635","doi":"10.6004/jnccn.2024.7061","title":"Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Sunnybrook Health Science Centre; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Prostate cancer; Prostatectomy; Hazard ratio; Cohort; Internal medicine; Proportional hazards model; Prostate-specific antigen; East Asia; Biopsy; Prostate biopsy; Propensity score matching; Logistic regression; Cancer; Demography; Oncology; China; Confidence interval","score_opus":0.024680822971680474,"score_gpt":0.30589881450825684,"score_spread":0.2812179915365764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404401635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96158516,0.030109994,0.0000061971573,0.0067863157,0.0005325426,0.0007088778,0.00008437953,0.000004458731,0.00018207463],"genre_scores_gemma":[0.9967357,0.0024424195,0.000121733035,0.0001951034,0.0003905721,0.00005963476,0.0000061230708,0.00002005083,0.000028696853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984792,0.000055908175,0.00051744014,0.0001967191,0.00058696896,0.00016374784],"domain_scores_gemma":[0.99832726,0.00004534092,0.0006297517,0.0000810086,0.0008235703,0.00009305946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015782219,0.00017071865,0.00049565634,0.00014710952,0.000048968755,0.000020973965,0.000070587535,0.000048506157,0.000026039294],"category_scores_gemma":[0.000024966335,0.00011002283,0.000098180986,0.0003642893,0.00014604176,0.00010214768,0.00004459426,0.00023891403,2.0671881e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037816009,0.00043810648,0.9180995,0.0021040118,0.0014242554,0.00027304902,0.0033054631,0.01593678,0.007713317,0.00040698473,0.004049563,0.042467345],"study_design_scores_gemma":[0.0019658802,0.00045345564,0.9778993,0.014402981,0.00023790539,0.00020883129,0.00041249732,0.0009792957,0.0020179006,0.0006934979,0.00061037176,0.00011809268],"about_ca_topic_score_codex":0.000046867153,"about_ca_topic_score_gemma":0.000034887187,"teacher_disagreement_score":0.059799768,"about_ca_system_score_codex":0.00037919427,"about_ca_system_score_gemma":0.0004831029,"threshold_uncertainty_score":0.44866008},"labels":[],"label_agreement":null},{"id":"W4404759855","doi":"10.6004/jnccn.2024.7053","title":"Comparative Safety and Effectiveness of Bevacizumab Biosimilars to Originator for the Treatment of Metastatic Colorectal Cancer","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"","keywords":"Bevacizumab; Medicine; Biosimilar; Internal medicine; Hazard ratio; Propensity score matching; Oncology; Proportional hazards model; Colorectal cancer; Irinotecan; Retrospective cohort study; Cancer; Chemotherapy; Confidence interval","score_opus":0.057561800520168335,"score_gpt":0.3925016962626685,"score_spread":0.33493989574250016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404759855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86083394,0.1310922,0.00020265642,0.0038579335,0.0017024414,0.0017619298,0.0004643987,0.0000054497896,0.000079025755],"genre_scores_gemma":[0.99419963,0.004823926,0.00022831278,0.00018849033,0.0003588127,0.00014317053,0.0000018558751,0.000011088877,0.000044701163],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9989186,0.00009788486,0.0003562728,0.00013012206,0.0003696606,0.00012744045],"domain_scores_gemma":[0.99620247,0.0021464627,0.00023474426,0.000053801952,0.0013109519,0.00005156553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015709783,0.0001546684,0.0006304453,0.000068885885,0.0001286687,0.00001075425,0.00008088556,0.000023549263,0.000017734597],"category_scores_gemma":[0.00003220106,0.00007386728,0.00026310465,0.0003578323,0.00014650235,0.00003918916,0.000026002563,0.00008359789,1.4523427e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18439801,0.0025475065,0.051879473,0.0050926325,0.09708718,0.000060056493,0.023274098,0.45668918,0.034461647,0.01040118,0.060592197,0.073516846],"study_design_scores_gemma":[0.011878315,0.011822026,0.6858608,0.004863355,0.00649043,0.00015274293,0.0009028411,0.0063906643,0.03477182,0.0025839733,0.2339136,0.0003694008],"about_ca_topic_score_codex":0.000044465844,"about_ca_topic_score_gemma":0.000075779266,"teacher_disagreement_score":0.63398135,"about_ca_system_score_codex":0.00070592365,"about_ca_system_score_gemma":0.0004425096,"threshold_uncertainty_score":0.30122203},"labels":[],"label_agreement":null},{"id":"W4405847696","doi":"10.6004/jnccn.2024.7063","title":"Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement","year":2024,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sarcoma; Osteosarcoma; Biopsy; Tissue bank; Ewing's sarcoma; Oncology; Internal medicine; Surgery; Pathology","score_opus":0.036203384515802135,"score_gpt":0.32985686990325114,"score_spread":0.293653485387449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405847696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84159356,0.13216653,0.000052436215,0.023870789,0.0015177007,0.00048306887,0.000056845085,0.000027297516,0.0002317865],"genre_scores_gemma":[0.9870358,0.0009904081,0.004890739,0.005006132,0.0019753305,0.00003171801,0.000010625701,0.000028513057,0.00003070826],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9980017,0.00018596606,0.0006601452,0.0002222157,0.00065816747,0.00027178237],"domain_scores_gemma":[0.99793696,0.00076213334,0.00037978764,0.00011131307,0.00065702625,0.00015277186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030757638,0.00021736143,0.0004953479,0.0001482853,0.0002360423,0.0000751249,0.00011400029,0.0000632405,0.00009343317],"category_scores_gemma":[0.00003391736,0.0001447919,0.00026648512,0.00031505316,0.00015085089,0.000077131284,0.00012243073,0.00043605696,0.0000042113106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054415725,0.0027451494,0.29700062,0.0008866768,0.014908964,0.00813653,0.003161876,0.029473132,0.010714514,0.012824219,0.52461624,0.09009049],"study_design_scores_gemma":[0.01028593,0.0017248798,0.81304127,0.005400024,0.0018334755,0.034963477,0.0005827877,0.004730715,0.0005854249,0.0044915145,0.12180746,0.0005530625],"about_ca_topic_score_codex":0.000021367403,"about_ca_topic_score_gemma":0.000006576658,"teacher_disagreement_score":0.5160406,"about_ca_system_score_codex":0.0008460582,"about_ca_system_score_gemma":0.00033861393,"threshold_uncertainty_score":0.5904442},"labels":[],"label_agreement":null},{"id":"W4406143906","doi":"10.6004/jnccn.2024.7071","title":"Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Nursing Research","keywords":"Medicine; Placebo; Dexamethasone; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Cancer-related fatigue; Physical therapy; Cancer; Nursing","score_opus":0.0640043063864643,"score_gpt":0.381203838341808,"score_spread":0.31719953195534367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406143906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95391965,0.01923155,0.0007621498,0.013826234,0.005895363,0.0055976873,0.000039715727,0.00002251915,0.0007051043],"genre_scores_gemma":[0.99284816,0.00079915795,0.00016049312,0.0012034958,0.0031938257,0.000721871,0.0000029643882,0.000021111775,0.0010489423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980294,0.0003219691,0.0005342344,0.00022778382,0.00064572523,0.00024086595],"domain_scores_gemma":[0.9939469,0.0031729632,0.000776344,0.00012228038,0.0018771609,0.00010436586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006429948,0.00023619497,0.001314142,0.00013641753,0.00021892168,0.0000405287,0.00018172571,0.00013815655,0.000025052112],"category_scores_gemma":[0.00030901228,0.00015058559,0.0008087508,0.00044788813,0.00017855549,0.000111250265,0.00007570951,0.00056888006,2.2146088e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9728914,0.00019224544,0.000069777394,0.00011268388,0.0023409,0.0000018036081,0.0003161575,0.010349327,0.00015840278,0.00085533905,0.009781823,0.0029301618],"study_design_scores_gemma":[0.9756579,0.0004070407,0.0005402176,0.0007352195,0.0022128809,0.000024153589,0.00006538911,0.010657651,0.00027437363,0.0031421946,0.0061332393,0.00014976278],"about_ca_topic_score_codex":0.00010501132,"about_ca_topic_score_gemma":0.00007770091,"teacher_disagreement_score":0.03892846,"about_ca_system_score_codex":0.00042449386,"about_ca_system_score_gemma":0.0010794946,"threshold_uncertainty_score":0.6140702},"labels":[],"label_agreement":null},{"id":"W4407360625","doi":"10.6004/jnccn.2024.7083","title":"Association Between Nonfatal Self-Injury and Survival Following a Cancer Diagnosis: A Comparative Population-Based Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Suicide and Self-Harm Studies","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Women's College Hospital; Queen's University; Health Sciences Centre; University of Toronto; University of Calgary; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Hazard ratio; Cancer; Retrospective cohort study; Cohort; Cohort study; Proportional hazards model; Oncology; Internal medicine; Confidence interval","score_opus":0.049944626875707596,"score_gpt":0.3922401091567441,"score_spread":0.3422954822810365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407360625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859653,0.005720014,0.000025962814,0.002257737,0.0048389384,0.0006296977,0.00007289557,0.000020520481,0.0004689506],"genre_scores_gemma":[0.99656343,0.000096227515,0.00005567983,0.0013260783,0.0014790168,0.0002628608,0.000005116329,0.000011915905,0.0001996533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751884,0.00059072796,0.00060565874,0.00023362506,0.00080265204,0.00024849913],"domain_scores_gemma":[0.9957483,0.00210547,0.0007803595,0.00010113728,0.0012129251,0.000051838368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058203435,0.00020261868,0.00061541976,0.0001323732,0.00043566278,0.000052600146,0.00023974078,0.00009185703,0.0000809974],"category_scores_gemma":[0.00010311897,0.00015621967,0.00023267022,0.00057230407,0.000024152672,0.00010994283,0.00007942493,0.00041215395,0.000001963473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013829173,0.000113072914,0.95146585,0.0000074915793,0.0055970866,0.0000020900422,0.00071777496,0.004011821,0.0000020480798,0.00007332906,0.037765477,0.00010567316],"study_design_scores_gemma":[0.0015337561,0.00008283992,0.99293774,0.000082915336,0.0010297539,4.0014342e-7,0.00057974155,0.00012362938,0.0000052118125,0.00043739518,0.0030452013,0.00014140915],"about_ca_topic_score_codex":0.0005788839,"about_ca_topic_score_gemma":0.00036626082,"teacher_disagreement_score":0.041471902,"about_ca_system_score_codex":0.000818266,"about_ca_system_score_gemma":0.00022719732,"threshold_uncertainty_score":0.6370453},"labels":[],"label_agreement":null},{"id":"W4407743712","doi":"10.6004/jnccn.2024.7082","title":"Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving Chemoimmunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chemoimmunotherapy; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Anxiety; Depression (economics); Geriatric Depression Scale; Population; Clinical trial; Internal medicine; Physical therapy; Lymphoma; Rituximab; Psychiatry","score_opus":0.017783172372039358,"score_gpt":0.30242581169189714,"score_spread":0.2846426393198578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407743712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98160565,0.0119775385,0.000010313296,0.0046379073,0.00079037994,0.00044332954,0.0000046629957,0.0000072138932,0.000522985],"genre_scores_gemma":[0.9952325,0.0006739162,0.00032798885,0.003308416,0.00021616383,0.000043013177,0.000002548949,0.0000131660245,0.00018228378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834096,0.000064057596,0.0005652852,0.00017416671,0.00065078796,0.00020475668],"domain_scores_gemma":[0.99704397,0.00031896489,0.00096334063,0.00013789712,0.0014838369,0.000052022413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081663624,0.00018902677,0.0004814338,0.00014186482,0.0001106374,0.000023049288,0.0001322799,0.000063947264,0.00005931707],"category_scores_gemma":[0.00010087907,0.00010512016,0.00021014539,0.00052471895,0.00006743654,0.000084351195,0.00004334345,0.00019593345,7.468483e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002023272,0.00045796097,0.9749958,0.000032606276,0.0013146804,0.00013731312,0.0002924935,0.006135931,0.000031629676,0.00008203466,0.0070019695,0.0074943355],"study_design_scores_gemma":[0.009827224,0.00017495398,0.9826005,0.0042546676,0.00016780179,0.00025191263,0.00011008588,0.000107611995,0.00034218899,0.00021853742,0.0018464525,0.00009803229],"about_ca_topic_score_codex":0.000058365804,"about_ca_topic_score_gemma":0.00003899345,"teacher_disagreement_score":0.013626833,"about_ca_system_score_codex":0.0009687417,"about_ca_system_score_gemma":0.0006878023,"threshold_uncertainty_score":0.42866758},"labels":[],"label_agreement":null},{"id":"W4408929030","doi":"10.6004/jnccn.2024.7259","title":"HSR25-164: Mapping Patient Reported Side-Effect Incidence to Degradation of Health-Related Quality of Life Dimensions in Lymphoma and Chronic Lymphocytic Leukemia – A Study From the Lymphoma Coalition’s 2024 Global Patient Survey on Lymphomas &amp; CLL","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Lymphoma; Incidence (geometry); Quality of life (healthcare); Internal medicine; Leukemia; Health related quality of life; Oncology; Nursing","score_opus":0.08067527100508136,"score_gpt":0.3747189196011525,"score_spread":0.2940436485960711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843924,0.011477979,0.0000699627,0.00093435444,0.0010409635,0.001882146,0.00013452001,0.000010577143,0.000057101293],"genre_scores_gemma":[0.9975737,0.0002735615,0.000113664944,0.0017578552,0.00012678845,0.000057558165,0.00003355408,0.00001951713,0.0000438202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911977,0.0028741462,0.002906554,0.00045949925,0.0021401271,0.00042198825],"domain_scores_gemma":[0.98951656,0.004931859,0.0023350497,0.00052398647,0.0024849102,0.00020766558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025753437,0.00032998133,0.0012367198,0.0002496537,0.00025301173,0.00003074148,0.0003723639,0.00014788682,0.000022160864],"category_scores_gemma":[0.004396819,0.00022056587,0.00025094178,0.0021851838,0.00022916606,0.00009913316,0.00039306516,0.00025187878,0.0000018785358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.013441809,0.00091499375,0.4859235,0.0005089881,0.0031913472,0.000057638896,0.0026280791,0.44228077,0.0007877609,0.0004352323,0.029851448,0.019978447],"study_design_scores_gemma":[0.0168436,0.001030891,0.9715572,0.0033768595,0.00012410119,0.00007050263,0.00044456444,0.0052219564,0.00015970622,0.00062785915,0.00037221334,0.00017055636],"about_ca_topic_score_codex":0.03793087,"about_ca_topic_score_gemma":0.006005204,"teacher_disagreement_score":0.4856337,"about_ca_system_score_codex":0.08551331,"about_ca_system_score_gemma":0.041593708,"threshold_uncertainty_score":0.96847564},"labels":[],"label_agreement":null},{"id":"W4408929182","doi":"10.6004/jnccn.2024.7279","title":"HSR25-165: The Effectiveness of Implementing a Community-Based Lung Clinic in Rural Community Cancer Center","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Public Health and Nutrition","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority","funders":"","keywords":"Medicine; Center (category theory); Lung cancer; Cancer; Rural community; Community health center; Family medicine; Oncology; Intensive care medicine; Internal medicine; Demography","score_opus":0.06144985360058012,"score_gpt":0.4246007846720235,"score_spread":0.36315093107144336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847708,0.0033294791,0.00009661806,0.009466751,0.0009602719,0.00060821336,0.000050803108,0.000005409862,0.00071166985],"genre_scores_gemma":[0.9918123,0.00024103139,0.000056478417,0.0074117086,0.00038391195,0.00004296214,0.000015891792,0.000008651345,0.000027058384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946854,0.003815378,0.0007150022,0.000054824068,0.00046600704,0.00026338344],"domain_scores_gemma":[0.99368316,0.0036630575,0.00058994663,0.00018714232,0.0018174031,0.00005927143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003810436,0.000121439894,0.00042128848,0.00015455646,0.00048302056,0.000014592876,0.00038474012,0.00007160107,0.000042358457],"category_scores_gemma":[0.00038099167,0.000075799704,0.00022291874,0.00073910115,0.00013050452,0.00007998776,0.00013431699,0.0017165365,2.6392772e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052282675,0.0006735279,0.9392273,0.0020591023,0.0005262919,0.0000018331367,0.0003459764,0.009478389,0.0011003144,0.00036822914,0.03942718,0.0015636091],"study_design_scores_gemma":[0.0057536727,0.00013636916,0.9718379,0.005717946,0.000107814856,0.000010785861,0.00038012155,0.0012852922,0.00029957166,0.0018058562,0.012595158,0.000069539085],"about_ca_topic_score_codex":0.00080621697,"about_ca_topic_score_gemma":0.00035626147,"teacher_disagreement_score":0.032610595,"about_ca_system_score_codex":0.00071238173,"about_ca_system_score_gemma":0.0011062627,"threshold_uncertainty_score":0.74575925},"labels":[],"label_agreement":null},{"id":"W4408929714","doi":"10.6004/jnccn.2024.7262","title":"HSR25-180: Real-World (rw) Characteristics, Treatment (tx) Patterns and Clinical Outcomes in Patients (pts) With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Received Chemoradiotherapy (CRT)","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Chemoradiotherapy; Stage (stratigraphy); Oncology; Internal medicine; Lung cancer; Cancer","score_opus":0.046397441055767874,"score_gpt":0.39264714849384935,"score_spread":0.3462497074380815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408929714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478556,0.004032824,0.000016512984,0.008252477,0.0011271756,0.0010793624,0.00015248827,0.000013156823,0.0005404171],"genre_scores_gemma":[0.9489272,0.036808982,0.00024779252,0.0062120194,0.0015337812,0.00010535232,0.0000166055,0.000052496787,0.006095744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972727,0.00025600055,0.0009145628,0.00035093262,0.0008015858,0.00040427753],"domain_scores_gemma":[0.99610806,0.00081931613,0.0007718326,0.00022202403,0.0019136945,0.00016508452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027350037,0.000337568,0.0011149364,0.0002493766,0.00017714188,0.0000484862,0.0002545906,0.000095937234,0.00007121983],"category_scores_gemma":[0.0001223459,0.00020418894,0.00024951133,0.0005045024,0.00018496443,0.000090961934,0.000098229764,0.0006668114,4.884229e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025494338,0.00039081438,0.97960025,0.00016929932,0.0018063497,0.000018038472,0.00020952031,0.0009454455,0.000014716217,0.000019383608,0.011506689,0.00277005],"study_design_scores_gemma":[0.010019443,0.0005859272,0.9750351,0.0017258732,0.00034972254,0.0000022269726,0.000049270344,0.00060858886,0.000050669154,0.000020891486,0.011374884,0.00017746016],"about_ca_topic_score_codex":0.00058924255,"about_ca_topic_score_gemma":0.0019548929,"teacher_disagreement_score":0.03585836,"about_ca_system_score_codex":0.0025133153,"about_ca_system_score_gemma":0.0009933925,"threshold_uncertainty_score":0.83265835},"labels":[],"label_agreement":null},{"id":"W4408940018","doi":"10.6004/jnccn.2024.7105","title":"BIO25-022: Why Don’t They Want to Wear Sunscreen? Quantifying Anti-Sunscreen Messaging on TikTok","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; Université de Sherbrooke; McGill University","funders":"","keywords":"Medicine; Sun protection factor; Sunscreening Agents; Dermatology; Internal medicine; Skin cancer","score_opus":0.22941395461455974,"score_gpt":0.3637065073801082,"score_spread":0.13429255276554844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408940018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9108363,0.0024168703,0.0011862858,0.06160496,0.011419117,0.00082053227,0.000103434264,0.00008583692,0.011526704],"genre_scores_gemma":[0.9672139,0.0002923761,0.00009157687,0.03038512,0.0010387948,0.000007386622,4.4079476e-7,0.000017933904,0.00095244526],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973769,0.00040487427,0.0005550359,0.00032101938,0.0009951626,0.00034700753],"domain_scores_gemma":[0.99717134,0.0012326178,0.00046927237,0.00018605204,0.00084535405,0.00009537667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030975995,0.00024201283,0.00041355845,0.0002416417,0.00084145326,0.0000963059,0.0005468132,0.00006473905,0.000086875196],"category_scores_gemma":[0.0005050277,0.0001634363,0.00027991555,0.0007612914,0.00009153891,0.00018551775,0.00019736879,0.00057575235,0.000016852679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015130278,0.00016744592,0.022817535,0.00006154652,0.00047362252,0.000023982653,0.0007772641,0.57734025,0.10546189,0.023554247,0.2666352,0.0011740266],"study_design_scores_gemma":[0.0018529951,0.00030198472,0.1360864,0.0015194757,0.0001636397,0.000059913116,0.0009583847,0.00135465,0.025311992,0.0071553537,0.8246467,0.00058851024],"about_ca_topic_score_codex":0.000018606539,"about_ca_topic_score_gemma":0.000032172582,"teacher_disagreement_score":0.57598555,"about_ca_system_score_codex":0.00028293103,"about_ca_system_score_gemma":0.00019688345,"threshold_uncertainty_score":0.66647387},"labels":[],"label_agreement":null},{"id":"W4408942933","doi":"10.6004/jnccn.2024.7252","title":"TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Immunotherapy; Oncology; Endometrial cancer; Internal medicine; Randomized controlled trial; Carcinoma; Cancer","score_opus":0.049249119791007004,"score_gpt":0.3769303939944209,"score_spread":0.3276812742034139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408942933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96326363,0.03314748,0.00003458995,0.0003387201,0.0007090183,0.0023892515,0.000020775515,0.000004481476,0.000092025264],"genre_scores_gemma":[0.99555343,0.0032648044,0.00052840315,0.0001201723,0.00040746335,0.000058167818,0.00000601947,0.000017681421,0.000043850083],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971298,0.0005570313,0.0011554783,0.00021894964,0.00072315655,0.00021558236],"domain_scores_gemma":[0.9944662,0.002712475,0.0013571756,0.00016915219,0.001263237,0.00003179951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006213981,0.00026389732,0.0013961572,0.0002777766,0.000097214244,0.000012707036,0.00016565452,0.000058568272,0.000023789638],"category_scores_gemma":[0.00023064938,0.00016107057,0.00034377925,0.0011080324,0.00024211488,0.00008426765,0.000029612733,0.00021354533,5.5822312e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8684163,0.0013660901,0.053087894,0.00008474557,0.0044960417,0.00000473065,0.0010612151,0.025324522,0.005835702,0.00001925387,0.00014048713,0.04016301],"study_design_scores_gemma":[0.55714536,0.0070134304,0.43006206,0.0016047925,0.0008779678,0.000010814238,0.0002626503,0.0010018983,0.0010140479,0.000013895059,0.00084659253,0.00014648766],"about_ca_topic_score_codex":0.00015858928,"about_ca_topic_score_gemma":0.000043375854,"teacher_disagreement_score":0.37697417,"about_ca_system_score_codex":0.0006106244,"about_ca_system_score_gemma":0.0006260665,"threshold_uncertainty_score":0.6568267},"labels":[],"label_agreement":null},{"id":"W4411211637","doi":"10.6004/jnccn.2025.7020","title":"Telehealth Geriatric Assessment and Supportive Care Intervention (GAIN-S) Program: A Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Frailty in Older Adults","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Telehealth; Randomized controlled trial; Intervention (counseling); Clinical trial; Physical therapy; MEDLINE; Telemedicine; Nursing; Health care; Internal medicine","score_opus":0.0582286536802449,"score_gpt":0.46480747684059,"score_spread":0.4065788231603451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411211637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86753476,0.04621399,0.0036297669,0.04339877,0.023120722,0.011930756,0.000048397203,0.000075530595,0.0040472946],"genre_scores_gemma":[0.98802614,0.001482544,0.0031173602,0.0031980332,0.0035039932,0.00012857141,0.000010740039,0.0000148035015,0.0005178114],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99656934,0.00096797355,0.001369826,0.00019641114,0.00069779804,0.00019867605],"domain_scores_gemma":[0.99407816,0.0015958028,0.001187524,0.00011471366,0.0029110424,0.00011274828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013895358,0.0001578087,0.0008750926,0.00013547359,0.00013055057,0.000038840764,0.000162881,0.0001140635,0.00003961151],"category_scores_gemma":[0.0008508007,0.00010053453,0.0006801631,0.00041414215,0.0002076831,0.00007561313,0.00010398051,0.0007055451,5.702954e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.628232,0.0009384486,0.012887292,0.0006301683,0.0031985887,0.000022976861,0.00043031192,0.002958296,0.0000138364285,0.0018270402,0.1423289,0.20653212],"study_design_scores_gemma":[0.8242077,0.001762042,0.12893099,0.0020666637,0.001280534,0.00009111644,0.0004018991,0.0028217635,0.000011403065,0.0034185622,0.034836046,0.00017125494],"about_ca_topic_score_codex":0.00001649076,"about_ca_topic_score_gemma":0.000013580638,"teacher_disagreement_score":0.20636088,"about_ca_system_score_codex":0.0006013833,"about_ca_system_score_gemma":0.0013511624,"threshold_uncertainty_score":0.40996793},"labels":[],"label_agreement":null},{"id":"W4411715496","doi":"10.6004/jnccn.2025.7029","title":"Association of Polypharmacy and Potentially Inappropriate Medications With Outcomes in Older Adults With DLBCL: A Population Study","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Polypharmacy; Hazard ratio; Internal medicine; Population; Comorbidity; Proportional hazards model; Emergency medicine; Confidence interval; Environmental health","score_opus":0.015517056097077942,"score_gpt":0.3569374022833494,"score_spread":0.3414203461862715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411715496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838338,0.0018276288,0.000058395974,0.013047944,0.00020582636,0.0008946248,0.000007588093,0.0000046451764,0.00011955442],"genre_scores_gemma":[0.998434,0.00024194943,0.00027670615,0.00057866867,0.00016324519,0.000035423473,0.0000018981392,0.000008026604,0.00026008414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812394,0.00014102494,0.00040978892,0.000121512574,0.0010635476,0.00014020609],"domain_scores_gemma":[0.9968339,0.00028704517,0.0006025898,0.00007659255,0.0021580039,0.000041852603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032111406,0.0001061749,0.00037311204,0.00018969888,0.00009544894,0.000012256706,0.00010994575,0.00003232566,0.0000087482085],"category_scores_gemma":[0.00017015614,0.000059116734,0.00005158527,0.0006325205,0.000056584548,0.000099333694,0.00004989407,0.00031564277,8.694603e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015481138,0.00029338812,0.98990804,0.00008361696,0.0013986167,0.0000034848665,0.00057075644,0.0038245455,0.000030600655,0.00005140887,0.001604165,0.00068324636],"study_design_scores_gemma":[0.008159339,0.00023680578,0.9890726,0.0011134545,0.00035350185,0.000008642943,0.00044933427,0.00021161084,0.0000200734,0.00015712669,0.00016530625,0.00005220029],"about_ca_topic_score_codex":0.00022129896,"about_ca_topic_score_gemma":0.00047764572,"teacher_disagreement_score":0.014600206,"about_ca_system_score_codex":0.0005619124,"about_ca_system_score_gemma":0.00046584048,"threshold_uncertainty_score":0.24107105},"labels":[],"label_agreement":null},{"id":"W4412751557","doi":"10.6004/jnccn.2025.7033","title":"Olanzapine for Anorexia in Patients With Incurable Cancer and Cachexia (OlAnCa): A Double-Blind, Placebo-Controlled, Randomized Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anorexia; Olanzapine; Cachexia; Placebo; Internal medicine; Nausea; Randomized controlled trial; Gastroenterology; Cancer; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.09292550295862327,"score_gpt":0.4331965260629955,"score_spread":0.34027102310437224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412751557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95260644,0.012842893,0.00027881734,0.022068761,0.003859439,0.007829841,0.00002806373,0.000011277296,0.00047449305],"genre_scores_gemma":[0.9752064,0.0019230653,0.0016444357,0.015581308,0.0039267167,0.0007284817,0.000014183114,0.000026952579,0.00094848097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976813,0.0002727347,0.0011571368,0.00017653691,0.0004813513,0.00023092303],"domain_scores_gemma":[0.9952707,0.0016802005,0.0008286985,0.00008106658,0.002032808,0.000106511296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014554292,0.00015916397,0.0012177788,0.00018304726,0.0001537357,0.000026778402,0.00011890855,0.000109778935,0.000028377239],"category_scores_gemma":[0.00037291454,0.00009269354,0.00027331585,0.0003475853,0.00013521411,0.000079109275,0.000035241927,0.0005533881,2.1520418e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.941935,0.0001870274,0.03534536,0.00011304133,0.0005457586,9.1533343e-7,0.000035249075,0.0018574784,0.0000012532089,0.00055881456,0.018914374,0.00050570176],"study_design_scores_gemma":[0.9617268,0.00033245183,0.021776857,0.001353999,0.00037256494,0.000004059293,0.000015904445,0.0016166412,0.0000024259903,0.0017284006,0.010981649,0.000088275556],"about_ca_topic_score_codex":0.000027238855,"about_ca_topic_score_gemma":0.000058080277,"teacher_disagreement_score":0.022599963,"about_ca_system_score_codex":0.00030597264,"about_ca_system_score_gemma":0.0009556719,"threshold_uncertainty_score":0.3779933},"labels":[],"label_agreement":null},{"id":"W4414195398","doi":"10.6004/jnccn.2025.7055","title":"Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Advanced Research","funders":"U.S. Department of Veterans Affairs","keywords":"Prostate cancer; Cohort; Cohort study; Association (psychology); Heterozygote advantage; MEDLINE","score_opus":0.015265263297621437,"score_gpt":0.3025436563592291,"score_spread":0.28727839306160763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91263974,0.034313552,0.00004693718,0.042148482,0.002215623,0.0014132396,0.00013194382,0.00001829397,0.0070722066],"genre_scores_gemma":[0.9891056,0.0044342033,0.00021203075,0.0023958073,0.000734149,0.00006370753,0.0000049036116,0.000016086282,0.003033537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827343,0.000082200546,0.0004794727,0.0001388664,0.00082094216,0.00020508212],"domain_scores_gemma":[0.9952491,0.0002664939,0.0010553518,0.000100890786,0.0032608542,0.00006731925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018843153,0.00015286896,0.0004393423,0.000094489005,0.000100075515,0.000018848092,0.00013708282,0.000066165885,0.0000843589],"category_scores_gemma":[0.000063950225,0.000091568785,0.0001845813,0.0005382433,0.00007726339,0.00010849297,0.0000462642,0.000290925,6.6636625e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012444613,0.00013230258,0.7467542,0.00009714373,0.0024626635,0.000005965608,0.00021495817,0.04988971,0.00028597965,0.0001820583,0.19694974,0.0017807839],"study_design_scores_gemma":[0.0036928053,0.00026337005,0.9486095,0.0023967484,0.0007753306,0.000008464213,0.0000741004,0.00034303206,0.0021069671,0.0008056883,0.04082147,0.0001025271],"about_ca_topic_score_codex":0.000093842165,"about_ca_topic_score_gemma":0.00008701225,"teacher_disagreement_score":0.20185526,"about_ca_system_score_codex":0.0015442519,"about_ca_system_score_gemma":0.0009711194,"threshold_uncertainty_score":0.40381652},"labels":[],"label_agreement":null},{"id":"W4414195497","doi":"10.6004/jnccn.2025.7056","title":"Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma","year":2025,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Perioperative; Context (archaeology); Sarcoma; Liposarcoma; Overall survival; Guideline; Soft tissue sarcoma","score_opus":0.031580722843369845,"score_gpt":0.3419503267951725,"score_spread":0.3103696039518027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91349345,0.08043351,0.000017264694,0.0048389942,0.0006023173,0.00027709964,0.000022597244,0.0000025871368,0.00031216576],"genre_scores_gemma":[0.99151653,0.005889656,0.0009286696,0.0007378065,0.0006037767,0.000027706212,0.0000015538855,0.000009705324,0.0002846136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882144,0.00014908983,0.00038353985,0.00011816067,0.00040129907,0.0001264664],"domain_scores_gemma":[0.99852514,0.00037131258,0.00021172305,0.00008430168,0.00074600824,0.00006149797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007502615,0.00014495903,0.000512762,0.000073233794,0.00007826721,0.00001492903,0.00006343136,0.000040926345,0.00009446207],"category_scores_gemma":[0.000017438706,0.000079881356,0.00023829743,0.00022667763,0.0001405232,0.000040768897,0.00002254731,0.00010740582,3.1376544e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008345192,0.0016881651,0.94468236,0.00011468934,0.0059645385,0.00029395887,0.0010281543,0.0060380995,0.0011707831,0.0023028918,0.004685201,0.023685986],"study_design_scores_gemma":[0.008471097,0.0009526886,0.91351587,0.000532245,0.00048223353,0.00028896242,0.0001213908,0.0005110309,0.00062044384,0.0002312839,0.07416887,0.00010390254],"about_ca_topic_score_codex":0.000020620239,"about_ca_topic_score_gemma":0.000010464942,"teacher_disagreement_score":0.078023046,"about_ca_system_score_codex":0.00046127875,"about_ca_system_score_gemma":0.00028083392,"threshold_uncertainty_score":0.32574672},"labels":[],"label_agreement":null}]}